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6ABBREVATIONS
Ab - Antibody
Ag - Antigen
α-GalCer - α-Galactosylceramide
  (2S, 3S, 4R)-1-O-(α-D-galactopyranosyl)-N-hexacosanoyl-2-amino-
  1,3,4-octadecanetriol)
APC - Antigen Presenting Cell
Bio - Biotin
BSA - Bovine Serum Albumin
BSS - Balanced Salt Solution
cDNA - Complementary DNA
CDR - Complementary Determining Region
CIAP - Calf Intestine Alkaline Phospatase
ConA - Concanavalin A
DEPC - Diethylpyrocarbonate
DMSO - Dimethyl sulfoxide
DNA - Deoxyribonucleic acid
dNTP - 100 mM solution of each dATP, dCTP, dGTP, dTTP
DP - Double Positive
EDTA - Ethylendiamintetracetic acid
FACS - Fluorescence activated cell scan
F344 - Fischer rat
FCS - Fetal Calf Serum
FITC - Fluoresceinisothiocyanate
FL - Fluorescence
FSC - Forward scatter
G418 - Geneticin
h - Hour
IFN - Interferon
Ig - Immunglobulin
IL - Interleukin
J - Joining segment of the T cell receptor variable domain
7kDa - Kilo Dalton
LEW - Lewis rat
LN - Lymph Node
M - Molar
mAb - Monoclonal Antibody
MHC - Major Histocompatibility Complex
min - Minutes
mRNA - Messenger RNA
NK - Natural Killer cell
NKT - Natural Killer T cell
NMIg - Normal mouse immunglobulin
OCH - Analog of α-Galactosylceramide
ON - Overnight incubation
PBS - Phosphate Buffered Saline
PCR - Polymerase chain reaction
PE - Phycoerythrin
RNAase - Ribonuclease A
RT - Room Temperature
S - Streptavidin
sec - Seconds
SP - Single Positive
SSC - Side Scatter
TCR - T-cell Receptor
TRIS - N, N, N', N'-Tetramethylethylenediamine
V - Variable segment of the T cell receptor variable domain
Zeo - Zeozin
8Chapter 1:
INTRODUCTION
1. MHC-restricted and MHC-unrestricted T lymphocytes
The immune sytem protects an individual organism against microorganisms, viruses
and parasites. There are two types of immune responses: the innate and adaptive
response. The innate system- “the first line of defence”, mediated by cells including
B-1 B, NK, NKT and γ/δT lymphocytes, immediately recognises and counters
infection.
NK cells represent a major subpopulation of innate cells. They are preferentially
expressed in the spleen and liver, but can be also found in the peripheral blood,
thymus, BM and lymph nodes (Kiessling et al., 1975). Activated NK cells possess
anti-tumor activity (Brittenden et al., 1996) and lyse cells with low expression level
of syngeneic MHC or cells expressing allogeneic MHC class I molecules (Ljunggren
et al., 1990). NK cells produce large amounts of IFN-γ and play an important role in
autoimmunity and in the defence to viral (Biron et al., 1999), bacterial and parasite
infections (Moretta et al., 1994; Grunebaum et al., 1989).
The second type of immunity- the adaptive immune system, which is regulated by B
and T lymphocytes, recognises antigen and triggers the reaction to eliminate a source
of Ag. B cells, through BCR, recognise Ag, proliferate and become plasma cells
capable of producing and secreting Ag-specific antibodies.
T cells develop in thymus and migrate to peripheral lymphoid organs, where they
mediate cellular immune responses. The majority of T lymphocytes express MHC-
restricted αβTCR, which specifically recognises peptide Ags in an association with
molecules encoded by class I or class II genes of the MHC (major histocompability
complex).
Products of MHC class I genes (MHC class I), expressed on lymphocytes and most
nucleated cells, present endogenous peptides to MHC class I restricted CD8+ α/βT
cells. By contrast, MHC class II is expressed in the thymus on epithelial cells as well
as on APCs: B lymphocytes, macrophages and DC. MHC class II is able to present
exogenous peptides, which arise from degradation of endocytosed Ags, to MHC II
9restricted CD4+ α/βT cells (Bevan et al., 1975; Carbone et al., 1990; Monaco et al.,
1995).
Since, CD8+ T and CD4+ T lymphocytes recognise different Ag, they differentially
contribute to immune system. The majority of T lymphocytes are MHC class II-
restricted CD4+ helper cells, which activate cytotoxic T cells and regulate the
functions of B cells. Whereas, CD8+ T lymphocytes are cytotoxic and lyse host cells
presenting “foreign” peptides on MHC class I molecules.
Almost all peripheral T helper and T cytotoxic cells express α/βTCR. Apart from
classical T cells, some populations of unconventional T cells like T lymphocytes
expressing γ/δTCR or CD1d-restricted NKT cells have been also described
(Bendelac et al., 2001). These unconventional T cells together with the B-1 subset of
B lymphocytes belong to the group of innate cells, that are actively involved in
innate responses and posses the ability to stimulate the cells of adaptive immunity
(Benlagha and Bedelac 2000-a).
Apart from their specificity, innate T lymphocytes differ from conventional T cells.
Firstly, they are autoreactive and express NK cell inhibitory receptors, which control
their autoreactivity and that are absent on conventional T cells (Bendelac et al.,
2001). Secondly, innate lymphocytes possess germline-encoded seminvariant
antigen receptor and have natural activated/memory or effector phenotype.
Furthermore, unlike classical T cells, most cells of innate immunity have tissue
specific distribution and are expressed at very low frequencies. Upon Ag stimulation
they rapidly release cytokines and often possess cytolytic activity (Benlagha and
Bendelac 2000-a; Bendelac et al., 2001).
Therefore, it can be concluded that innate autoreactive γ/δT and CD1d-restricted T
cells share phenotypic and functional features with NK and classical T cells. Table 1
and Table 2, presenting the classification and functional characterisation of innate T
cells may be useful for understanding the correlation of these cells with conventional
T lymphocytes.
Since unconventional T lymphocytes play important functions in the triggering of
innate and adaptive responses, we took attempts to identify and characterise the
population of rat NKT cells. Features and functions of human and mouse Vα14+ T
cells are described in the first part of the introduction. The second part of this chapter
presents characteristics of the MHC class I like molecule CD1d.
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Properties of NKT cells
2. Phenotype, frequency and tissue distribution of NKT cells
Human and mouse natural killer T cells (NKT) constitute a population of
lymphocytes that posses an invariant T cell receptor, expressed together with NK
cell markers such as NK1.1 or NKRP1Aint, IL2Rβint, CD69int, DX5, Ly49A and
Ly49C (Bix et al., 1995; Exley et al., 1998).
The majority of mouse NKT cells have Vα14Jα18 TCR α-chain, preferentially
paired either with Vβ8 (mainly Vβ8.2), Vβ7 or Vβ2 (Koseki et al., 1991; Arase et
al., 1992; Lantz and Bendelac 1994; Makino et al., 1995; Bendelac et al., 1997).
Human CD1d-restricted NKRP1A+ NKT cells are characterised by the presence of
an invariant Vα24JαQ TCR, which predominantly pairs with Vβ11 TCR (Porcelli et
al., 1993; Dellabona et al., 1994; Lantz and Bendelac 1994; Exley et al., 1997).
In terms of coreceptor expression, mouse NKT cells consist of CD4+ (60%) and DN
cells (40%), with an activated T cell phenotype: CD62Llow, CD5high CD44high
CD45Rbhigh CD69+ (Hayakawa et al., 1992; Bendelac et al., 1994; MacDonald et al.,
1995).
The phenotype of human NKT cells may vary depending on the tissue distribution. It
has been shown that CD1d-restricted Vα24+JαQ TCR with no N region nucleotides
is expressed by DN or CD4+ human PBMC, but it is absent on CD8+ cells
(Dellabona et al., 1994; Davodeau et al., 1997; Porcelli et al., 1993; Lee et al.,
2002). In the contrast to human blood NKT cells, the majority of hepatic Vα24Vβ11
NKT cells have been reported to be CD8+ or DN (Kenna et al., 2003). However, it is
not clear wether these cells are CD8αα+ or CD8αβ+ cells.
NKT cells have a tissue specific distribution. In mice, they represent 20% of α/β T
cells in bone marrow, 2-5% of splenic, 0.3-0.5% of thymic and around 30% of
hepatic T lymphocytes. NKT cells are rarer (0.1%-0.5%) in peripherial lymph nodes
(Godfrey et al., 2000; Bendelac et al., 1997; Matsuda et al., 2000; MacDonald 2000;
Bendelac et al., 1994).
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Human Vα24JαQVβ11+ cells are not as frequent as mouse Vα14Jα18+ cells,
however they can be detected among human PBLs (0.02%) or intrahepatic
lymphocytes (0.5% of CD3+ cells) by staining with mAbs or CD1d-tetramers (Kenna
et al., 2003; Exley et al., 2002).
3. Development of Vα14+ T cells
The classical NKT cells originate in the thymus, while the extrathymic origin has
been proposed for other NKT-like cells (Benlagha et al., 2002; Eberl et al., 1999-b;
Bendelac et al., 1995-a; Tilloy et al., 1999; Pellicci et al., 2002). Additionally, NKT
cells may develop in the fetal liver or thymic organ cultures (Shimamura et al.,
1997; Makino et al., 1994).
Thymic development
The canonical NKT cells originate in the thymus, where they undergo positive and
negative selection. The positive selection of Vα14+ cells, which requires β2m and
the presence of CD1d+ cortical thymocytes, results in CD4+ or CD4-CD8- NKT cells
(Gapin et al., 2001; Coles et al., 2000; Bendelac et al., 1995-a). CD8- a putative co-
receptor for CD1d, contributes to the increased avidity of immature NKT cells for
CD1d, and leads to negative selection of Vα14+ autoreactive T cells (Bendelac et al.,
1994; Bendelac et.al., 1997). However, the binding of CD8 to CD1d as well as
negative selection of Vα14+ cells have been tested only indirectly in CD8αβ
transgenic mice, and have not been formally proven so far (Lantz and Bendelac
1994).
There are two models explaining the mechanisms of NKT cells development in
thymus:
1. Mainstream model
The mainstream model, which seems to be more probable, suggests that NKT cells
arise as by-product of conventional T cell development. The CD4+CD8+ precursors
expressing invariant TCR (with randomly rearranged TCR-α genes) are able to
interact with CD1d before lineage commitment, and can down regulate both CD4
13
and CD8, emerging as either CD4+ or CD4-CD8- (but not CD8+) mature NKT cells
(Pellicci et al., 2002; Bendelac et al., 1995-a; Lantz and Bendelac 1994).
After positive selection, immature DP Vα14+ T cells are CD44low and do not express
NK receptors (Gapin et al., 2001). During further development they first become
CD44high NK-receptor-negative and then they acquire the NK markers characteristic
of the mature Vα14+T cell population (Benlagha et al., 2002).
2. The pre-commitment model
According to this model, NKT cells differentiate along an independent intrathymic
NKT cell lineage, in which the NKT precursor cell would be rescued from cell death
upon expression of invariant TCR and recognition of CD1d (Bendelac et al., 1997).
Peripheral selection of Vα14+ T cells
Mouse NKT cells are absent at birth, but gradually accumulate in the thymus, spleen
and liver, reaching a plateau by 6-8 weeks of life (Bendelac et al., 1994; Ohteki et
al., 1994).
Once NKT cells reach these organs, they might migrate to other organs or to the
sites of inflammation. The circulation of Vα14+ T cells is regulated by chemokines
(MIP-2- macrophage inflammatory protein 2; MCP1- monocyte chemotactic
protein) or by the presence of adherence molecules (LFA1- lymphocyte function-
associated antigen) (Ohteki et al., 1999; Miaymoto et al., 2000).
Factors influencing the development of NKT cells
The presence of selection molecules as well as different cytokine and chemokines is
necessary for development and function of NKT cells.
Mice deficient in genes encoding lymphotoxin (LT) (Elewaut et al., 2000), IL-2
receptor β (IL-2Rβ) (Ohteki et al., 1997), interferon (IFN)-regulatory factor 1 (IRF-
1) (Ohteki et al., 1998) and fyn (Eberl et al., 1999-a) lack NKT cells, suggesting that
these molecules are required for the generation of these cells.
The frequency and functions of NKT cells can be also regulated by cytokines. IL-18
might stimulate the cytotoxic activity of Vα14+ T cells (Dao et al., 1998), while IL-7
and IL-15 influence their frequency (Vicari et al., 1994; Matsuda et al., 2002; Ohteki
et al., 1997). Additionally, the survival of CD1d-restricted cells in the periphery can
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be affected by other IL-15-responsive populations, such as NK cells or CD8+
memory cells, which compete for IL-15 (Matsuda et al., 2002).
4. Heterogeneity of NKT cells
Most of human and mouse TCRinv positive NKT cells recognise the α-GalCer
antigen, derived from a marine sponge, presented by CD1d. However, on the basis
of differences in the phenotype, α-GalCer reactivity and CD1d restriction a few
subpopulations of NKT cells can be distinguished.
1. Canonical NKT cells
NK1.1+CD1d-tetramer+ T cells expressing invariant TCR with CD4+ or CD4-CD8-
phenotype. CD1d-dependent CD4+, DN NKT cells have phenotype of activated T
cells (CD62L-, CD69+) and express low levels of Ly49A and DX5 (Eberl et al.,
1999-c).They are mainly found in thymus and liver of normal mice but are absent in
CD1d or Jα281 deficient mice (Chen et al., 1997-a; Matsuda et al., 2000; Hong et
al., 1999; Eberl et al., 1999-c; Hammond et al., 1999).
2. NK1.1+, CD1d-α-GalCer tetramer- T cells
Abundant in spleen or BM, CD1d-independent NK1.1+ tetramer- T cells are CD8+ or
DN, express NK markers (Ly49A, DX5) and have a phenotype corresponding to
naive T cells (CD62L+, CD69-) (Eberl et al., 1999-c). In contrast to classical CD1d-
restricted NKT cells, such cells do not express TCR α-invariant, have different
antigenic specificity and recognise self-antigens presented by CD1d, but do not
respond to α-GalCer (Benlagha et al., 2000-b).
3. The subset of NK1.1- but tetramer+ cells
Despite the absence of NK1.1 expression, these cells are CD1d-dependent, express
invariant TCR and bind CD1d-α-GalCer tetramer. The lack of NK1.1 marker might
be caused by the loss of NK1.1 expression (Chen et al., 1997-a) or can be dictated
by the level of NKT cell maturation (Matsuda et al., 2000).
Similarly to canonical NKT cells, CD1d-restricted but NK1.1- T cells are CD4+ or
DN and are preferentially present in LN, in the small intestine and in gut epithelium
(Hammond et al., 2001; Benlagha et al., 2000-b; Sykes et al., 1990).
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5. Antigen recognition by NKT cells
Site-directed mutagenesis of CDR3 residues of TCR, experiments with gene transfer
as well as generation of Vα14Jα18 transgenic mice showed that the TCR of
Vα14+ Τ cells is responsible for recognition of lipid and glycolipid antigens (Grant
et al., 1999).
The specificity of the Ag recognition by NKT cell depends on type of carbohydrate
rather than on the length of the lipid moieties. Vα14+ TCR is able to discriminate a
glucose from galactose, or an alpha from a beta anomeric form of galactose (Burdin
et al., 1998).
The α-anomeric form of the sugar in α-GalCer or α-GlcCer (glucosylceramide) is
essential for contacting the invariant TCR of NKT cells. The β-GalCer and
gangliosides can bind to CD1d but they are not antigenic because of their sugar β-
linkage and failure to properly contact the TCR invariant (Kawano et al., 1997;
Nieda et al., 1999; Sidobre et al., 2002; Naidenko et al., 1999). It is possible that
self-antigens in β forms may be stress antigens, while exogenous α forms are not.
Self- or foreign-antigens can be recognised by CD1a, CD1b, and CD1c restricted T
cells with various αβTCRs. By contrast, NKT cells, expressing invariant TCR
recognise α-GalCer, self GPI-antigens (phosphatidylinositol or
phosphatidylglycerol) and some unidentified lipid-antigens (Chiu et al., 1999) in a
CD1d-restricted manner.
6. Functions of NKT cells
NKT cells recognise glycolipid Ags presented by CD1d molecules (Bendelac et al.,
1995-b) in a similar manner as peptides are recognised by cytotoxic T lymphocytes
(CTL). The engagement of Vα14+ TCR with specific Ag induces a series of cellular
activation events, which result in: cytokine release (Burdin et al., 1999-a), the
induction of co-stimulatory molecules (like B7.2, CD80, CD86) and the activation of
other cell types of innate and adaptive immunity (Hermans et al., 2003; Kitamura et
al., 1999; Carnaud et al., 1999).
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Activated NKT cells secrete Th1 (TNFβ, IFN-γ), and Th2 (IL-4, IL-10) cytokines,
which might influence Th1-Th2 polarisation (Hayakawa et al., 1992; Burdin et al.,
1999-a; Bendelac et al., 1992; Joyce et al., 2001; Singh et al., 1999) and provide
help for conventional T (Hermans et al., 2003; Stober et al., 2003; Nishimura et al.,
2000) or B cells (Gali et al., 2003; Kitamura et al., 2000; Hansen et al., 2003), as
well as NK cells (Carnaud et al., 1999; Metelista et al., 2001; Eberl et al., 2000), DC
cells (Gillessen et al., 2003; Fujii et al., 2003-b) and macrophages (Nakagawa et al.,
2000).
NKT cells influence other cells by producing cytokines or directly through surface
receptor interaction (Nishimura et al., 2000). They may also induce the maturation
of other cells for example DC (Fuji et al., 2003-a; Vincent et al., 2002; Shreedhar et
al., 1999).
Additionally, the activated NKT cells, like CTLs and NK cells are able to kill target
cells by Fas and perforin-dependent mechanism (Nicol et al., 2000; Kawano et al.,
1998; Kaneko et al., 2000).
The stimulation of CD1-restricted T cells may occur in lymphoid tissues as well as
at the peripheral sites of inflammation. Because NKT cells express lymphoid tissue-
homing chemokine receptors (CCR7, CXCR5) and homing receptors for inflamed
tissue (CCR2, CCR5, CXCR3) (Kim et al., 2002-b; Thomas et al., 2003), they might
migrate to sites of infection, where they directly or indirectly regulate immune
responses (Gumperz et al., 2002).
Therefore, NKT cells display regulatory functions at the onset of immune responses,
long before classical B or T lymphocytes have been recruited. They influence the
innate and the adaptive immune system and contribute to anti-tumor, and anti-
microbial immunity, as well as autoimmunity (MacDonald et al., 1995; Brutkiewicz
et al., 2002; Gumperz et al., 2002; Schaible et al., 2000-b).
6.1. CD1-restricted cells in anti-microbial and anti-parasite immunity
CD1-restricted T cells improve host control of various bacterial (Mycobacterium
tuberculosis (Behar et al., 1999-a; Moody et al., 2000; Schaible et al., 2000-b),
Mycobacterium bovis (Emoto et al., 1999; Dieli et al., 2003), Borrelia burgdorferi
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(Kumar et al., 2000), Pseudomonas aeruginosa, Listeria (Emoto et al., 1995-b),
Yersinia pseudotuberculosis (Guinet et al., 2002)) and protozoan infections
(Plasmodium yoelii, Toxoplasma gondii, Trypanosoma cruzi, Plasmodium berghei
(Denkers et al., 1996; Hansen et al., 2003; Miyahira et al., 2003)).
Th1-biased human CD1a, b, and CD1c restricted T cells secrete IFN-γ and cytotoxic
granules containing granulysin able to lyse immature DCs infected with
Mycobacterium tuberculosis, Mycobacterium bovis or to directly kill the released
mycobacteria (Sugita et al., 2000-b; Emoto et al., 1999; Schaible et al., 2000-a).
In contrast, activation of CD1d-dependent NKT cells does not depend on foreign
Ag. These cells usually migrate to sites of inflammation, where they influence the
functions of macrophages, DCs, B cells and NK cells (Gillessen et al., 2003;
Carnaud et al., 1999; Galli et al., 2003).
Such helper function of NKT cells has been demonstrated in several infection
models. During Toxoplasma gondii infection, CD4+ NKT cells secrete IL-2 and
provide help to CD8 cells, allowing them to clonally expand and respond to this
parasite (Denkers et al., 1996). However, by interfering with γδT cells, that have a
protective role in T.gondii infections, NKT cells may suppress protective immunity
against this parasite (Nakano et al., 2001)
In experimental infection models of Pseudomonas aeruginosa or Cryptococcus
neoformans, CD1d restricted T cells secrete IFN-γ,  induce Th1 response and
activate macrophages, which are important for resistance to these pathogens
(Kawakami et al., 1994; Kawakami et al., 2001).
Furthermore, NKT cells, via IL-4 secretion, might promote B cell proliferation
(Kitamura et al., 2000) and enhance anti-parasite specific antibody (against GPI-
anchored surface proteins from parasites such as Plasmodium, Trypanosoma and
Leischmania) production (Schofield et al., 1999; Gali et al., 2003; Hansen et al.,
2003).
6.2. Antiviral functions of CD1-restricted T cells
NKT cells play an important role during viral infections of the liver. In mice,
infection with hepatitis B virus directly or indirectly provokes activation of NKT
cells and inhibition of virus replication (Kakimi et al., 2000).
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Furthermore, α-GalCer-activated NKT cells are known to protect wild type mice
against the diabetogenic cytopathic virus, respiratory syncytial virus, genital Herpes
Simplex Virus type 2 (HSV-2) or encephalomyocarditis virus (EMCV-D) (Exley et
al., 2001; Exley et al., 2003; Ashkar et al., 2003).
In the human system, NKT cells may play a role during HIV-1 infection, since the
number of these cells was decreased in tested HIV-1 infected individuals (van der
Vliet et al., 2002; Motsinger et al., 2002).
6.3. CD1-restricted T cells and cancer
NKT cells are usually required for rejection of tumors. To protect the host from
certain tumors, NKT cells either directly recognise changes to self-glycolipid
antigens presented on CD1+ tumors, or produce cytokines and chemokines which
activate anti-tumor cells, such as DC (Gillessen et al., 2003), NK cells (Hayakawa et
al., 2002; Metelitsa et al., 2001) and CTLs (Baxevanis et al., 2003; Nishimura et al.,
2000). However, in some cases NKT cells may have opposite effect and may
mediate the inhibition of anti-tumor immune responses via an IL-13- and IL-4R-
STAT6-dependent suppression of CTLs (Terabe et al., 2000).
6.4. CD1-restricted cells and autoimmunity
Vα14+ T cells are regulatory and effector cells that may play a critical role in
autoimmunity. The protective effect of NKT cells in variety of autoimmune diseases
such as type I diabetes (Wilson et al., 1998; Hong et al., 2001), multiple sclerosis
(MS) (Illes et al., 2000; Araki et al., 2003; Yamamura 2003), systemic sclerosis
(Sumida et al., 1995), EAE-experimental autoimmune encephalomyelitis (Jahng et
al., 2001; Singh et al., 2001) or lupus (Zeng et al., 1998) depends on their ability to
secrete L-4 and/or IL-10 (Godfrey et al., 2000; Miyamoto et al., 2001).
Therefore, in the NOD mice, the reduced number of NK1.1+ Vα14Jα18+ T cells and
inability to produce IL-4 usually correlates with enhanced disease (Gombert et al.,
1996; Hammond et al., 1998).
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6.5. NKT cells and tolerance
NKT cells may be crucial for the induction of tolerance. In ACAID (anterior
chamber-associated immune deviation) model, systemic tolerance is induced to Ag
introduced into the immunologically privileged anterior chamber of the eye. The
induction of this tolerance depends on IL-10 produced by CD1-restricted NKT cells
that regulates suppressor cells mediating tolerance. The tolerance in ACAID requires
the presence of Vα14+ T cells and it is abrogated in CD1-deficient mice (Sonoda et
al., 1999; Sonoda et al., 2002-a; Nakamura et al., 2003).
NKT cells may also affect GVHD (graft-versus-host disease) by enhancing the
effectiveness of BM transplantations. Bone marrow derived NK1.1+ T cells, when
added to the donor bone marrow cells infused into the recipient mice, could suppress
GVHD. In this case, the protective effect strictly depended on IL-4 secreted by NKT
cells (Zeng et al., 1999).
Additionally, NKT cells are involved in the protection of embryos during pregnancy.
Under physiological conditions, Vα14 NKT cells prevent the rejection of the fetus.
In contrast, upon α-GalCer stimulation they secrete TNF-α and IFN-γ and provoke
abortion by perforin-dependent killing (Ito et al., 2000; Mrakovcic-Sutic et al., 2003;
Boyson et al., 2002).
7. Properties of rat “NKT” cells
Mouse and human NKT cells are well characterised, while these cells remain
uncharacterised in rats.
The presence of NKRP1+ lymphocytes in rat spleen was first described by Kaufman
and co-workers (Kaufman et al., 1993). These splenic cells were of three different
phenotypes: NKRP1brightαβTCR-, NKRP1dimα βT C R +, or NKRP1dimαβTCR-
(Kaufman et al., 1993) and were expressed at very low frequency.
The subset of NKRP1dimαβTCR+ lymphocytes, which phenotypically would
correspond to mouse NKT cells, expressed CD8 but did not contain cytoplasmic
granules and did not exhibit NK lytic activity (Kaufman et al., 1993; Brissette-
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Storkus et al., 1994). Since no information about functional features of these cells
was given, it is not clear if rat NKRP1dimαβTCR+ cells indeed represented the
population of mouse Vα14+ T cells.
A second report on “rat NKT cells” describes PVG rat NKRP1dimαβTCR+ clones,
generated in vitro by culture of splenic cells with MIP-1α (macrophage
inflammatory protein-1α) (Knudsen et al., 1997). PVG rat Vβ8.2+ clones were either
CD4+ or CD4-CD8- (DN) and could release various cytokines (Knudsen et al., 1997).
However, it was difficult to find a correlation between the phenotype of these clones
and the cytokine secretion pattern.
The existence of the NKT cells in rats was questionable until 2000, when Matsuura
and co-workers identified a population of F344 rat CD44high T lymphocytes
expressing the Vα14+ TCR, with Vα−Jα junctional region corresponding to mouse
invariant TRAV14-J18 (Matsuura et al., 2000). The nomenclature of TCRα given by
Matsuura does not correspond to the generally accepted nomenclature of IMTG
(http://imgt.cines.fr:8104). However, the Matsuura nomenclature was more
appropriate for analysis of rat Vα14+ TCR cloned in this thesis, and was therefore
used thoughout the thesis.
Rat invariant TCRα is coded by four TRAV14 genes, which on the basis of diversity
accumulated in CDR2 region can be categorised into two groups (Matsuura et al.,
2000). Type 1 invariant TCRα, including products of TRAV14S1 and TRAV14S2
genes, is preferentially expressed by hepatic and thymic lymphocytes. Whereas, type
II represented by the product of TRAV14S3 gene is expressed predominantly in the
spleen (Matsuura et al., 2000).
The presence of Vα14+ TCR cells in various F344 rat organs confirms the existence
of NKT cells in species other than human or mouse. Unfortunately, data presented
by Matsuura allow only the genomic and phenotypic characterisation of F344 NKT
cells but functional capabilities of these cells remain unknown.
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CD1d- Ag presenting molecule
8. The CD1 family
CD1 molecules are cell surface glycoproteins, able to present lipid and glycolipid
antigens to T cells (Porcelli et al., 1995-b; Bendelac et al., 1997). The
nonpolymorphic CD1 genes map outside the MHC region and encode: CD1a, CD1b,
CD1c and CD1e in humans, and CD1d1 and CD1d2 proteins in mice (Calabi et al.,
1986; Martin et al., 1986; Balk et al., 1989). Based on sequence homology in leader
α-1 and α-2 domains, CD1 molecules can be divided into two groups: group I
comprises human CD1a, CD1b, and CD1c, and group II includs human and mice
CD1d (Porcelli et al., 1995-a; Sugita et al., 2000-b; Calabi et al., 1991). Human
CD1e, for which the gene is known but the gene product has not been yet identified,
is intermediate between group I and group II of CD1 molecules.
Except in humans, the CD1 family genes have been found in mouse (Bradbury et al.,
1990), rat (Ichimiya et al., 1994), rabbit (Calabi et al., 1989), cow (MacHugh et al.,
1988), pig (Chun et al., 1999), cat (Woo et al., 1997), guinea pig (Dascher et al.,
1999), rhesus macaques (Kashiwase et al., 2003) and sheep (Ferguson et al., 1996).
In mice, there are two CD1 homologous genes: CD1d1 and CD1d2 (carrying a point
mutation, which prevents its surface expression), which are related to human CD1d
(Porcelli et al., 1995-a).
Rat has only one CD1 gene encoding CD1d protein with high structural similarity to
human and mouse CD1ds (Ichimiya et al., 1994). Two diverse allelic forms of
CD1d, expressed in different rat strains, have been described (Katabami et al.,
1998).
9. Expression of CD1
Human group 1 CD1 molecules (CD1a, b, c) are expressed in thymus, on immature
cortical thymocytes (Wang et al., 2000). Extrathymically, CD1 is present on
professional APCs, epidermal Langerhans cell, dendritic cells, activated
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macrophages, and on subset of B cells (with high expression of CD1d by marginal
zone B cells) (Porcelli et al., 1995-a; Beckman et al., 1995; Sonoda et al., 2002-b;
Amano et al., 1998; Canchis et al., 1993; Blumberg et al., 1991).
Additionally, human group 2 CD1 (CD1d) appears to be highly expressed on liver
hepatocytes (Bleicher et al., 1990; Sugita et al., 2000-b) and to some extent on the
intestinal epithelial cells (Balk et al., 1994; Blumerg et al., 1991). By contrast, the
presence of CD1 on mouse IEC is controversial (Brossay et al., 1997).
In mouse and rat, CD1d can be detected in lymphoid organs including: lymph nodes,
thymus and spleen as well as in nonlymphoid organs like liver, kidney and lung
(Brandbury et al., 1990; Ichimiya et al., 1994; Brossay et al., 1997).
10. Structure of CD1
Protein sequences of human and rodent CD1d show high structural homology. The
heavy chain of CD1d protein contains leader sequence, three extracellular domains
(α1, α2 and α3), a transmembrane region, and a short 6-10 amino acid cytoplasmic
tail. A leader peptide signals co-translational insertion of the heavy chain into the ER
membrane. The α1 and α2 domains of the extracellular region form the antigen
binding pocket of CD1, while the α3 domain associates noncovalently with β2-
microglobulin (Zeng et al., 1997; Calabi et al., 1991; Ichimiya et al., 1994).
Rat CD1d
Rat CD1d cDNA contains an open reading frame of 1008 bp, which encodes a
polypeptide of 336 amino acids. A high level of sequence similarity between rat and
mouse CD1d can be observed, especially in the extracellular domains. Rat CD1d
shows more homology with mouse CD1d1 than CD1d2 (Ichimiya et al., 1994; Kasai
et al., 1997).
Antigen-binding groove of CD1d
The antigen-binding groove of CD1d is narrower and deeper than that of MHC class
I or II and forms a large hydrophobic pocket, well adapted to bind fatty-acid chains
(Zeng et al., 1997; Burdin et al., 2000; Grant et al., 1999). The polar head group of
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presented lipid is important for the positioning and the presentation of antigenic
residues to TCR (Cantu et al., 2003; Park et al., 1998-a).
Four amino acid residues of antigen-binding groove have been shown to be crucial
for α-GalCer presentation. Asp80, Arg 79 and Glu 83 are important for binding to
carbohydrate region, while Asp153 is necessary for interaction with amine group of
fatty acyl chain (Kamada et al., 2001).
The binding of ligands to antigen-binding groove, which occurs via hydrophobic
interactions is stable but non-specific and of low affinity, allowing many types of
lipids to be buried in different positions in the groove (Schaible et al., 2000-a; Park
et al., 2000; Cantu et al., 2003).
11. Assembly of CD1d protein. Intracellular distribution of CD1
 isoforms and pathways of CD1d antigen presentation.
During generation, the CD1 protein is translocated into the endoplasmatic reticulum
(ER), where the heavy chain associates with calnexin and careticulin, (which have
chaperone-like function) and assembles with β2m (Sugita et al., 1997; Park et al.,
1998-a; Jayawardena-Wolf et al., 2001; De Silva et al., 2002).
The binding of lipid Ags might occur in the secretory pathways, either directly at the
cell surface or after internalisation in acidified intracellular compartments (Park et
al., 2000). CD1 isoforms may have different cellular distribution. Human CD1b is
mostly expressed intracellularly, accumulated in lysosomes. CD1c has been found
on the plasma membrane and in intracellular vesicles (Sugita et al., 1996; Schaible et
al., 2000-b). CD1a accumulates in endocytic compartments of Langerhans DCs,
while CD1d is present in lysosomes. Therefore, human CD1a and CD1c can be
detected mainly in early endosomes, CD1b and CD1d as well as mouse CD1d in late
endosome and lysosome (Briken et al., 2000; Moody et al., 2003; Park et al., 1998-
a).
Human CD1b and human or mouse CD1d proteins transit first to the cell surface,
before they reach endosomes (Moody et al., 2003). The access to the endocytic
pathway is regulated by tyrosine-based targeting motif YXXZ (where Y is tyrosine,
X any amino acid and Z is a bulky hydrophobic aa), present in the cytoplasmic tail
24
of CD1 (Jackman et al., 1998; Porcelli et al., 1995-a; Cernadas et al., 2003). The
mutant CD1b and CD1d molecules, lacking this cytoplasmic tail motif fail to
redistribute in the cell and lose the ability to present glycolipids to NKT cells (Chiu
et al., 2002; Sugita et al., 2000-a; Park et al., 1998-a; Park et al., 2000; Briken et al.,
2000; Elewaut et al., 2003).
12. Functions of CD1 molecules: presentation of lipid antigens to
 NKT cells
The CD1 molecules present lipid and glycolipid antigens to T cells (Briken et al.,
2000; Moody et al., 2003; Gumperz et al., 2000). Distinct innate or acquired
immunity derived lipid antigens, accumulated in endocytic compartments bind to
group 1 of CD1 molecules. The endosomal pathways promote the presentation of
foreign glycolipids that are internalized from exogenous sources by antigen-
presenting cells. Self-lipids that comprise the membranes of APCs, can be presented
to autoreactive T cells within non-endosomal compartments (Moody et al., 2003).
Different classes of lipid Ags may be presented by CD1 to CD1-restricted T cells.
Foreign mycobacterial lipids, which are structural components of the mycobacterial
cell wall such as mycolic acids, glucose monomycolate and derivatives of
lipoarabinomannans (LAM) (e.g.phospatidylinositolmannosides) are presented to
human CD4-CD8- αβTCR+ T cells by CD1b, whereas hexose-1- phosphoisoprenoids
are presented in the context of CD1c (Sieling et al., 2000; Moody et al., 1997;
Porcelli et al., 1992; Prigozy et al., 1997; Sieling et al., 1995; Moody et al., 2000;
Park et al., 2000; Schaible et al., 2000-b).
α-GalCer
Human and mouse CD1d have not yet been shown to present pathogen-derived lipid
antigens. Nevertheless, various glycosylated ceramides, like α-GalCer and self
glycosylphosphatidylinositol (GPI) anchors, that stimulate NK1.1 T cells have been
described (Joyce et al., 1998; Burdin et al., 1998; Kawano et al., 1997).
Obtained from the marine sponge Agelas mauritanius, α-GalCer-antigen has been
first identified in the screen of reagents that could prevent tumor metastases in
mouse liver (Morita et al., 1995; Natori et al., 1997; Kobayashi et al., 1995). α-
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GalCer  contains α-anomeric sugar with sphingosine base and 26 carbon long acyl
chain. Used in picomolar concentrations it specifically activates mouse Vα14/Vβ8.2
and human Vα24/Vβ11 NKT cells, making it a valuable reagent for the analysis of
CD1d-restricted T cells (Morita et al., 1995; Kawano et al., 1997; Brossay et al.,
1998-c; Spada et al., 1998; Matsuda et al., 2000).
Other ceramide- and phosphatidylinositol-based glycolipids compete with α-GalCer
for binding to CD1d. When loaded on CD1d, they inhibit presentation of α-GalCer
to NKT cells, but themselves fail to stimulate α-GalCer-restricted cells (Benlagha et
al., 2000-b).
Additionally, mouse CD1d was reported to present hydrophobic peptides (Castano et
al., 1995; Brossay et al., 1998-b). As shown by binding-competition assays, the
binding of peptide antigen to CD1d probably takes place outside the groove or to the
groove of a subset of CD1d molecules. Thus, glycolipids and peptides do not
compete for the same binding site (Naidenko et al., 1999; Tangri et al., 1998).
13. Tetramers
CD1d-α-GalCer loaded multimers have been recently created as a new, efficient tool
to identify Vα14+ T cells within complex mixtures of cells. These oligomers have
long half-life and are usually cross-reactive. Mouse CD1d-α-GalCer complexes
might be used to stain both mouse and human NKT cells (Benlagha et al., 2000-b).
Similarly, human CD1d oligomers positively stain mouse α-GalCer specific cells,
confirming that CD1d/Vα14 T cell system is highly conserved across species
(MacDonald 2000; Matsuda et al., 2000; Brossay et al., 1998-c).
The reactivity of CD1-α-GalCer complexes requires multimerization, and neutral pH
for loading with Ag (Matsuda et al., 2000). Monomers composed of mouse CD1d
molecule loaded with α-GalCer are able to significantly but weakly stain
Vα14+Jα18+ cells. CD1d dimers are more effective than monomers, while CD1d-α-
GalCer tetramers are the most efficient and bind to NKT cells with around 50-fold
greater fluorescence intensity than monomers (Matsuda et al., 2000; Benlagha et al.,
2000-b).
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As previously reported, CD1d-tetramers are not restricted to a particular Vα14-Vβ
combination (Matsuda et al., 2000). They are also much more sensitive than
classical monoclonal antibodies and are able to positively stain small populations of
cells (e.g. intestine or lymph nodes NK1.1- but tetramer+ lymphocytes), not
detectable by conventional FACS staining (Benlagha et al., 2000-b; Matsuda et al.,
2000).
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Chapter 2.
MATERIALS AND METHODS
MATERIALS
Chemical reagents
Agar-agar Roth (Karlsruhe, Germany)
α-GalCel National Institute of Neuroscience, NCNP
(Tokyo, Japan)
α-GalCel-mCD1d-PE tetramer Olga V. Naidenko, Ph.D., La Jolla Institute for
Allergy and Immunology San Diego, CA
(reference: Hammond et al., 2001)
Agarose Roth (Karlsruhe, Germany)
Ammoniumchloride Roth (Karlsruhe, Germany)
Ampicillin Gibco BLR (Eggenstein, Germany)
APS Roth (Karlsruhe, Germany)
β-mercaptoethanol Gibco BLR (Eggenstein, Germany)
Boric acid Roth (Karlsruhe, Germany)
Calcium Chloride Roth (Karlsruhe, Germany)
Concavalin A ICN (Meckenheim, Germany)
DEPC (Diethylpyrocarbonate) Sigma (Deisenhofen, Germany)
Diatomaceous earth Sigma (Deisenhofen, Germany)
DMSO (Dimethyl sulfoxide) Sigma (Taufkirchen, Germany)
dNTP Set Peqlab Biotechnologie
(Erlangen, Germany)
Ethanol Roth (Karlsruhe, Germany)
Ethidium bromide Roth (Karlsruhe, Germany)
Ficoll-Paque Pharmacia Biotech
Formaldehyde Roth (Karlsruhe, Germany)
Formamide Roth (Karlsruhe, Germany)
G418 (Geneticin solution) Sigma (Schnelldorf, Germany)
Glycine Roth (Karlsruhe, Germany)
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IL-2 (recombinant human interleukin-2) Hoechst (Frankfurt, Germany)
IL-6 (recombinant human interleukin-6) Strathamann Biotec AG
(Hamburg, Germany)
IPTG (Isopropyl-βD-Thiogalactopyrasoide) Biomol Feinchemikalien
(Ilvesheim, Germany)
Isopropanol Roth (Karlsruhe, Germany)
LB (Broth Base medium) Gibco BLR (Eggenstein, Germany)
Magnesium Chloride Roth (Karlsruhe, Germany)
Mineral oil Sigma (Schnelldorf, Germany)
Sodium Azide E.Merck (Darmstadt, Germany)
Sodium Chloride Roth (Karlsruhe, Germany)
Sodium Butyrate Sigma (Deisenhofen, Germany)
Nylon wool Fenwal Laboratories (Deerfield, USA)
OCH National Institute of Neuroscience,
NCNP (Tokyo, Japan)
(reference: Miyamoto et al., 2001)
PEG 1500 (Polyethylenglycol) Boehringer (Mannheim, Germany)
Penicillin Gibco BLR (Eggenstein, Germany)
Percoll Amersham Pharmacia
(Freiburg, Germany)
Polybrene (Hexadimthrinbromide) Sigma (Deisenhofen, Germany)
SDS Sodium dodecyl sulfate Sigma (Deisenhofen, Germany)
Trypan blue Sigma (Deisenhofen, Germany)
Tween 20 Sigma (Deisenhofen, Germany)
X-Gal (5-Bromo-4-Chloro-3Indolyl-β-D-Galactopyranose)
Quantum Appligene
Zeozin Cayla (Toulouse Cedex, France)
Media, Buffers, Solutions:
Media used for cell cultures were obtained from GibcoBRL (Eggenstein, Germany):
DMEM (Dulbecco's Mod Eagle Medium) with Pyruvate, without HEPES
#41966-029
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DMEM (Dulbecco's Mod Eagle Medium) without Pyruvate, with HEPES
#41966-027
RPMI- RPMI 1640 L-Glutamine #21875-034
RPMI+ RPMI- with 10% of SC (supplemet complete)
• SC-supplement (50 ml of SC per 500 ml of RPMI-):
500 ml heat-deactivated FCS
 100 ml Na puryvate 100 mM
100 ml non-essential amino acids
100 ml Penicillin-Streptomycin (10000U/ml)
      5 ml β-Mercaptoethanol 50 mM
 58.4 ml L-Glutamine solution 5%
• ATV:
0.05% Trypsin
0.02% EDTA in PBS
• 10*Trypan Blue Buffer:
0.5% Trypan Blue
0.5% Xylenxyanol
50% Glycine
10 mM EDTA
• Trypan blue solution:
0.04% Trypan blue in PBS/BSA/Azide
• BSS (Hanks balanced salt solution):
to prepare BSS 125 ml of BSS I was mixed with 125 ml of BSS II add filled with
water to 1 L
BSS I: 50 g Glucose
3 g KH2PO4
11.9 g NaH2PO4
0.4 g Phenylred
water to 5 L
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BSS II: 9.25 g CaCl2
20 g KCl
320 g NaCl
10 g MgCl2
10 g MgSO4
water to 5 L
• BSS/BSA
0.2 % BSA in BSS
• DEPC water
0.1 g DEPC
Water to 1 L, sterilised in autoclave
• 2*HBS
50  mM HEPES pH 7.05
10  mM KCl
12  mM Glucose
280 mM NaCl
1.5 mM NaH2PO4
Three different pH (pH 7.0, 7.05, 7.1) were prepared and tested. Aliquots were
stored at -20°C.
• LB- medium
20 g LB
Water to 1 L, autoclaved and stored at 4°C
• PBS (Phosphate buffered saline)
4    mM KH2PO4
16  mM Na2HPO4
115 mM NaCl
pH 7.3
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• PBS/BSA/Azide
0.2% BSA
0.02% Na-Azide in PBS
• TAC (Tris-Ammoniumchlorid):
20 mM Tris pH 7.2
0.82% NH4Cl
• 10*TBE
890 mM Tris
890 mM Boric acid
20  mM EDTA
• Hyper-Magic MiniPrep Reagents:
Buffer 1:
50 mM Tris-HCl pH 7.5
10 mM EDTA pH 8.0
100 µg/ml RNAse
Buffer2:
0,2 N NaOH
1% SDS
Buffer3:
2.55 M K-Acetate pH 4.8
pH adjusted with glacial acid
Buffer L6:
Guanidinium thiocyanyte
0.1M Tris-HCl pH 6.4
0.5M EDTA pH8.0
destilled water
Triton X100- all dissolved at 37°C
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Dia-Mix:
10 g Diaetomaceous earth
50 ml destilled water
50µl concentrated HCl
Washing Buffer:
100 mM NaCl
10 mM Tris-HCl pH 7.5
2.5 mM EDTA
destilled water
ethanol
• Reagents needed for cell fusion:
Following media and reagents were used during fusion procedure:
1 ml of PEG 1500 (Polyethylenglycol)- Boehringer (Mannheim, Germany)
15 ml of RPMI medium
30 ml of RPMI medium supplemented with 10% SC and
5% FCS (Gibco BRL # 10081;
   Karlsruhe, Germany)
100 ml of RPMI medium containing 10% of SC, 5% FCS and IL-6 (60 µl of
stock 5 µg/ml per 100 ml medium)
To prepare 250 ml of selection HAT medium
202.5 ml of RPMI medium
10 ml of HAT
25 ml of SC
12.5 ml of FCS were taken.
For further incubation HT-medium was used. 500ml of HT medium consisted of:
415 ml of RPMI medium
10 ml of HAT
50 ml of SC
25 ml of FCS
300 µl of IL-6 (stock 5 µg/ml)
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Cell lines:
293T transformed primary human embryonal kidney cells ATCC#CRL 1573
BW5147 Do-11.10.7 hybridoma derived  AKR/J mouse αβTCR-negative cell
lymphoma; ATCC#TIB-233
M12.4.1.C.3 MHC II negative mouse B cell lymphoma (reference: Glimcher et al.,
1985)
P80 P815 mouse (DBA/2) cell mastocytoma (ATCC#TIB-64) transduced
with rat CD80
RMA-S RMA-derived TAP2-deficient mouse T lymphoma
A20J mouse B cell lymphoma; ATCC#TIB-208
RAJI human Burkin lymphoma; ATCC#CCL 86
H-4-II-E rat hepatoma, Reuber H35 CRL-1548; Prof. Dr. O.Götze Zentrum für
Hygiene und Humangenetik, Göttingen
FAO rat hepatoma- a differential line derived from H4-11-E-C3ECACC
89042701; Prof. Dr. O.Götze Zentrum für Hygiene und Humangenetik,
Göttingen
JM2 rat Fischer F344 liver hepatoma; ICLC ATL99009; B.Parodi,
National Institute for Cancer Research, Genova
A20mCD1d mouse A20 cell line infected with mouse CD1d
KT12 mouse KT12 hybridoma expressing mouse TCRinv; last two cell lines
were a gift of Susanna Cardell, Immunology section, Department of
Cell and Molecular Biology, Lund University, Sweden; (reference:
Makowska et al., 2000)
SP2/O murine myeloma used as fusion partner, ATCC CRL 1581
Animals:
Mouse:
C57/Bl6J were inbred in the Institute for Virology and
Immunobiology animal facility
BALB/cJ CD1d-/- were provided by S. H. Kaufmann, Department of
Immunology, Max-Planck-Institute, Berlin, Germany
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Rats:
F344/Crl were obtained from Charles River Wiga (Sulzfeld,
Germany)
LEW/Crl were inbred in the Institute for Virology and
Immunobiology animal facility
Vectors:
Topo pCR®2.1-TOPO – TOPO Vector was obtained from Invitrogen Karlsruhe,
Germany
pVSVG pCZVSV-G wt, containing env form Vesicular Stomatitis Virus (VSV)
(Yee et al., 1994)
pHIT-60 pHIT60-CMV-MVV-gag-pol-SV40ori; containing gag and pol  from
Moloney Murine Leukemia Virus (MoMLV) under the control of
human Cytomegalovirus (CMV) promotor
pczCG5 IEGZ and pczCG5 IEGN- Retroviral vectors for the MuLV driven
constitutive expression of the gene of interest inserted in the Polylinker
(EcoRI/NcoI/BamHI) and through IRES mediated expression the
EGFP-Zeo (EGZ) or EGFP-Neo (EGN) fusion protein; kindly provided
by I.Berberich, Institut für Virologie und Immunbiologie, Universität
Würzburg
Antibodies:
Mouse Abs:
F23.1 mouse anti-mouse Vβ8.1, 8.2 TCR
(isotype: mouse IgG2a; reference: Behlke et al., 1986)
mCD3 hamster anti-mouse CD3ε chain
(isotype: hamster IgG1κ; reference: Leo et al., 1987)
1B1 rat anti-mouse CD1d
(isotype: rat IgG2b; reference: Brossay et al., 1997)
CD4 anti-mouse CD4
(isotype: rat IgG2b; reference: Wineman et al., 1992)
35
CD8 anti-mouse CD8β
(isotype: rat IgG2b; reference: Takahashi et al., 1992)
NK1.1 PK136 anti-mouse NK1.1
(isotype: mouse IgG2a; reference: Koo et al., 1984)
Rat Abs:
R73 anti-rat TCR-α/β 
(isotype: mouse IgG1κ; reference: Hünig et al., 1989)
R78 rat TCR-Vβ8.2 in LEW rat TCR-Vβ8.4 in DA
(isotype: mouse IgG1κ; reference: Torres-Nagel et al., 1993)
W3/25 anti-rat CD4
(isotype: mouse IgG1κ; reference: Mason et al., 1983)
OX35 anti-rat CD4
(isotype: mIgG2a; reference: Jefferies et al., 1985)
OX38 anti-rat CD4
(isotype: mIgG2a; reference: Jefferies et al., 1985)
3.4.1 anti-rat CD8
(isotype: mouse IgG1κ; reference: Torres-Nagel et al., 1992)
NKRP1-A anti-rat NKRP1-A
(isotype: mouse IgG1κ; reference: Kraus et al., 1996)
controls, secondary antibodies:
NMIg - normal mouse Ig
L180 - mouse antibody specific to sheep red blood cells
  (reference: Hünig et al., 1985)
2.4.G.2 - culture supernatant containing Abs against mouse Fcγ receptor
  anti rat CD16- Ab blocking binding to rat Fc receptor
  (reference: Latour et al., 1992)
DαMIg -PE or Cy5.5 conjugated (Fab')2 fragment of donkey anti-mouse IgG
Streptavidin-Cy-Chrom
All monoclonal Abs were from PharMingen (Heidelberg Germany), while secondary
detection Abs were from Serotec (Düsseldorf, Germany).
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Kits:
Rneasy(r) MiniKit # 74104 QIAGEN (Hilden, Germany)
Plasmid Maxi Kit # 12163 QIAGEN (Hilden, Germany)
QIAquick PCR Purification Kit # 28104 QIAGEN (Hilden, Germany)
First Strand cDNA Synthesis Kit # K1612 MBI Fermentas
(St.Leon-Rot, Germany)
BigDye Terminator Cycle Sequencing # 4303152 Applied Biosystem
(Warrington, United Kingdom)
Topo pCR®2.1-TOPO-TA Cloning®Kit; # K450-01 Invittrogen
(Karlsruhe, Germany)
ELISA kits were obtain from BD Bioscience Pharmigen (Heidelberg, Germany):
OPTEIA mouse IL-2 Set # 555148
OPTEIA mouse IL-4 Set # 555232
OPTEIA mouse IFN-γ Set # 555138
OPTEIA rat IL-4 Set # 2631KI
OPTEIA rat IFN-γ Set # 2696KI
Oligonucleotides
Oligonucleotides were obtained from MWG- Biotech AG (Ebersberg, Germany)
• Control primers:
β-actin-Fow 5'-CTA TCG GCA ATG AGC GGT TC-3'
β-actin-Rev 5'-CTT AGG AGT TGG GGG TGG CT-3'
• Primers binding to the vector sequence, used for cloning:
M13F 5'-GTA AAA CGA CGG CCA-3'
M13R 5'-CAG GAA ACA GCT ATG AC-3'
PSI 5'-CAC GTG AAG GCT GCC GAC C-3'
IRES 5'-CTT CGG CCA GTA ACG TTA GG-3'
• Primers used for PCR of mouse and rat Vα14 TCR:
rVα14/1,2,3Fow 5'-TTT GGG GCT AGG CTT CTG-3'
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Vα14Leader 5'-ATG AAA AAG CGC CTG AGT GCC TGC
TGG-3'
RCαend-STOP-anti 5'-TCA ACT GGA CCA CAG CCT TAG CG-3'
RCαendRev 5'-TGA ATG GTC AGC AGC AGC AA-3'
mVα14kos 5'-TAA GCA CAG CAC GCT GCA CAT-3'
rVα14kos 5'-TAA GCA CAG CAC CCT GCA CAT-3'
Cαkos-anti 5'-AGT CGG TGA ACA GGC AGA GG-3'
• Primers used for cloning of mouse and rat Vα14 TCR as also for production of
chimeric Vα14 TCRs:
rVα14-EcoRI-Fow 5'-GGG CTA GAA TTC TGC AGA AAA ACC
ATG GGG AAG C-3'
rVα14-EcoRI-Rev 5'-CGC GAA TTC AAT CTC AAC TGG ACC
   ACA GCC-3'
mVα14-EcoRI-Fow5'-GGG GAA TTC AAC CAT GAA AAA GCG
   CC-3'
mVα14-EcoRI-Rev 5'-CCC GAA TTC CTC AAC TGG ACC ACA
   GCC-3'
r/mVα14Rev 5'-CAC CAC ACA GAT GTA GGT GGC AG-3'
mVα14endSTOP 5'-TTA GCA TCT TTA TCC AGA GTT GC-3'
RVα14endSTOP 5'-TTA GCG CCT TCA TCC AGA GTT GCC
      G-3'
• Primers used for cloning of mouse Vβ8.2 TCR:
mVβ8.2-BamHI 5'-CGG GAT CCT GAG ATG GGC TCC AGG
CTC TTC-3'
mCαend-BamHI 5'-GGG GGA TCC TCA GGA ATT TTT TTT
   CTT GAC C-3'
• Primers used for cloning and screening of rat CD1d:
rCD1dRev 5'-TTC TGA GCA GAC AAG GAC TGA-3'
N366 5'-TCG GAG CCC AGG GCT GTG TAG A-3'
E1R 5'-TTG ATA GGA GCG TCT CCT TT-3'
E2F 5'-TGT ACC TAC CGT GCC TGT TG-3'
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E2R 5'-GAT GAT GTC CTG CCC CTC TA-3'
E3F 5'-TCC AGC AGA ATT ACA CCT TCC-3'
Enzymes, Inhibitors
Rnase A Promega (Heidelberg, Germany)
T4-DNA-Ligase Promega (Heidelberg, Germany)
Pfu-DNA-Polymerase Stratagene (Heidelberg, Germany)
MBI Taq-DNA Polymerase MBI Fermentas (St.Leon-Rot, Germany)
HotStar DNA Polymerase Qiagen (Hilden, Germany)
CIAP MBI Fermentas (St.Leon-Rot, Germany)
Restriction Enzymes: MBI Fermentas (St.Leon-Rot, Germany)
(EcoRI, BamHI, HindIII,
PstI, EspI(Bpu1102I))
METHODS
Cell Culture Methods:
1. Cell culture
Cells were cultured in sterile conditions in CO2 cell culture incubator at 37°C with
5% CO2 and H2O-saturated atmosphere. Almost all cell types were cultivated in
RPMI+ medium. DMEM medium was used for hepatomas and adherent cell lines.
The cells were maintained in 24-well tissue culture plates and 50 ml culture flasks.
For cell expansion 12, 6-well plates and 250 ml plastic flasks were used. Depending
on cell type (cell line) cells were fed every three or four days. For adherent cells
ATV or trypsin were used to detach cells from the plates.
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2. Freezing
Frozen cells were stored at -140°C in freezing medium (10% DMSO, 50% FCS,
40% RPMI+). Cells in a proliferative stage of growth were harvested, diluted in 0.5
ml of growth medium and stored on the ice for 30 min. Then 0.5 ml of freezing
medium was added to each vial and cells were frozen at –70°C. On the next day cells
were transferred to the –140°C freezer.
3. Thawing
To thaw cells stored in liquid nitrogen, cells were warmed at RT. The cell
suspension was transferred by dropping into a 15 ml tube containing 5 ml medium
and centrifuged at 1600 rpm (400 g) for 5 min. The medium was discarded, cell
pellet was resuspended in culture medium and centrifuged. Washing step was
repeated twice. At the end cells were diluted in culture medium and incubated at
37°C.
4. Cell viability
To determine the percentage of viable cells within population, the cells were diluted
with a trypan blue solution and counted in a Neubauer Chamber under the
microscope. Only unstained, living cells were counted.
5. Preparation of the cells:
5.1. Lymphoid organ cell suspensions
Animals used in experiments were sacrificed by anoxia with CO2. All procedures to
obtain single cell suspension were carried out in sterile conditions. Lymphoid
organs: LN (a pool of mesenteric, cervical and submandibular lymph nodes), spleen
and thymus were removed aseptically and placed into ice-cold centrifugation tubes
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containing 5 ml of RPMI+ medium. Organs were homogenised by passing through a
metal sieve placed on tissue culture dish. At this step cells were released into
medium. Cell suspension was transferred into the tube and left for 10 min to allow
tissue debris to settle on the bottom of the tube. The supernatant containing cells was
transferred to the new tube and centrifuged for 5 min at 1600 rpm (400 g). To
remove erythrocytes from cell suspension, pellet was resuspended in 3 ml of TAC
Buffer, incubated at RT for 10 min and centrifuged for 5 min at 1600 rpm (400 g).
After erythrocyte lysis cells were washed twice and cell number was counted.
5.2. IHL cell suspensions
Mouse and rat intrahepatic lymphocytes were isolated according to two different
protocols:
5.2.1. Protocol I
(by Olga Naidenko; personal communication)
• Liver was flushed of the blood with 20-50 ml syringe containing complete
medium via portal vein
• Liver was mashed and passed through 70 µm nylon mesh. Cell suspension was
centrifuged at 1200 rpm (225 g) for 10 min to pellet
• Pellet containing cells was resuspended in 28 ml of 40% Percoll (prepared in
RPMI with 5% FCS) and layered over 12 ml 80% Percoll
• Percoll gradient was spun down for 20 min at 2500 rpm (970 g), RT, without
brakes. After centrifugation the top face of the gradient contained liver tissue, the
bottom face hepatocytes
• Lymphocytes from the interface were collected, resuspended in complete
medium and washed twice to remove traces of the Percoll
5.2.2. Protocol II
(modified from Emoto et al., 1995-a)
• Liver was perfused with 20-50 ml RPMI+ medium to eliminate blood in the liver
• Liver was passed through a stainless steel mesh. Cells were washed for 10 min
at 1200 rpm (225 g)
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• Cell pellet was resuspended in 25 ml medium and centrifuged at 570 rpm (50 g)
for 30-60 s. The supernatant was harvested and replaced with fresh medium.
This washing-centrifugation procedure was repeated 2-4 times.
• Supernatants containing cells were centrifuged for 10 min at 1200 rpm (225 g)
• Pooled cells were purified from tissue debris and adherent cells by passing
through a 20 ml syringe column packed loosely with nylon wool
•  In order to obtain pure lymphocytes fraction Percoll density gradient was
performed. 3 ml of 40% Percoll containing cells was layered onto 2 ml of 70%
Percoll
• Percoll gradients were centrifuged at 2000 rpm (600 g), 20°C for 25 min
• Lymphocytes present in the interface were collected and washed for 5 min at
1600 rpm (400 g)
• After erythrocyte lysis lymphocytes were washed twice and counted
To prepare 100% Percoll, 90 ml Percoll was mixed with 10 ml of 10*PBS. This
Percoll/PBS mixture was then considered 100% and used to make 40 and 80% by
adding required amount of RPMI with 5% FCS.
6. Purification of the cells through nylon wool column
1.2 g of loosely connected nylon wool was packed in 20 ml syringe and autoclaved.
Those columns were rinsed with around 60 ml of column medium (RPMI-5%FCS).
In order to lyse erythrocytes, pellet containing splenic or hepatic cells was diluted in
5-20 ml of TAC buffer. After 10 min incubation at RT suspensions was spun down,
washed twice and diluted in column medium. Cells isolated from one spleen were
usually purified through one nylon wool column. Splenocytes were incubated on the
columns for 45-60 min at 37°C to allow B cells and adherent cells to adhere to the
wool. Then non-adherent cells were eluted at 1 drop per 3 sec by washing of the
column with around 40 ml of column medium pre-warmed to 37°C. Cells were
washed, counted and used in functional assays.
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7. Immunofluorescence and flow cytometry
Fluorochrome labelled Abs are useful tools to detect surface or intracellular antigens.
In order to determine the phenotype of rat hepatic and splenic NKT and also in order
to detect surface expression of chimeric TCRs and rCD1d, different mouse and rat
Abs were used. All antibodies were titrated and the optimal Ab concentration was
used in staining. Isotype controls were included in labelling protocol as negative
controls. 2*105 cells diluted in 100 µl of FACS buffer (PBS/BSA/Azide) were
usually used for immunofluorescent staining. To block unspecific binding or binding
to Fc receptor, mouse cells were treated for 10 min at 4°C with NMIg or 2.4.G2 Ab.
Then cells were stained with the first usually FITC conjugated Ab and incubated for
30 min at 4°C. After incubation cells were washed by centrifugation in 4 ml of
FACS buffer for 5 min at 1600 rpm (400 g). Supernatants were discarded and cell
pellet was labelled with second PE conjugated Ab for 30 min at 4°C. Washed cells
were then incubated for 30 min in the presence of biotinylated Ab. The bio-Ab was
visualised by incubation with Streptavidin-Cy-Chrome. Unconjugated antibodies,
used in indirect immunofluorescent staining, were detected by using fluorochrome
conjugated antisera (as secondary Ab). After binding of secondary Ab, cells were
blocked by addition of 10 µg/ml mouse IgG before staining with other antibodies.
After final washing the antigen expression was analysed by flow cytometry.
Staining with α-GalCer-mCD1d-PE tetramer:
α-GalCer-mCD1d-PE tetramer consisting of mouse CD1d loaded with α-GalCer,
visualised with PE was used for specific identification of hepatic NKT cells within a
mixture population of liver cells. This oligomer was also used for staining of Vα14+
cell lines and hybridomas. Only cells containing TCRinv recognising α-GalCer
presented by CD1d molecule were positive in the staining and could bind to α-
GalCer-mCD1d-PE tetramer.
The staining with α-GalCer-mCD1d-PE tetramer was performed as normal FACS
staining with one difference: cells were incubated with oligomer not at 4°C but at
RT in the dark for 30-60 min. Washed PE positive cells were analysed by flow
cytometry.
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8. Generation of anti-rat CD1d monoclonal antibody
The CD1d DNA obtained from F344 rat BM was cloned into the retroviral pczCG5
IEGZ vector and used for transfection of 293T and infection of M12 cells. GFP-
positive cells were used for immunisation of Balb/c CD1d-/- mice. Animals received
5 weekly i.p. injections of GFP-rCD1d-M12 cells (1*107 cells diluted in 300-500 µl
of PBS), and were rested for three weeks. After that time the last injection was done
via i.v. route and 3 days later the fusion of mouse splenic cells with SP2/O fusion
partner was done.
Splenic cells obtained according to standard preparation protocol, were washed
twice with BSS and once with RPMI medium (without FCS). SP2/O fusion partner-
myeloma cells were washed once with BSS and additionally once with RPMI
medium. Both cell types were counted and mixed in 5:1 ratio (4 parts of splenic cells
and one part of myeloma cells).
Cell fusion:
The cell mixture was resuspended in 50 ml warm RPMI- medium and centrifuged for
10 min at 1200 rpm (225 g). Then, all steps were performed at 37°C. The cell pellet
was gently resuspended and 1ml of PEG was added dropwise over 1 min with
shaking. Within next 10 min following solutions were added to fusion mixture:
5 ml of RPMI- (without FCS) at around 1ml/min
10 ml of RPMI- (2ml/min)
30 ml of RPMI+ (RPMI medium containing 10% SC and 5% FCS).
Then the fusion mixture was incubated for 30 min at 37°C and centrifuged for 10
min at 1600 rpm (400 g). The pellet was carefully resuspended with 100 ml of
RPMI+ medium containing IL-6 and plated into 96-well flat bottom plates, by adding
(using 1 ml plastic pipet) 100 µl of suspension per well. Fusion plates were
incubated for 24h at 37°C and then 100 µl of 2 times concentrated HAT selection
medium were added into each well. After 7-10 days incubation at 37°C, first positive
clones were checked under microscope, supernatants were taken and tested. If
necessary, clones were further expanded.
The CD1 specificity of clones was tested by FACS staining of rCD1d transduced
cell lines and primary CD1d+ rat cells. As a negative control wild type or mock-
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infected cells were used. Hybridomas secreting antibodies, which stained CD1d+
cells were cloned by single cell dilution.
9. Cell stimulation
Different cell types (primary cells, cell lines, hybridomas) were stimulated with
several stimuli for either 24 or 72h. Then the levels of cytokines released by these
cells into supernatants were analysed.
9.1. Ab stimulations:
Depending on the experiment Ab stimulation protocols were used:
 9.1.1. R73/ R78 Stimulation
• 96 well flat bottom plate was coated with 50 µl/well ShαMIg (300 ng/ml in
coating buffer) and incubated ON at 4°C
• next day the plate was washed 3 times with BSS and coated with 100 µl of R78
supernatant (previously diluted 1:3000 in BSS) or with 100 µl of R73 Ab (2
µg/ml). The plate was left for 2h at 37°C
• The plate was washed 3 times with BSS and appropriate cells in medium were
plated.
9.1.2. CD3 Ab Stimulation
• 96 well flat bottom plate was coated with 100 µl/well of 10 µg/ml mCD3Ab
diluted in PBS  overnight at 4°C
• Next day the plate was washed 3 times with PBS and cells were plated. Different
concentration of the cells were used for stimulation:
Cell lines 5*104 cell/well
APC: - splenocytes  5*105 cell/well
          - thymocytes 1*106 cell/well
Cell lines used as APC 5*104 cell/well
Cells were cultured in the presence of Ab usually for 24h and 3 days and then
supernatants were harvested and analysed by ELISA.
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9.2. Ag (α-GalCer/OCH) stimulation
NKT cells are able to recognise α-GalCer presented by APC in the context of CD1d
molecule. Once stimulated they become blasts, start to proliferate and produce
cytokines like IL-4 and IFN-γ. In functional assays the response of mouse and rat
splenic and liver cells to different doses of α-GalCer and OCH (the analog of α-
GalCer) was tested in vitro.
10. Supernatant cytokine ELISA
In order to detect cytokines produced by activated cells the supernatants were
harvested after 24h or 72h depending on the experiment setup. The samples were
stored at –20°C until testing. IL-2, IL-4, IL-10 and IFN-γ in supernatants were
measured using ELISA Kits (BD Pharmigen) according to the manufacturer’s
instructions.
Molecular biology methods
11. RNA isolation
RNA was isolated from cytoplasmic extracts of primary cells or cell lines according
to the protocol of Rneasy®MiniKit(QIAGEN#74104). All steps of the procedure
were carried with precautions to minimise RNAase activity:
• chemicals, plastic ware, and pipet tips were RNAase-free
• disposable gloves were worn during the preparation and analysis of RNA
To isolate RNA usually 1*107 cells were used. At the end the RNA concentration
was estimated spectrophotometrically.
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12. Specrophotometric determination of the RNA (DNA) amount
To measure the amount of RNA or DNA an aliquot of the sample was prepared and
read in spectrophotometer at wavelengths of 260 nm, 280 nm. The reading at 260
nm gives the concentration of nucleic acid in the sample. The ratio OD260/OD280
estimates the purity of the preparation.
13. RT-PCR
The synthesis of cDNA suitable for PCR amplification was usually performed
according to manufacturer’s RT-PCR protocol supplied with RT-PCR MBI
Fermentas Kit (#K1612).
14. PCR
PCR reaction mixture (25 µl) containing:
2.5 µl 10*PCR buffer with (NH4)2SO4
1.5 µl MgCl2 (25 mM)
1    µl dNTP mix (each of 2,5 mM)
17.5 µl PCR water
0.04 µl MBI Taq Polymerase (5U/1µl)
1 µl cDNA (1pg-1ng)
1 µl primers (10 mM each)
was prepared and amplified as follows:
- denaturation: 4 min at 94°C
- amplification- 35 cycles: 
1 min at 94°C
     1 min at temp of anneling suitable for primers, counted
according to: Tm=((G/C)*4°C+(A/T)*2°C)-2°C
1 min at 72 °C
   - 10 min at 72 °C.
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Than samples were stored at 4°C until the electrophoresis was performed. As
positive control PCR with β-actin specific primer was done. In some cases HotStar
Taq Polymerase instead of MBI Taq Polymerase was used.
15. Transformation of competent cells
Transformation of competent E.coli was carried using TOPO-Cloning Kit (K450-01
Invitrogen), which allows the transformation of bacteria with PCR product, plasmid
DNA or ligation product. Competent E.coli cells stored at -70°C were thawed on
ice.1- 2 µl DNA of interest were gently added to vial containing 50 µl of competent
E.coli. The tubes were incubated first on ice for 30 min and later in a preheated
water bath at 42°C for 30 sec. The samples were rapidly cooled on the ice for 2 min.
250 µl of SOC medium was added to each tube and then probes were transfered to a
shaking incubator and incubated for 30 min at 37°C, 200 rpm.
90 mm plate LB-ampicillin-agar were prepared in sterile conditions and then stored
at 4°C until they were needed. Before use they were kept at RT for 30-60 min to
eliminate problems of condensation. After 30 min incubation with rotation, DNA-
transfected bacteria were ready to grow and divide. 50 µl or 150 µl of competent
cells were spread on the agar plates. When a PCR product was cloned into
TOPOCloning-Vector, plates contained both X-Gal and IPTG. The plates were
inverted and incubated ON at 37°C. Only bacteria expressing an ampicillin
resistance gene encoded by the plasmid could grow on the selection plates. On the
next day positive white colonies were analysed either by PCR or by Miniprep and
digestion with restriction enzymes.
16. Mini preparation of plasmid DNA
Positive colonies were picked from agar plates, transferred into 5 ml of LB medium
containing 50 µl of ampicillin and incubated in shaking incubator ON at 37°C. Next
day bacterial cells were harvested by centrifugation in Eppendorf centrifuge at
13000 rpm for 3 min. Bacterial pellet was resuspended in 150 µl of ice-cold Buffer 1
(components of buffers in “Media, Buffers, Solutions”). 150 µl of Buffer 2 was
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added and eppendorf tubes were mixed 5 times. Then 150 µl of Buffer 3 was added
and samples were spun down at 13000 rpm for 5 min. After centrifugation
supernatants with plasmid DNA was transferred to the new tube containing 900 µl of
Buffer L6 and 50 µl of Diatomacenous earth. Samples were left for 5 min at RT and
then were loaded on the MiniWizard columns connected with vacuum. Columns
were washed twice with 3 ml of washing buffer and spun down. DNA from
minicolumn membrane was eluted with 30 µl water. Plasmid DNA was digested
with restriction enzymes and DNA fragments were separated by electrophoresis
17. Maxi preparation of plasmid DNA
To obtain large amount of the plasmid DNA Maxi preparation was performed
according to the orginal protocol from QIAGEN Plasmid Purification Handbook.
18. Cleavage of plasmid DNA by restriction enzymes
Restriction enzymes are able to cleave a specific sequence of nucleotides. They are
useful at different steps of cloning: to analyse the restriction maps of plasmids or for
preparation of the insert and vector before ligation. Digestion with appropriate
restriction enzymes was done for plasmid DNA obtained after Mini or Maxi
preparations following the producer instructions supplied with enzymes (MBI
Ferments: St.Leon-Rot, Germany).
19. Sequencing
Amplification of DNA
PCR mix containing:
500 ng plasmid
1 µl primer (20 µM= 10pmol)
3 µl BD (big dye)
water to 10 µl
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was amplified as follow:
25 cycles: 10 sec at 96°C
 5 sec at 50°C
 4 min at 60°C
DNA precipitation:
Each DNA sample was prepared for sequencing as follows: To 10 µl of PCR mix 90
µl of water and 10 µl of 3 M Sodium Acetate pH5.2 were added and mix was
vortexed. Then 250 µl of 99.9% Ethanol was added and vortexed once again.
Samples were centrifuged in Eppendorf centrifuge at 14000 rpm for 20-30 min,
DNA pellet was washed twice with 250 µl of 70% Ethanol for 5 min or once for 20
min at 14000 rpm and then dried at RT. DNA was diluted in 25 µl of HiDi and
samples were boiled at 94°C for 2 min, cooled on ice and transferred into new
sequencing tube and sequenced using an ABI sequencer.
20. Cloning
20.1. Cloning of PCR product
Cloning of PCR product into TOPO-cloning vector was done according to
manufactures instructions TOPO-cloning-Kit
20.2. Cloning into viral expression vectors
In order to express genes of interest two retroviral vectors were used
• pczCG5 IEGZ (“EGZ”) containing genes for zeozin resistance,
• pczCG5 IEGN (“EGN”) with genes for neomycin resistance.
Different restriction sites of those vectors were used for the cloning of different
molecules:
Cloned molecule Restrition sites Vector
mouse Vα14 TCR
mouse Vβ8.2 TCR
rat CD1d molecule
EcoRI
BamHI
EcoRI
pczCG5 IEGZ
mouse Vα14-rat JC TCR
rat Vα14-rat JC TCR
EcoRI/HindIII
EcoRI/HindIII
pczCG5 IEGN
In all cases cloning method consisted following steps:
• Preparation of insert
• Vector preparation
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• Ligation
• Screening of positive clones
20.2.1. Preparation of insert
• Digestion of the plasmid DNA with appropriate restriction enzyme was usually
performed as follow:
30 µl of plasmid with the gene of interest
5 or 10 µl 10* appropriate buffer
10 µl milipore water
5 µl of restriction enzyme (10U/µl), sometimes two restriction enzymes
were used.
• Digestion was carried out for 2h at 37°C and stopped by heating the samples for
20 min at 65°C.
• To isolate and to purify insert DNA from plasmid DNA, long agarose gel
electrophoresis was done:
0.99% agarose gel
6 µl of size marker
55 V
3h
• The band of the right size was cut out from the gel warmed at 55°C in the
presence of 600 µl buffer L6 and purified through MiniPrep column according to
the standard MiniPrep protocol
 20.2.2. Vector preparation
• Vector DNA was digested with the right restriction enzyme using a similar
protocol as for insert preparation
•  Additionally in order to protect against religation of vector DNA the
dephosphorylation of 5’ vector ends was done:
to 50 µl of digestion mixtures
5 µl of 10*CIAP reaction buffer and
1 µl of CIAP (1U/µl)- Calf Intestine Alkaline Phosphatase were added
and incubated for 15 min at 37°C. Then 0.5 µl of CIAP was added and mixture
was incubated for another 15 min at 37°C. Dephosphorylation reaction was
stopped by heating at 85°C for 15 min
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• To purify vector DNA, long agarose gel electrophoresis was done, DNA band
was cut out from the gel and was purified according to the procedure used for the
purification of insert DNA
20.2.3. Ligation
In order to find the optimal conditions for ligation, agarose gel electrophoresis of
purified insert and vector DNA was usually done before ligation. The insert DNA
was cloned into retroviral vector DNA during 6h incubation at 12°C in the presence
of T4 DNA Ligase. Ligation reaction was stopped by heating the reaction mix at
65°C for 10 min. To check efficiency of ligation a control electrophoresis was
performed, E.coli bacteria were transformed and positive clones were screened by
PCR and MiniPrep.
21. Transfection and infection
To express the gene of interest in mammalian cells, virus particles were produced by
transfection of 293T cells. Then virus supernatants were used for infection of cell
lines or primary cells. A transient three-plasmid expression system was used:
Day 1:
• 293T cells were plated into 6 cm dishes using 2*106 cells in 5 ml DMEM, 10%
IFS
•  Plasmid DNA (EGN/EGZ-gene of interest + pHIT60 + pVSVG) were
precipitated with 90% Ethanol and Sodium Acetate buffer, washed once with
70% Ethanol, dried at RT and resuspended in 100 µl of sterile H2O. DNA
samples were stored ON at 4°C. 15 µg of total DNA were used per 6 cm plate
transfection.
Day 2:
• Medium from 6 cm dishes was aspirated and 4 ml of fresh media without Hepes
were gently added. The plates were returned to the incubator.
• Combined DNA was brought to 438 µl with sterile H2O then 62 µl of 2M CaCl2
solution and 500 µl of 2*HBS were added. Eppendorfs were inverted 3-4 times
and transfection solution was immediately added to the plates. Plates were gently
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shaken to distribute the precipitate evenly and returned to the incubator for 7-10
hours.
• After 7-10 hours incubation media were replaced carefully with 5 ml of fresh
normal IFS media. Plates were incubated O/N at 37°C, 5% CO2
Day 3:
• In order to activate the CMV Promoter media from the plates were replaced with
3 ml of fresh normal DMEM medium containing 10 mM Na-Butyrate.
• Plates were incubated at 37°C, 5% CO2 for 8-12 hours and then Na-Butyrate
containing media were aspirated, 293T cells were washed once with 3 ml normal
medium and 3 ml of fresh medium were added for O/N incubation at 37°C, 5%
CO2.
Day 4:
• The 293T cell supernatant containing viral particles was harvested with a syringe
and pushed through a 0.45 µm filter into a 15 ml Falcon tube containing 30 µl of
Polybrene (800µg/ml, the final concentration of Polybrene was 8 µg/ml)
• Viral supernatants were plated onto 12 well plate and 1*105 target cells per well
were added. Plates were returned into incubator and incubated for 0.5-1.5h.
• To increase the efficiency of infection plates were centrifuged for 1.5h at 32-
37°C at 2000 rpm
• After centrifugation plates were incubated at 37°C for 1h. Infection supernatants
were then replaced by fresh growth medium
• The expression of gene of interest in target cells was analysed by FACS at the
time point depending on the confluency of target cells.
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Chapter 3:
RESULTS
I. Properties of rat NKRP1A+TCR+ cells
1.1. Phenotype
Human and mouse natural killer T cells express CD1d-restricted TCR invariant
(Vα24JαQ/Vβ11 in human and Vα14Jα18/Vβ8.2 in mouse, respectively) together
with NK cell specific markers. In terms of co-receptor expression, human and mouse
NKT cells belong either to the single-positive CD4+ or to the double-negative CD4-
CD8α/β−  subset of lymphocytes.
Mouse TCRintNK1.1+ cells show tissue-specific distribution- they are preferentially
present in the liver and in a low proportion in: spleen, thymus, lymph nodes and
bone marrow.
1.1.1. Phenotype of rat hepatic and splenic lymphocytes
Since mouse Vα14+ T cells are most frequent in the liver and spleen, we determined
if the population of cells with the same phenotype and CD1d reactivity also exists in
rat. To this end, the phenotype of lymphocytes isolated from F344 rat liver and
spleen was determined by FACS staining. Because no anti-TCRinv monoclonal Ab is
available, only cells co-expressing TCR (CD3ε) together with NK1.1 (NKRP1-A)
were analysed as positive and were designated NKT cells.
Figure 1 shows a representative experiment, in which the expression of surface
antigens on mouse and rat lymphocytes was analysed by FACS staining. Mouse
cells, used as a control, were stained with culture supernatant containing anti-mouse
NK1.1 antibodies, which then were detected with donkey anti-mouse IgG.
Therefore, some unspecific binding of this secondary antibody to mouse cells could
be seen, probably as a result of the population of B lymphocytes present in cell
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preparations. Basing on the definition of NKT cells, we analysed only CD3+NK1.1+
cells present in the upper right quadrant, while “false positive” cells from the upper
left quadrant were not taken into account.
As it is presented in Figure 1, the phenotype of rat liver lymphocytes was distinct
from the phenotype of mouse NKT cells. The population of TCR+NKRP1+ cells in
F344 rat liver (6.39%) was much smaller than the population of mouse IHLs
(32.18%). In terms of CD4/CD8 co-expression, the majority of rat hepatic
lymphocytes expressed CD8 (4.97%) rather than CD4 (1.47%), while mouse
counterparts were CD4+ (21.55%).
The frequency of TCR+NKRP1+ cells (figure 1, right panel) in rat spleen (4.04%)
was higher than the frequency of mouse NK1.1+TCR+ splenocytes (2.89%). Rat
spleen NKT cells were mostly CD8+ (3.29%). This time, the CD8 marker was
preferentially expressed also by the majority (2.06%) of mouse splenic NKT cells.
Therefore, rat TCR+NKRP1+ cells in liver were not as frequent as mouse NKT cells.
With regard to CD8 expression rat NKT cells were more similar to mouse spleen
rather than liver lymphocytes.
1.1.2. Phenotype of rat NKT cells in different rat organs
In order to test if TCR+NKRP1A+ cells were present in other rat tissues, lymphocytes
isolated from F344 rat liver, spleen, lymph nodes, bone marrow and thymus were
labelled with mAbs.
To stain CD8 positive cells, antibodies recognising the heterodimeric α/β form of
CD8 were used, to exclude the possibility of detecting of α/αCD8 homodimer,
which is often expressed by activated T cells.
Table 3:
Phenotype and frequency of rat NKT cells differ significantly from that of mouse
NKT cells. FACS staining of F344 rat lymphocytes isolated from various organs-
data from one representative experiment.
% of lymphocytes
BM thymus liver spleen LN
TCR+NKRP1A+ 1.09 0.32 6.21 3.85 1.51
CD4+NKRP1A+ 2.92 0.41 3.97 4.18 2.05
CD8+NKRP1A+ 2.57 0.10 3.12 2.53 1.08
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The frequency of TCR+NKRP1A+ cells in rat organs varied between preparations but
usually was much lower than frequency of mouse counterparts. F344 liver was an
organ, where rat NKRP1A+TCR+ cells were the most frequent (6.21 % of total
lymphocytes). BM contained 1.09 % and spleen around 3.85 % of TCR+NKRP1A+
cells. A very small proportion of cells with this phenotype could be found in thymus
(0.32%) and LN (1.51%).
In contrast to mouse NKT cells, rat TCR+NKRP1A+ cells expressed not only CD4
but also CD8.
1.1.3. Staining of rat splenocytes and intrahepatic lymphocytes with
α-GalCer-mCD1d-PE tetramer
Both mouse and human invariant NKT cells recognise lipid antigens presented by
the MHC class I-like CD1d molecule. Basing on the mechanisms of natural antigen
recognition by TCRinv, α-GalCer loaded CD1d tetramers have been generated.
Tetramers are able to bind to TCRinv NKT cells within a mixed lymphocyte
population.
To further characterise rat TCR+NKRP1A+ cells, we used α-GalCer-mCD1d-PE
tetramer, which due to high homology between human and mouse CD1ds can
positively stain NKT cells from both species.
Figure 2 shows that a significant proportion of mouse (26.61%) but not rat liver
lymphocytes (0.25%) could bind to mouse α-GalCer-mCD1d-PE tetramer. Whether
such weak binding of mCD1d tetramer to F344 rat lymphocytes was specific will be
discussed in later chapters of the thesis.
It should be pointed out that the percentage of tetramer positive cells in mouse liver
varied (in the range of 2-41%) between cell preparations and was strictly dependent
on the frequency of NK1.1+TCR+ cells which could be obtained. Tetramer positive
cells represented around 85-95% of mouse NK1.1+TCR+ hepatic lymphocytes.
Data presented in the Table 4 shows that tetramer-binding cells could also not be
found in rat splenocytes. This might suggest that rat NKRP1A+TCR+ cells did not
bind or bound very weakly to mouse CD1d tetramer.
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When mouse spleen NKT cells (positive control) were stained with tetramer, 1.69%
from 2.29% NKT cells in spleen could bind to this oligomer.
The lack of α-GalCer-mCD1d-PE tetramer-positive cells in rat liver and spleen
raises the question if rat NKRP1A+CD8+ cells were CD1d-restricted and if they were
able to bind to α-GalCer.
1.2. Functional characterisation of rat NKRP1A+TCR+ cells.
Stimulation of rat IHL and splenocytes with α-GalCer in vitro
Upon α-GalCer stimulation mouse liver NKT cells become activated, they
proliferate and produce cytokines like IL-4 and IFN-γ. Because rat splenocytes and
IHLs showed no clear binding to mouse CD1d tetramer, there was a need to check if
these cells, similarly to mouse cells, could respond to α-GalCer. To this end,
lymphocytes prepared from F344 liver were cultured in the presence of α-GalCer or
vehicle (DMSO) as negative control. The level of IL-4 and IFN-γ released into
supernatants was analysed after 24h co-culture.
As shown in Figure 3, upon α-GalCer stimulation both mouse and rat IHLs were
able to secrete cytokines in Ag-dependent manner. Rat liver lymphocytes, when
compared with mouse counterparts released less IL-4 (around 15% of that produced
by mouse IHLs) but produced higher levels of IFN-γ. Some background IFN-γ
production (Figure 3B) was found for rat IHLs incubated in the presence of control
medium or vehicle. However, when these cells were stimulated with 100 ng/ml of α-
GalCer, the level of IFN-γ in supernatants increased suggesting Ag-dependent
cytokine production.
The liver was an organ where rat NKRP1A+TCR+ cells were the most frequent but
the numbers of IHLs obtained were always low. Therefore, in experiments in which
high cell number was needed splenic rather than hepatic lymphocytes were used.
As it is shown in Figure 4, either total or nylon wool purified F344 spleen cells were
co-cultured for 24 or 72 hours with different doses of α-GalCer, and then levels of
IL-4 and IFN-γ in supernatants were measured by ELISA.
Figure 3: F344 rat intrahepatic lymphocytes (1*105cells) produce 
both IL-4 (3A) and IFN-γ (3B) after 24h stimulation with α-GalCer.
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Because we were not able to obtain enough purified lymphocytes from mouse
spleen, the comparison of IFN-γ production by mouse and rat splenocytes only after
24h coculture is presented (Figure 4C).
Upon α-GalCer stimulation F344 rat splenocytes, similar to mouse cells, were able
to release IFN-γ. However, the level of rat IFN-γ was much lower than mouse
cytokine, and could be detected only for cells incubated with the highest dose (20
ng/ml) of α-GalCer.
For IL-4, which is released usually shortly after α-GalCer stimulation, data after 24
and 72h co-culture are shown (Figure 4 A and 4 B). Both mouse and rat splenocytes
showed the same pattern of activation. The amounts of IL-4 increased with the
increments of α-GalCer in the culture.
After 24h culture total rat and mouse spleen cells released significant amounts of IL-
4. After 3 days of stimulation, the cytokine secretion increased further in Ag-dose
dependent manner.
When nylon wool purified splenocytes were used in these assays, the detection level
of IL-4 in supernatants was much lower. Only in long term culture and at the highest
α-GalCer (20 ng/ml) concentration could a low level of IL-4 be measured. The level
of IL-4 released by rat splenic lymphocytes was lower than that produced by mouse
counterparts- rat total splenocytes secreted 3.96% and purified 14.06% of that IL-4
released by mouse total and purified splenocytes, respectively. Given that APCs are
removed during nylon wool purification, this could suggest that the activation of rat
splenocytes was CD1d dependent and it could take place only in the presence of
CD1d+ APCs.
The presence of IL-4 and IFN-γ producing cells in rat liver and spleen confirmed
that rat cells could respond to α-GalCer. The level of IL-4 produced by rat
splenocytes or IHLs was lower than the level of IL-4 detected for mouse NKT,
suggesting the presence much smaller population of “NKT” cells in rat organs.
Alternatively, rat NKT cells may be biased toward producing more IFN-γ than IL-4.
Figure 4: F344 rat splenocytes produce IL-4 and IFN-γ after stimulation with α-GalCer.
5*105 of total or nylon wool purified mouse and rat splenocytes were cultured for 24h with α-GalCer or Vehicle. 
The level of released IL-4 and IFN-γ was estimated by supernatant ELISA.
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II. Characterisation of rat Vα14+TCR
Mouse NKT cells express a particular invariant TCR consisting of Vα14Jα18 chain,
paired together with Vβ8.2 chain. Thus, we wanted to check if the population of rat
liver or spleen derived lymphocytes could express TCRinv, which structurally and
functionally would be similar to mouse receptor.
2.1. Frequency of Vα14+Jα18+ TCR in rat organs
In rats, four TRAV14 genes encoding TCRinv have been described. According to the
diversity accumulated in the CDR2 region, the products of TRAV14 genes may be
categorised into two types:
Type I:    Type II:
            -    TRAV14S1        -    TRAV14S3
- TRAV14S2
- TRAV14S4 (pseudo-gene)
The invariant TRAV14-positive rat NKT cells show tissue-specific distribution.
Cells expressing type I invariant TCR are frequent in rat liver and thymus, while
type II invariant TCR (TRAV14S3) positive cells are present in the spleen
(Matsuura et al., 2000).
To confirm the presence of Vα14 TCR positive cells in different F344 rat organs,
TRAV specific RT-PCR was done. As a template for cDNA, the RNA isolated from
lymphocytes obtained from different rat tissues was used.
Results presented in Table 5 (look: results/chapter 4/page 93) show that PCR
positive signal was found for F344 rat thymus, liver and spleen. No or only weak
band could be seen for cDNA from LN lymphocytes.
RT-PCR confirmed the presence of TCRinv in different F344 rat organs. However,
the Vα14+ PCR signal for rat organs was much weaker than that from mouse tissues.
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2.2. Cloning and expression of rat Vα14+Jα18+ chain from F344 liver cDNA
       functional characterisation of rat TCRinv.
PCR products were cloned into TOPO-Cloning vector and sequenced. Analysis of
Vα14+ clones isolated from liver showed that rat Vα14 invariant TCR could be
rearranged not only with Jα18 but also with other J segments. The low number of
clones with in frame Vα14Jα18 rearrangement could suggest only a very small
proportion of rat liver lymphocytes to be CD1d restricted NKT cells.
To facilitate the direct structural and functional characterisation of rat Vα14TCR, rat
Vα14+ TCR transgenic cells were generated and their reactivity to α-GalCer was
tested.
The DNA of Vα14Jα218 TCR isolated from rat liver cDNA was sequenced. Two
mutations in the V-region of cloned rat TCRinv were found. The comparison of
mutated rat receptor with mouse and two published in GeneBank rat Vα14+ TCRs is
presented in the Figure 10 (page 76) and will be discussed in chapter 2.2.4. Rat
TCRinv DNA was cloned into GFP+- retroviral vector (EcoRI site) and used for
transfection of 293T cells and infection of TCR-/- cell lines: BW58 or BW58
expressing a chimeric rat/mouse (r/m) CD28 molecule. Vα14+-GFP+ cells were then
infected with rat Vβ8.2 chain. In parallel, as a control, mouse TCRinv and mouse/rat
chimeric TCRs were generated.
The surface expression of α/βTCRs was analysed by FACS staining with anti-mouse
CD3ε and anti-mouse or anti-rat Vβ8.2 monoclonal antibodies. The representative
staining of BWr/mCD28 cells expressing either mouse or rat TCRinv with anti-mouse
CD3 mAb is presented in Figure 5. Additionally, to check if cloned TCRinv had the
same specificity for CD1d-α-GalCer complex as primary liver or splenic
lymphocytes, Vα14+ transgenic cells were stained with mCD1d-α-GalCer tetramer.
Mock infected BWr/mCD28 cells lacked TCR on their surface therefore they were
negative in anti-CD3 mAb or tetramer staining.
Both mouse (mVα14mVβ8.2) or rat (rVα14rVβ8.2) Vα14+ TCRs were successfully
expressed on the surface of BWr/mCD28 (Figure 5) or BW (data not shown) cells,
since these cells were positive in the staining with anti-mouse CD3 mAb. It was also
the case for positively labelled BWr/mCD28 cell lines expressing chimeric
mouse/rat TCR (mVα14/rVβ8.2 and rVα14/mVβ8.2- data not shown).
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When BWr/mCD28 cell line expressing mouse or rat TCRinv were stained with
mCD1d-α-GalCer tetramer (Figure 5), only cells positive for mouse but not rat TCR
could bind to tetramer. Cloned rat Vα14+ TCR, similar to rat IHLs, did not have the
specificity for mouse CD1d tetramer.
2.2.1. Cytokine production by rat Vα14+ cells upon Ab and Ag stimulation
Purified by MACS or FACS sorting, TCR transgenic cells were used in functional
assays, in which the capacity of these cells to produce IL-2 upon Ab (Figure 6A) or
Ag (Figure 6B) stimulation was tested.
Upon anti-mouse CD3 or anti-Vβ8.2 Ab stimulation, BWr/mCD28 cells transduced
with control GFP-vector did not secrete any IL-2, since they lacked the TCR on their
surface. BWr/mCD28 cell line expressing rat TCRinv was functional and able to
release large amounts of IL-2 after 24h stimulation with anti-CD3 or anti-Vβ8.2
Abs. No IL-2 was found when cells were cultured with medium only.
To test the specificity of rat liver TCRinv for α-GalCer, rat or mouse Vα14+ TCR
transgenic cells were stimulated with α-GalCer presented by CD1d+ thymocytes.
After 24h coculture, the IL-2 level in culture supernatants was measured by ELISA.
The results are presented in Figure 6B.
Despite cytokine production upon Ab stimulation, BWr/mCD28 cell line expressing
rat TCRinv did not have the specificity for α-GalCer. No IL-2 could be detected in the
supernatants of rat Vα14+TCR-positive cells incubated with α-GalCer-loaded rat
(both F344 and LEW) or mouse thymocytes. On the other hand, the positive control-
BWr/mCD28mVα14mVβ8.2 cells secreted high amounts of IL-2 in the response to
rat, and less IL-2 in the response to mouse APCs in an Ag-dose dependent manner.
Figure 6: 
Mouse but not rat Vα14+TCR produce IL-2 after stimulation with α-GalCer.
IL-2 production by BWr/mCD28 cell line expressing either mouse or rat Vα14+TCR (5*104 cells) 
after stimulation with anti-mCD3 (10 µg/ml) and anti-Vβ8.2 (F23.1 Ab-10 µg/ml, R78 Ab- 2 µg/ml) 
monoclonal antibodies (6A) or α-GalCer (6B).
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2.2.2. Generation of chimeric mouse/rat TCR+ cell lines- functional
characterisation of rat Vβ8.2 TCR
It was not clear why the rat TCRinv was not stained with mCD1d tetramer and was
unresponsive to α-GalCer stimulation. The explanation, that the cloned rat Vα14+
TCR was not CD1d restricted is questionable, since IL-4 and IFN-γ secretion by rat
splenic lymphocytes was strictly α-GalCer and CD1d-dependent.
However, it could be possible that the lack of the rat TCRinv specificity for α-GalCer
was caused by differences in α/β chain pairing of mouse and rat TCRs. To test if rat
TCR β-chain was permissive, mouse Vα14 TCR was expressed together with rat
Vβ8.2 or Vβ8.4 chain in BWr/mCD28 cells.
In rats, there are two BV segments: BV8S2 (Vβ8.2) and BV8S4 (Vβ8.4), which are
highly homologous to mouse Vβ8.2. LEW rats of Tcrbl haplotype possess only one
functional allele-Tcrb-Vb8.2l (BV8S2A1) (Zhang et al., 1992). The Tcrb-Vb8.4l
(BV8S4A1) allele due to one nucleotide deletion is out of the frame and is not
expressed (Asmuss et al., 1996). By contrast, in rat strains of Tcrba haplotype (like
F344 or DA) both Tcrb-Vb8.2a (BV8S2A2) and Tcrb-Vb8.4a (BV8S4A2) alleles are
expressed (Herrmann et al., 1994).
The analysis of genomic Tcrb sequences showed that Tcrb-V8.2 and Tcrb-V8.4
alleles of Tcrbl and Tcrba hyplotypes are closely related (Asmuss et al., 1996). The
sequence of Tcrb-Vb8.2a differs from the sequence of Tcrb-Vb8.2l by seven
nucleotides resulting in three aa substitutions (Gold et al., 1994). Whereas, F344
Tcrb-V8.4a allele differs from LEW Tcrb-V8.2l in seven aa, which were
predominantly located in the CDR2 and CDR4 regions (Asmuss et al., 1996).
Due to differences in the aa sequence of Tcrba and Tcrbl, some interstrain differences
in terms of T cell activation by SAgs and recognition by R78 mAb, between F344
and LEW rats, can be observed. Only cells expressing Tcrb-V8.2l or Tcrb-V8.4a
alleles carry the R78 epitope (R at position 9 and N at position 62) and can be
stained with anti-TCR β-chain R78 mAb. F344 Tcrb-V8.2a and non-functional LEW
Tcrb-V8.4l are negative in the R78 staining. In terms of stimulation by SAgs, only
R78+ cells of LEW haplotype (Tcrbl) but not R78+ cells of F344 rat Tcrba haplotype
respond to the bacterial SAgs (e.g. SEB, staphylococcal enterotoxin B) (Asmuss et
al., 1996).
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Since R78 mAb used in the thesis for detection of rat TCRβ positive cells was able
to recognise LEW Tcrb-Vβ8.2l and F344 Tcrb-Vβ8.4a, it might be concluded that
Tcrb-Vβ8.4a of F344 is the functional analog of mouse Vβ8.2 and LEW Tcrb-
Vβ8.2l. In order to check wether Vβ8 TCR of F344 and LEW rat could equally
contribute to the TCR activation, both rat β-chains were expressed with mouse
Vα14+TCR in BWr/mCD28 cells, and the response of chimeric mouse/rat TCRs to
α-GalCer in vitro stimulation was tested.
Two rat Vβ8 TCRs were used: classical LEW Tcrb-Vβ8.2l (further called rVβ8.2)
and it’s mutated form-Vβ8.2TCR-CDR(2+4), which due to mutation in CDR2 and
CDR4 region, showed high homology with F344 Tcrb-Vβ8.4a. Therefore, the
mutated form of LEW Tcrb-V was used instead of F344 βTCR and was further
referred to as rVβ8.4.
Table 6: Correlation between the classification and nomenclature of rat TCRβ:
Tcrb-V
specificity
for anti-Vβ8.2
mAbs
name of
TCRβ used
in thesis
name of TCR,
expressed in
BWr/mCD28 cells
Mouse Tcrb-V8.2 recognised by F23.1 mVβ8.2 mVβ14mVβ8.2
Tcrb-V8.2l recognised by R78 rVβ8.2 mVβ14rVβ8.2
Tcrb-V8.2l
CDR(2+4)mutant
recognised by R78 rVβ8.4 mVβ14rVβ8.4
LEW
Tcrb-V8.4l not labelled by R78 - -
Tcrb-V8.2a not labelled by R78 - -
F344
Tcrb-V8.4a recognised by R78 - -
The response of either mouse or chimeric mouse/rat TCRinv positive cell lines to α-
GalCer presented by mouse and rat thymocytes was tested (Figure 7 B-D). As
positive control, stimulation of these cells with anti-mouse CD3 mAb was performed
(Figure 7A).
In this experiment, the differences in Ag presentation by mouse and rat CD1d+ APCs
as well as the capability of TCR+ cells to produce cytokine were tested.
Figures 7C and 7D show, that BWr/mCD28 cell line expressing mouse
(mVα14mVβ8.2) or chimeric mouse/rat TCRinv (mouse Vα14 chain expressed
together rat Vβ8.2) secreted comparable amounts of IL-2 in the response to α-
GalCer-loaded rat (F344 or LEW) thymocytes.
Figure 7: 
Comparison of IL-2 production by BWr/mCD28 cells expressing mVα14
with rat Vβ8.2 or Vβ8.4 after 24h stimulation with mCD3 mAb or α-GalCer.
C57/Bl6, F344 or LEW thymocytes (1*106) loaded with α-GalCer were used to 24h stimulation
of BWr/mCD28 infectants. 
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When C57/Bl6 mouse CD1d+ thymocytes were used as APCs (Figure 7B), some
differences in the levels of produced IL-2 by TCR-transgenic cells, depending on
expressed TCR, could be seen. Because mouse thymocytes cultured with α-GalCer
secreted significant amounts of IL-2, it is not clear wether the cytokine production
by activated BWr/mCD28 cells expressing mVα14rVβ8.2 was really specific.
Nevertheless, data presented in Figure 7 suggest that BWr/mCD28 cells positive for
mouse (mVα14mVβ8.2) but not mouse/rat (mVα14rVβ8.2) TCRinv were responsive
and could produce IL-2 in α-GalCer-dose dependent manner (Figure 7 B). In
addition, the cytokine secretion by BWr/mCD28 cell line expressing mVα14rVβ8.4
TCR was the best regardless of the type of used APCs.
In conclusion, the α-GalCer recognition and the IL-2 production could be decreased
by expression of mouse Vα14 chain together with LEW Vβ8.2, but on the other
hand it could be enhanced by pairing of mouse α-chain with F344 rat Vβ8.4.
In this functional assay three TCRinv-positive cell lines having the same α- but
different β-chain had diverse reactivity to α-GalCer. Thus, it might be possible that
β-chain of TCRinv influences the Ag recognition depending on the CD1d used for
Ag-presentation.
2.2.3. Staining of mouse TCRinv transgenic cell lines with mCD1d α-GalCer
 tetramer
If the β-chain of TCRinv indeed preferentially distinguishes between mouse and rat
CD1d, it was important to check if the expression of different Vβ8.2 chains also
influences the binding of CD1d tetramers. Therefore, cells used in functional assay
were additionally stained with mCD1d-α-GalCer tetramer.
Figure 8 shows that the pattern of the tetramer staining of different mouse cell lines
correlated with the results from the stimulation assay. The binding of mouse CD1d
tetramer to mouse/rat (mVα14rVβ8.2) TCRinv was much weaker than binding to the
classical mouse (mVα14mVβ8.2) counterpart. BWr/mCD28 cell line expressing
mVα14 chain paired together with rat Vβ8.4, had the comparable level of CD3
expression as mVα14rVβ8.2-positive cells, but it was the most positive in tetramer
staining. Therefore cells, which produced less IL-2 upon α-GalCer stimulation, were
Figure 8:
The staining of BWr/mCD28 cells expressing mVα14+TCR and diverse 
Vβ8 chains with mCD1d-α-GalCer-tetramer PE and anti-mouse CD3 mAb.
The numbers in the histograms show mean fluorescence intensity of positively stained cells, 
corrected for background staining. 
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stained with tetramer only to some extent, while good IL-2 producers had high
affinity for mCD1d-α-GalCer tetramer.
Thus, the coexpression of mouse Vα14-chain with diverse Vβ8.2 chain influenced
both α-GalCer recognition and cytokine production as well as the binding to mouse
CD1d-α-GalCer tetramer.
However, results from functional assay can be questionable. As it was presented in
Figure 7A, upon anti-mouse CD3 mAb stimulation mouse Vα14+ transgenic cells
produced different amounts of IL-2. Furthermore, the level of IL-2 released by
mouse thymocytes cocultured with α-GalCer was relatively high. To get more
comparable results, the cytokine production upon α-GalCer was normalised to the
cytokine production upon CD3 mAb stimulation. The results are presented in Figure
9. Similar to the results in Figure 7, F344 and LEW thymocytes used as APCs
presented α-GalCer to Vα14+ cells even better than mouse cells did. By contrast, the
pattern of IL-2 production by BWr/mCD28 cells transduced with mouse Vα14 chain
and mouse or rat Vβ8 chain was different from this before standardisation. This
time, mouse TCR (Vα14/mVβ8.2) responded to α-GalCer stimulation the best,
regardless of the type of APCs used.
After standardisation, the differences in the level of IL-2 released by BWr/mCD28
cells expressing two chimeric mouse/rat TCRs (Vα14/rVβ8.2 andVα14/rVβ8.4)
were significant only for cells stimulated with α-GalCer presented by mouse
thymocytes (Figure 9A). In agreement what was presented previously,
mVα14/rVβ8.4-TCR was more responsive than mVα14/rVβ8.2-TCR. However,
bearing in mind high background IL-2 production by mouse thymocytes, it is very
likely that IL-2 detected in the supernatants of BWr/mCD28mVα14rVβ8.2 cells
cocultured with α-Galcer loaded mouse thymocytes was produced not by TCR-
transgenic cells but rather by APCs.
When BWr/mCD28mVα14/rVβ8.2 and BWr/mCD28mVα14/rVβ8.4 cells were
stimulated with α-GalCer-loaded LEW and F344 thymocytes, both cell lines
released comparable amounts of IL-2.
To conclude, one experiment, two different ways of presenting results, two different
conclusions. From both Figure 7 and Figure 9, we can say that indeed there were
differences in the response of TCRinv transgenic cell lines to α-GalCer stimulation,
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Figure 9: 
Comparison of IL-2 production by BWr/mCD28 cells expressing 
mVα14 with rat Vβ8.2 or Vβ8.4 after 24h stimulation with α-GalCer.
The IL-2 production upon α-GalCer stimulation was standardized according to the IL-2 
production upon mCD3 mAb stimulation.  
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depending on the combination of expressed Vα and Vβ8 of TCR. However, it was
difficult to estimate if the Vβ8.2 TCR of LEW and the Vβ8.4 TCR of F344 rat had
the same or different capacities to trigger the response of mVα14+BWr/mCD28 cells
to α -GalCer. Since the results from the tetramer staining of TCRinv transgenic
BWr/mCD28 cells (Figure 8) correlate more with the data from stimulation assay
presented in Figure7, therefore we assume that the first interpretation of results was
more likely.
2.2.4. Sequencing and amino acid analysis of rat liver Vα14+TCR
The pairing of mouse Vα14 chain with Vβ8 chains representing two rat strains
resulted in different response to α-GalCer. When Ag was presented by mouse CD1d+
thymocytes, BWr/mCD28 cell line expressing rat Vβ8.2 was less functional than
cells positive for mouse Vβ8.2 or rat Vβ8.4 chain.
Because the same Vβ8.2 chain was a part of rat TCRinv, therefore, it could be
possible that the lack of the rat TCRinv reactivity to α-GalCer was partially due to the
presence of ”not functional” Vβ-chain.
Another reason for the lack of α-GalCer specificity could be due to the Vα-chain of
rat TCRinv. To check this possibility, the amino acid sequence of rat liver Vα14 chain
(marked in Figure 10 in black) was compared with the Vα14.1 (AB036694) and
Vα14.1 (AB036695) TCR sequences, representing type I of rat TCRinv, that is
predominantly expressed in rat liver (Matsuura et al., 2000).
The alignment (presented as Figure 10) of the sequence of cloned rat Vα14-chain
with the published in GeneBank rat Vα14 TCR sequences (here in blue) revealed the
presence of two alterations in the V-region.
In this thesis, the amino acid numbering of TCR V-regions was according to
Matsuura (Matasuura et al., 2000). Since this nomenclature differs from that of Sim
(Sim et al., 2003) and the commonly used nomenclature of IMTG
(http://imgt.cines.fr:8140), the amino acids depicted in Figure 10 and according to
two nomenclatures are presented in Table 7.
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Table 7:
Matsuura et al.,
2000
IMTG
(Sim et al., 2003)
Start codon 1 1 (responds to 22 aa
by Matsuura)
First aa alteration 22 1
Second aa alteration 72 51
CDR1-region 47-53 25-32
CDR2-region 70-77 49-55
The arginine (R) at position 22 (according to Matsuura’s numeration, responds to aa
1 according to IMTG nomenclature), as well as threonine (T) at position 72 (51
according to IMTG) in published rat TCR sequence were exchanged for lysine (K).
The first K at position 22 of cloned rat TCR sequence was also present in the
functional mouse Vα14-chain, therefore we suggest that this amino acid was not
responsible for lack of rat TCR reactivity to α-GalCer.
Matsuura and coworkers have reported that the CDR1 (amino acids from 47 to 53)
region of rat TCR invariant is conserved between four rat TRAV14 proteins. By
contrast, the CDR2 region (amino acids from 70 to 77) is variable (Matsuura et al.,
2000). Additionally, six amino acids at positions: 4H (histidine), 72T (threonine),
73N (asparagine), 75E (glutamic acid), 77K (lysine) and 80R (argine) are common
for TRAV14S1, TRAV14S2 and TRAV14S4 (Matsuura et al., 2000). Therefore, we
suggest that the amino acid alteration at position 72 of cloned rat TCR might have
been critical for Ag-recognition. The exchange of threonine having uncharged side
group into basic lysine, which has a charged side chain, in the CDR2 region
(complementarity determining region) of rat TCRα could have destroyed the
interaction of TCR with CD1d molecule and abolished α-GalCer recognition.
Furthermore, when the sequence of cloned rat TCRinv was compared with responding
mouse sequence (M14506), one amino acid difference within the CDR3 regions was
found. Instead of alanine (A) present in mouse sequence, the rat CDR3 contained
valine (V).
The V-region and J18 region of rat TCR are known but the region where V and J
regions are joined was predicted according to IMGT database and might contain
either alanine (A) or valine (V), while in the mouse sequence alanine (A) or glycine
(G) can be found. Therefore, it is not clear if valine, which was the last aa of the V-
region, could negatively influence the α-GalCer recognition by rat TCRinv.
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2.3. Generation and expression of chimeric rat Vα14+ TCR
To generate the rat TCRinv free of mutations, the cloning procedure was repeated.
Several cDNA-derived F344 liver and splenic Vα14+ TCRs were analysed but each
time the cloned sequences were different with published ones.
To determine whether aa differences in cDNA sequence appeared as PCR errors, the
expression of four TRAV14 gene products was analysed on the genomic level, using
high fidelity DNA Polymerase. The germline sequence was identical with published
one- the PCR product was free of mutations.
In order to generate rat TCR invariant containing a canonical J-region, the sequence
of rat TCR obtained from cDNA (“F344 liver rVα14*TCR” marked in Figure 10 in
black) containing mutations was replaced for the right Vα14 sequence from gDNA
(in grey), creating in this way chimeric rVα14(gDNA)/rJC(cDNA) (depicted in
violet) rat TCR. As a source of rat JC-region another rat liver TCR (sequence in red)
was used. Similarly to the previously cloned rat Vα14+ TCR, the new TCR had
mutations in V-region but in contrast with old rat TCR, it contained at the VJ-joining
region not valine but alanine, typical for mouse TCR.
The cloning strategy is presented in Figure 11. The digestion with EspI restriction
enzyme allowed excision of the part of V-region containing mutations off leaving
the CDR3 region and V-J juncional region untouched.
In parallel, the mouse (Figure 10: bright green sequence- “cloned mVa14”) and
mouse/rat chimeric (“mVα14rJC” marked in dark green) TCRs were generated as
positive control.
Cloned into retroviral GFP vector (EcoRI/BamHIII site) rVα14+rJC or mVα14+rJC
TCRs were used for transfection of 293T cells and infection of BW58 or
BWr/mCD28 cell lines. Similar to previously, Vα14+-GFP+ cells were infected with
either mouse or rat Vβ8.2 chain generating the panel of chimeric TCRs.
The surface expression of new TCRs was analysed by FACS staining. Only cell
lines positive for Vβ8.2 and mCD3 Abs had TCR receptor on the surface.
Data from representative staining, presented as Figure 12, showed that only
BWr/mCD28 expressing mouse canonical mVα14TCR rearranged with rat Vβ8.2
was positively stained with anti-Vβ8.2 and anti-CD3 mAbs. BWr/mCD28 cells
positive for mVα14rJC or rVα14rJC TCR, paired with rat Vβ8.2 chain, were
r
V
αααα 1
4
(
g
D
N
A
)
/
r
J
C
 
(
c
D
N
A
)
 
 
 
 
M
G
K
H
L
S
A
C
W
V
L
L
W
L
H
H
Q
W
V
A
G
R
T
Q
V
E
Q
S
P
Q
S
L
V
V
H
E
G
E
S
C
V
L
Q
C
N
Y
T
V
T
P
F
N
N
L
R
W
Y
K
Q
D
R
G
R
A
P
V
S
L
T
V
L
T
N
K
E
E
K
T
S
R
G
R
Y
S
A
T
L
D
A
D
A
K
H
S
T
L
H
I
T
A
S
L
L
D
D
A
A
T
Y
I
C
V
V
A
D
R
G
S
A
L
G
K
L
Y
F
G
I
G
T
Q
L
T
V
T
P
D
V
T
D
P
E
P
A
V
Y
Q
L
K
D
P
Q
S
D
N
I
T
L
C
L
F
T
D
F
D
S
Q
T
N
V
S
Q
S
A
S
S
E
A
F
V
S
G
N
T
V
M
D
M
K
A
M
D
S
K
S
N
G
A
I
A
W
S
N
Q
T
S
F
S
C
K
D
A
F
K
K
N
A
S
H
P
T
S
D
V
P
C
D
A
K
L
V
E
K
S
F
E
T
D
M
N
L
N
F
Q
N
L
S
V
M
G
L
R
I
L
L
L
K
V
A
G
F
N
L
L
M
T
L
R
L
W
S
S
 
m
V
αααα 1
4
/
r
J
C
 
 
 
 
M
K
K
R
L
S
A
C
W
V
L
L
W
L
H
Y
Q
W
V
A
G
K
T
Q
V
E
Q
S
P
Q
S
L
V
V
R
Q
G
E
N
C
V
L
Q
C
N
Y
S
V
T
P
D
N
N
L
R
W
F
K
Q
D
T
G
K
G
L
V
S
L
T
V
L
V
D
Q
K
D
K
T
S
N
G
R
Y
S
A
T
L
D
K
D
A
K
H
S
T
L
H
I
T
A
S
L
L
D
D
A
A
T
Y
I
C
V
V
A
D
R
G
S
A
L
G
K
L
Y
F
G
I
G
T
Q
L
T
V
T
P
D
V
T
D
P
E
P
A
V
Y
Q
L
K
D
P
Q
S
D
N
I
T
L
C
L
F
T
D
F
D
S
Q
T
N
V
S
Q
S
A
S
S
E
A
F
V
S
G
N
T
V
M
D
M
K
A
M
D
S
K
S
N
G
A
I
A
W
S
N
Q
T
S
F
S
C
K
D
A
F
K
K
N
A
S
H
P
T
S
D
V
P
C
D
A
K
L
V
E
K
S
F
E
T
D
M
N
L
N
F
Q
N
L
S
V
M
G
L
R
I
L
L
L
K
V
A
G
F
N
L
L
M
T
L
R
L
W
S
S
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
F
ig
u
re
 1
1:
 G
en
er
at
io
n
 o
f 
ch
im
er
ic
 V
αααα 1
4 
T
C
R
s.
T
he
 r
at
 V
α1
4 
T
C
R
 o
bt
ai
ne
d 
fr
om
 g
D
N
A
 w
as
 d
ig
es
te
d 
w
ith
 E
co
R
I/E
sp
I,
 w
hi
le
 r
at
 V
α1
4r
JC
 T
C
R
 o
bt
ai
ne
d 
fr
om
 c
D
N
A
 a
s 
w
el
l a
s 
m
ou
se
 V
α1
4m
JC
 T
C
R
 w
er
e 
di
ge
st
ed
 w
ith
E
co
R
I/E
sp
I/B
am
H
III
 e
nz
ym
es
. 
A
pp
ro
pr
ia
te
 D
N
A
 f
ra
gm
en
ts
 w
er
e 
pu
rif
ie
d 
af
te
r 
ag
ar
os
e
 g
el
 e
le
ct
ro
ph
or
es
is
 a
nd
 w
er
e 
lig
at
ed
 w
ith
 T
4 
Li
ga
se
 in
to
 E
co
R
I/B
am
H
III
 s
ite
 o
f r
et
ro
vi
ra
l
pc
zC
F
G
5-
IE
G
N
 v
ec
to
r.
C
M
V
   
   
   
  E
co
R
I  
   
   
   
   
   
E
sp
I  
   
   
   
   
B
am
H
III
  E
G
F
P
/N
eo
m
V
αααα 1
4r
JC
C
M
V
   
   
   
  E
co
R
I  
   
   
   
   
   
E
sp
I  
   
   
   
   
B
am
H
III
  E
G
F
P
/N
eo
rV
αααα 1
4r
JC
V
-r
eg
io
n 
   
 J
C
-r
eg
io
n
E
co
R
I  
   
   
   
  
E
sp
I 
   
   
   
   
   
B
am
H
III
E
co
R
I  
   
   
   
  
E
sp
I 
   
   
   
   
   
B
am
H
III
E
co
R
I  
   
   
   
  
E
sp
I 
   
   
   
   
   
B
am
H
III
E
co
R
I  
   
   
   
  E
sp
I
ra
t V
αααα 1
4 
(g
D
N
A
)
ra
t V
αααα 1
4 
(c
D
N
A
)
m
o
u
se
 V
αααα 1
4 
78
GFP
m
Ig
G
1k
 P
E
h
Ig
G
1 
b
io
GFP
R
78
 P
E
m
C
D
3 
b
io
GFP-vector
mVα14rJCrVβ8.2
rVα14rJCrVβ8.2
rVα14rJCrVβ8.4
mVα14rJCrVβ8.4
mVα14rVβ8.2
mVα14rVβ8.4
Figure 12:
Expression of rat Vβ8.2 and Vβ8.4 but not mouse CD3 on the surface of 
BWr/mCD28 cells transduced with chimeric mouse and rat Vα14+TCR.
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80
positively stained with anti-rat Vβ8.2 mAb but were negative for anti-mouse CD3
Ab, suggesting that the rat Vβ8.2 chain could appear on the surface of BWr/mCD28
cells as a homodimer. These observations are consistent with a previous study
showing rat but not mouse Vβ8.2 expression on the surface of BW cells without
CD3 (Anne Asmuss’s PhD thesis). Neither rat/rat (rVα14rJC) nor mouse/rat
(mVα14rJC) chimeric TCR could be successfully expressed with mouse Vβ8.2
chain. The absence of CD3-α/βTCR complex on the surface made these transgenic
cells unresponsive to Ab or Ag stimulation.
The rat Vα14+ TCR was cloned twice. First TCR could be successfully expressed on
the surface of BWr/mCD28 cells but probably due to mutation present in V-region it
could respond to Ab but not to α-GalCer stimulation. The second Vα14+TCR,
generated using molecular biology methods had the canonical amino acid sequence
but it could not be paired with any of Vβ-chains and therefore it could not be
expressed on the surface of BWr/mCD28 cells.
The comparison of the sequences of both cloned rat TCRinv (Figure 10) as well as the
generation of chimeric TCR comprising rat Vα14-region rearranged with mouse JC
region will allow the definition of the positions in rat TCR responsible for the lack of
α-GalCer reactivity.
III. RAT CD1d
3.1. Expression of rat CD1d in different rat organs
To closer identify rat NKRP1A+TCR+ cells and the mechanisms of their α-GalCer
recognition, the capacity of rat CD1d molecule to present this Ag was tested.
Rat CD1d has been described as nonpolymorphic surface glycoprotein consisting of
a heterodimer of α-chain (45kDa) associated with β2m. CD1d can be expressed in
lymphoid (thymus, LN, spleen) and nonlymphoid (liver, kidney, heart, lung) organs.
81
No anti-rat CD1d monoclonal antibody is available for the detection of rCD1d
surface expression. To confirm the presence of CD1d in different rat organs, RNA
from thymus, liver, spleen and bone marrow lymphocytes was isolated and RT-PCR
with CD1d specific primers was done.
According to data presented in Figure 13, rat CD1d could be detected on mRNA
level in all tested organs. A strong signal for rCD1d was found in BM, weaker in
spleen and liver. No or only a weak band was observed for cDNA prepared from
RNA isolated from thymocytes.
3.2. Cloning and expression of ratCD1d
To characterise the specificity of rat NKRP1A+TCR+ cells for α-GalCer, rat CD1d
was cloned. The CD1d DNA prepared from F344 rat bone marrow was cloned into
TOPO-cloning vector and sequenced. Alignment of cloned rat CD1d with published
rat (AB029486) and mouse CD1ds (mCD1d1-NM_007639; mCD1d2-
NM_007640) is shown in Figure 14.
Mouse and rat CD1d molecules were highly homologous. One nucleotide at the
position 28 of cloned rCD1d was different with rCD1d sequence published in the
GeneBank (NM_017079, sequence not shown), but identical with other rCD1d
submitted under the number AB029486. The arginine 28 (responding to 11. aa
according to numbering by Ichimiya (Ichimiya et al., 1994) was also found in the
mouse CD1d sequence. Furthermore, the tyrosine-targeting motif (YXXZ-marked
by quadrant frame), required for endosomal localisation of CD1d as well as four aa
(Arg79, Asp80, Glu83 and Asp 153), important for the glycolipid presentation by
mouse CD1d (Kamada et al., 2001) were also found in the rat CD1d sequence.
Therefore, it is very possible that both mouse and rat species have the same or
similar pathway of processing and Ag presentation.
N366  E2F            E3F                          E2R                                       E1R
  5‘U/L                   α-1              α-2              α-3                            TM/C           C/UN3‘
  97/61                   270             279             279                           100              22/29
100 bp    BM     Spl    Th      Liv     Wat    BM      Spl     Th      Liv     Wat    BM     Spl     Th    100 bp
E3F/E1R E3F/E2R E2F/E2R
950 ntd 828 ntd 889 ntd
Figure 13: Detection of F344 rat CD1d mRNA by RT-PCR.
500 ng of RNA isolated from bone marrow (BM), spleen (Spl), thymus (Th) and liver (Liv)
lymphocytes were used to prepare cDNA, which was further amplified with rCD1d specific
primers (E3F/E1R, E3F/E2R, E2F/E2R).
82
F
ig
u
re
 1
4:
 C
o
m
p
ar
is
o
n
 o
f 
cl
o
n
ed
 r
at
 C
D
1d
 w
it
h
 p
u
b
lis
h
ed
 m
o
u
se
 a
n
d
 r
at
 C
D
1d
 s
eq
u
en
ce
s.
F
34
4 
ra
t 
B
M
 d
er
iv
ed
 D
N
A
 w
as
 a
m
pl
ifi
ed
 w
ith
 N
36
6/
E
1R
 p
rim
er
s,
 c
lo
ne
d 
in
to
 T
op
oC
lo
ni
ng
 v
ec
to
r 
an
d 
se
qu
en
ce
d 
w
ith
 T
op
oC
lo
ni
ng
 v
ec
to
r 
sp
ec
ifi
c 
pr
im
er
s 
(M
13
F
/M
13
R
)
bi
nd
in
g 
ex
te
rn
al
ly
 t
o 
th
e 
in
se
rt
. 
T
he
 a
lig
nm
en
t 
of
 c
lo
ne
d 
ra
t 
C
D
1d
 (
in
 r
ed
) 
w
ith
 p
ub
lis
he
d 
rC
D
1d
 (
A
B
02
94
86
) 
an
d 
m
ou
se
 C
D
1d
1 
(N
M
_0
07
63
9)
 a
nd
 C
D
1d
2 
(N
M
_0
07
64
0)
se
qu
en
ce
s.
 I
de
nt
ic
al
 a
a
 a
re
 p
re
se
nt
ed
 a
s 
da
sh
es
, 
di
ffe
re
nt
 a
a
 a
s 
a 
bo
ld
 le
tte
rs
, 
an
d 
am
in
o 
ac
id
 d
el
et
io
ns
 a
re
 r
ep
re
se
nt
ed
 b
y 
a 
( *
). 
F
ou
r 
am
in
o 
ac
id
s 
in
vo
lv
ed
 in
 t
he
α-
G
al
C
er
-C
D
1d
 in
te
ra
ct
io
n 
(A
rg
79
, 
A
sp
80
, 
G
lu
83
 a
nd
 A
sp
15
3;
 K
am
ad
a
 e
t a
l.,
 2
00
1)
 a
re
 p
re
se
nt
ed
 a
s 
un
de
rli
ne
d 
bo
ld
 le
tte
rs
. 
A
la
ni
ne
 a
t 
po
si
tio
n 
11
9 
ty
pi
ca
l f
or
 F
34
4 
ra
t
st
ra
in
 (
K
at
ab
am
i e
t a
l.,
 1
99
8)
 is
 d
ep
ic
te
d 
by
 b
lu
e 
ar
ro
w
. 
T
he
 n
um
be
rin
g 
of
 a
a
 r
es
po
nd
s 
to
 t
he
 n
um
be
rin
g 
gi
ve
n 
by
 I
ch
im
iy
a
 (
Ic
hi
m
iy
a
 e
t a
l.,
 1
99
4)
.
L
e
a
d
e
r
 
 
 
 
 
αααα -
1
 
-
1
8
 
 
 
 
 
 
 
1
 
 
 
 
C
l
o
n
e
d
 
r
C
D
1
d
M
L
Y
L
P
C
L
L
L
W
A
F
P
Q
F
W
G
Q
S
E
V
Q
Q
*
N
Y
T
F
R
C
L
Q
I
S
S
F
A
N
R
S
W
S
R
T
D
S
V
V
W
L
G
D
L
Q
T
H
R
W
S
N
D
S
D
T
I
S
F
T
K
P
W
S
Q
G
K
F
S
N
Q
Q
W
E
K
L
Q
A
B
0
2
9
4
8
6
/
r
C
D
1
d
-
L
-
-
-
C
-
-
-
-
-
-
P
-
F
-
-
-
-
-
V
-
-
*
-
-
-
-
R
-
-
-
I
-
-
-
-
-
R
-
-
-
-
-
-
-
V
V
W
-
-
-
-
-
-
-
-
-
-
-
-
-
D
-
-
-
-
-
-
-
-
-
-
-
-
F
-
-
-
-
-
-
-
-
-
N
M
_
0
0
7
6
3
9
/
m
C
D
1
d
1
-
R
-
-
-
W
-
-
-
-
-
-
L
-
V
-
-
-
-
-
A
-
-
K
-
-
-
-
R
-
-
-
M
-
-
-
-
-
R
-
-
-
-
-
-
-
V
V
W
-
-
-
-
-
-
-
-
-
-
-
-
-
A
-
-
-
-
-
-
-
-
-
-
-
-
L
-
-
-
-
-
-
-
-
-
N
M
_
0
0
7
6
4
0
/
m
C
D
1
d
2
-
R
-
-
-
C
-
-
-
-
-
-
L
-
V
-
-
-
-
-
V
-
-
K
-
-
-
-
R
-
-
-
T
-
-
-
-
-
I
-
-
-
-
-
-
-
L
I
L
-
-
-
-
-
-
-
-
-
-
-
-
-
A
-
-
-
-
-
-
-
-
-
-
-
-
L
-
-
-
-
-
-
-
-
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
αααα -
2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7
9
 
 
 
 
8
3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
1
9
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H
M
F
Q
V
Y
R
T
S
F
T
R
D
I
K
E
I
V
K
M
M
S
P
K
E
D
Y
P
I
E
V
Q
L
S
A
G
C
E
M
Y
P
G
N
A
S
E
S
F
L
H
V
A
F
Q
G
E
Y
V
V
R
F
H
G
T
S
W
Q
K
V
P
E
A
P
S
W
L
D
L
P
I
K
M
L
N
A
-
-
-
-
-
-
-
T
-
-
-
-
-
-
K
-
I
-
-
-
-
-
-
-
-
-
-
-
-
-
V
-
-
-
A
-
-
-
-
-
-
-
-
-
-
-
-
-
L
-
-
-
-
-
-
E
-
V
-
-
-
H
-
-
-
-
-
K
-
P
E
-
-
-
-
-
-
-
-
-
-
M
-
-
-
-
-
-
-
-
-
-
V
-
-
-
-
-
-
Q
-
L
-
-
-
-
-
-
-
-
-
-
-
-
-
I
-
-
-
A
-
-
-
-
-
-
-
-
-
-
-
-
-
L
-
-
-
-
-
-
K
-
V
-
-
-
W
-
-
-
-
-
T
-
P
G
-
-
-
-
-
-
-
-
-
-
V
-
-
-
-
-
-
-
-
-
-
V
-
-
-
-
-
-
Q
-
L
-
-
-
-
-
-
-
-
-
-
-
-
-
I
-
-
-
T
-
-
-
-
-
-
-
-
-
-
-
-
-
F
-
-
-
-
-
-
K
-
A
-
-
-
R
-
-
-
-
-
R
-
L
G
-
-
-
-
-
-
-
-
-
-
V
-
-
-
            
            
    
        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
αααα -
3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
5
3 D
E
G
T
R
E
T
V
Q
I
L
L
N
D
T
C
P
Q
F
V
R
G
L
L
E
A
G
K
P
D
L
E
K
Q
E
K
P
V
A
W
L
S
R
G
P
N
P
A
H
G
H
L
Q
L
V
C
H
V
S
G
F
H
P
K
P
V
W
V
M
W
M
R
G
D
Q
E
Q
G
G
T
H
R
G
D
I
-
E
-
-
R
E
-
-
-
I
-
-
-
-
-
C
-
Q
-
V
-
-
-
-
-
-
-
-
P
-
-
-
-
-
-
-
-
-
-
-
-
-
R
G
-
N
P
-
H
-
-
L
-
-
-
-
-
-
-
-
-
H
-
-
-
-
-
-
-
W
-
-
-
-
-
-
-
G
-
-
-
-
-
-
I
-
Q
-
-
S
A
-
-
-
M
-
-
-
-
-
C
-
L
-
V
-
-
-
-
-
-
-
-
S
-
-
-
-
-
-
-
-
-
-
-
-
-
S
V
-
S
S
-
D
-
-
R
-
-
-
-
-
-
-
-
-
Y
-
-
-
-
-
-
-
C
-
-
-
-
-
-
-
Q
-
-
-
-
-
-
F
-
Q
-
-
S
A
-
-
-
T
-
-
-
-
-
W
-
Q
-
A
-
-
-
-
-
-
-
-
S
-
-
-
-
-
-
-
-
-
-
-
-
-
S
V
-
S
S
-
H
-
-
L
-
-
-
-
-
-
-
-
-
Y
-
-
-
-
-
-
-
W
-
-
-
-
-
-
-
Q
-
-
-
-
-
-
F
 
 
 
 
 
T
M
/
C
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C
L
P
N
A
D
E
T
W
Y
L
Q
A
T
L
D
V
E
A
G
D
E
A
G
L
A
C
R
V
K
H
S
S
L
E
G
Q
D
I
I
L
Y
W
G
G
R
Q
V
S
P
V
L
I
F
L
I
V
G
V
L
V
L
V
V
C
A
V
A
Y
Y
I
I
R
K
R
R
R
S
Y
Q
D
I
M
 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
D
-
-
-
-
-
-
-
-
-
-
-
-
-
E
-
-
-
-
-
-
-
-
G
G
-
-
V
S
P
V
-
-
F
L
-
-
G
V
L
V
L
-
-
C
-
-
A
-
-
-
I
-
K
-
-
R
S
-
-
-
-
M
 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
E
-
-
-
-
-
-
-
-
-
-
-
-
-
G
-
-
-
-
-
-
-
-
D
A
-
-
A
P
V
G
-
-
V
F
-
-
L
I
M
L
V
-
-
G
-
-
V
-
-
-
W
-
*
-
-
S
A
-
-
-
-
R
 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
E
-
-
-
-
-
-
-
-
-
-
-
-
-
G
-
-
-
-
-
-
-
-
D
A
-
-
A
P
V
G
-
-
V
F
-
-
L
I
M
L
V
-
-
G
-
-
V
-
-
-
W
-
*
-
-
S
A
-
-
-
-
R
83
84
3.3. Functional characterisation of cloned rCD1d
The question was if the structural amino acid homology of rat and mouse CD1d
corresponded to functional homology. Cloned into bicistronic retroviral vector BM
derived rat CD1d was used for transfection of 293T cells and infection of different
human, mouse and rat cell lines. GFP-positive cells were then used in functional
assays, in which the capacity of rCD1d transduced cell lines to present α-GalCer
was tested.
3.3.1. Presentation of α-GalCer by CD1d transgenic cells to KT12 hybridoma
As example, JM2-rat F344 hepatoma infected with rat CD1d was loaded with
different doses of α-GalCer and was used for stimulation of mouse Vα14+ KT12
hybridoma. The level of IL-2 produced by KT12 was tested in supernatants after 24h
co-culture. Results from this assay are presented in Figure 15.
KT12 hybridoma cells, due to high autopresentation, could secrete some IL-2 when
cultured with α-GalCer only (not depicted in Figure 15). JM2 cells as hepatic cells
expressed some endogenous rCD1d, therefore the wild type or mock-infected cells
were able to stimulate IL-2 production by KT12 hybridoma. However, when KT12
hybridoma was co-cultured in the presence of JM2 transduced with rCD1d cells, the
amounts of mouse IL-2 significantly increased. Therefore, cloned rat CD1d was
present on the surface of JM2 hepatoma and efficiently stimulated IL-2 production
by KT12 in α-GalCer dose dependent manner.
JM2 cells derive from F344 tissues. Therefore, it could be possible that cloned rat
CD1d molecule was efficiently expressed on the surface of this hepatoma due to
species/tissue specificity. To test whether rCD1d could be expressed in other cells,
diverse cell lines were infected with this CD1d and were used as APCs in functional
in vitro assays.
KT12 hybridoma could be efficiently stimulated with α-GalCer presented by mouse
RMA-S (Figure 16 D), P80 (Figure 16 B), and BW (Figure 16 C), human RAJI
(Figure 16 A), or rat H-II-4-E (Figure 16 E) cell lines transduced with rat CD1d. In
all cases, the increase in IL-2 secretion, as compared with control wild type or GFP-
vector infected cells, was especially visible for KT12 hybridoma stimulated with
rCD1d transgenic cells, loaded with lower doses of α-GalCer.
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Figure 15: 
IL-2 production by KT12 hybridoma after 24h stimulation with 
α-GalCer presented by JM2 cells transduced with rat CD1d.
2.5*104 of JM2 transgenic cells, plated onto 96 well flat bottom plate, were loaded 
ON with α-GalCer. Next morning 5*104 of KT12 hybridoma cells were added to APCs. 
After 24h culture at 37°C, the IL-2 in supernatants was measured by  ELISA.
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Figure 16: 
IL-2 production by KT12 hybridoma after 24h stimulation with 
α-GalCer presented by cell lines expressing rat CD1d. 
To 5*104 of CD1d transgenic cells, loaded for 1-2h  with α-GalCer, 5*104 of KT12 
hybridoma cells were added. After 24h coculture at 37°C, the IL-2 in supernatants 
was measured by ELISA.
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The differences in terms of α-GalCer presentation to KT12 hybridoma, by CD1d+
cell lines could be caused by differences in cell line origin or/and differences in α-
GalCer processing. Additionally, the natural capacity of CD1d+ cells for Ag
presentation should be also taken into account.
3.3.2. Presentation of α-GalCer by CD1d transgenic cells to mouse TCRinv. The
 importance of CD80-CD28 co-stimulatory pathway in the activation of
 Vα14+ cell lines.
The presence of CD80-CD28 co-stimulatory signal is necessary for efficient
activation of T cells. NKT cells express CD28 molecule, thus the interaction
between CD28 and CD80 present on APC could be important for activation of NKT
cells.
From previous functional assays (data not presented in the thesis), we knew that the
expression of TCRinv alone on the surface of BW cell line was not efficient in
triggering cytokine secretion. In contrast, BW cells positive for CD28, when
transduced with TCRinv could be activated and could respond to α-GalCer-CD1d
stimulation.
To enhance the response of BWm/rCD28+ cells expressing mouse TCRinv to α-
GalCer, rat CD80 molecule was expressed on the surface of CD1d+ cell lines,
creating in this way optimal conditions for co-stimulation. In the presence of two
signals: TCR-α-GalCer-CD1d and CD28-CD80, the stronger response of
BWr/mCD28-mVα14+ cells to α-GalCer was expected.
Different P80 CD1d+rCD80+ APCs, loaded with α-GalCer were used for 24h
stimulation of mouse TCRinv transgenic BWr/mCD28 cells. The cytokine secretion
was estimated by ELISA and results are shown in Figure 17.
No or low levels of IL-2 could be detected in supernatants of BWr/mCD28-mVα14+
cells incubated with P80 wild type, P80-GFP, P80mCD1d+ or P80rCD1d+ cells.
When P80 cells positive for rCD80 and either rat or mouse CD1d were used as
stimulus, the cytokine secretion increased significantly. Comparing the capability of
mouse and rat CD1d to present α-GalCer, in this experiment the presentation of Ag
by rat CD1d was better than the presentation by mouse counterpart- mouse Vα14+
cells produced more IL-2 in the response to rat than to mouse CD1d.
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Figure 17: 
Importance of CD28-CD80 co-stimulatory interactions for responses of Vα14 positive cells.
5*104 APCs were loaded with different doses of α-GalCer and were used for 24h stimulation of BWr/mCD28 (5*104) cells 
expressing mVα14mVβ8.2 TCR. After 24h IL-2 in supernatants was measured by ELISA.
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Figure 18: 
Inhibition of IL-2 production by anti-rat CD80 mAb.
BWr/mCD28mVα14mVβ8.2 (5*104) cells were incubated for 24h 
with α-GalCer loaded APCs and either hCD25 or rCD80 mAbs.
IL-2 in supernatants  was measured by ELISA. 
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Furthermore, BWr/mCD28 cell line expressing mouse TCRinv could recognise α-
GalCer presented by both mouse and rat CD1d but only in the presence of two
stimulatory signals.
Figure 18 shows that the IL-2 production by BWr/mCD28mVα14mVβ8.2 cells
could be inhibited in the presence of anti-rat CD80 mAb (10 µg/ml), while the
addition of isotype control (here hCD25 Ab at 10 µg/ml) to the culture did not
influence cytokine secretion.
Therefore, the presence of CD80-CD28 costimulatory pathway was not only
important but rather necessary for efficient activation of mouse Vα14+ cell lines by
α-GalCer presented by P80CD1d transgenic cells.
In conclusion, the CD1d-lipid Ag-Vα14TCRinv system shows similarities to MHC-
peptides Ag-TCR system. In both cases, Ag recognition and efficient cell activation
can take place only in the presence of two stimulatory signals.
The cloning and over-expression of rCD1d on the surface of different cell lines did
not represent the natural situation in vivo. Nevertheless, it allowed confirmation that,
similar to mouse, rat CD1d was functional and able to represent α-GalCer to KT12
hybridoma and BWr/mCD28 cell line expressing mouse TCRinv.
3.4. Production of anti-rat CD1d monoclonal Ab
Because no anti-rat CD1d monoclonal antibody is available, we attempted to
generate such an antibody. To this end, M12 lymphoma cells, known to be efficient
APCs, were transduced, via retroviral infection, with genes encoding rat CD1d.
GFP-positive cells were used for immunisation of BALB/c CD1d-/- mice (detailed
protocol is written in Materials and Methods).
Fusion was done using SP2/O fusion partner and supernatants were tested for rCD1d
specificity by FACS staining using rat thymocytes and splenocytes or rCD1d
transgenic cells.
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3.4.1. Screening of fusion supernatants on P80-CD1d transgenic cells
The capability of rCD1d fusion hybridomas to produce anti-rat CD1d mAb was
tested on human RAJI and mouse P80 rCD1d transgenic cells.
As example, the staining of P80rCD1d cells is shown in Figure 19A. P80 wild type,
as well as mock or mouse/rat CD1d infected P80 cells were incubated with the
culture supernatant from one of the fusion hybridomas. The presence of anti-rat
CD1d specific Abs bound to surface CD1d was detected with donkey anti-mouse
IgG-PE.
Novel anti-rat CD1d Ab was specific not only for rat but also mouse CD1d. The rat
antibody recognised mCD1d naturally expressed on the surface of P80 cells but
when these cells were additionally transduced with cloned mCD1d much higher
expression of CD1d could be detected. Furthermore, the novel rat antibody
positively stained rCD1d but not mock infected P80 cells confirming it’s specificity
for rCD1d.
Similar staining was performed for human RAJI cell line transduced with rCD1d.
Only RAJI cells expressing rCD1d, but not wild type or GFP-vector infected cells,
were positively stained with fusion hybridoma supernatant and DαMIgGPE (data
not shown).
3.4.2. Screening of fusion supernatants on mouse and rat primary cells
Mouse splenocytes and thymocytes are known to be CD1d-positive. Therefore, the
rCD1d specificity of fusion supernatant was tested on mouse (control) and rat
thymus and spleen-derived lymphocytes. Here, only FACS staining of thymocytes is
presented.
Figure 19B shows that the 1B1 anti-mouse CD1d mAb, used as a control, positively
labelled CD1d expressed by mouse but not rat thymocytes, excluding its cross-
reactivity.
When thymocytes of both species were stained with a fusion supernatant, positive
cells could be detected in both rat and mouse, confirming the species cross-reactivity
of novel anti-rat CD1d Ab. Furthermore, the better binding of rCD1d
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Ab/DαMIgGPE complex to LEW than F344 thymocytes could be observed. This
may suggest that some inter-strain differences in the natural level of CD1d
expression, among LEW and F344 rat, can be observed.
A similar pattern of the staining was found when mouse and rat splenocytes were
used (data not shown).
The staining of primary rat cells and the staining of CD1d transgenic cell lines
suggest that the novel T cell hybridoma produces antibody against rCD1d which is
cross-reactive with mouse CD1d. The specificity of culture supernatant will be
further tested in the functional assays and analysed using immunoprecipitation and
Western Blot methods.
IV. The comparison of CD1d-α-GalCer-TCRinv system in
F344 and LEW rat
4.1. F344 and LEW splenocytes respond differently to α-GalCer
stimulation
α-GalCer is the specific Ag activating mouse NKT cells but also (as presented
above) lymphocytes isolated from F344 liver or spleen. In order to check whether
the response of rat cells to α-GalCer stimulation was characteristic only for F344 rat
strain, lymphocytes isolated from F344 and LEW spleen were stimulated with α-
GalCer or its chemical analog- OCH. After 3 days culture the production of
cytokines by these cells was measured by ELISA.
Figure 20 indicates that upon α-GalCer stimulation F344 but not LEW splenocytes
were able to produce significant amounts of IFN-γ (Figure 20 A) and IL-4 (Figure 20
B) in an Ag-dose dependent manner. When OCH was used as stimulus, the response
of F344 cells was much weaker suggesting that only α-GalCer was able to
efficiently activate rat NKT cells. This is a surprising result given that Myamoto et
al., (2001) used OCH to treat autoimmune disease in mice.
Table 5:
Detection of rat Vα14 mRNA by RT-PCR.
500 ng of mRNA isolated from mouse or rat lymphocytes obtained from LN, thymus,
spleen, and liver were used to prepare cDNA. 1 ml of each cDNA was amplified with
Vα14TCR specific or β-actin primers. The PCR signal was estimated as follows: (+++)-
very strong band, (++)- strong band, (+)- positive, (+/-)- slightly positive, (-)- negative.
++-+++Liver
++/-+Spleen
++/-++Thymus
+/--++LN
F344LEW
RatC57Bl6
mouse
Organ
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Figure 20: 
Comparison of IFN-γ (A) and IL-4 (B) production by F344 and LEW 
splenocytes (5*105cells) after 24h stimulation with α-GalCer and OCH.
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In contrast to F344, LEW rat splenocytes responded similarly to α-GalCer and OCH
stimulation. In both cases no IL-4 and very low levels of IFN-γ could be detected in
culture supernatants.
The results from functional assays are in agreement with data obtained from the RT-
PCR analysis of Vα14 mRNA in different LEW and F344 rat tissues. As it was
shown in Table 5, in all tested organs the Vα14+-PCR signal was weaker in LEW
than in F344 rat tissues. Therefore, it is likely that LEW rat, in contrast to F344 rat,
did not contain or contained only a small proportion of α-GalCer responding cells.
4.2. Characterisation of rat CD1d+ APCs
As it was previously shown, rat thymocytes, similar to mouse cells, were able to
present α-GalCer and efficiently stimulate the IL-2 production by BWr/mCD28 cell
line expressing mouse TCRinv. Given the different response of LEW and F344 rat
splenocytes to α-GalCer stimulation it was important to check if these two stains
have also different capacities of Ag presentation. To this end, mouse (as a control)
and LEW and F344 rat CD1d+ thymocytes were loaded with different doses of α-
GalCer and were used for stimulation of Vα14+ KT12 hybridoma. The level of IL-2
released by activated KT12 cells, after 24h coculture, was determined by supernatant
ELISA and was presented in Figure 21.
Both F344 and LEW thymocytes were able to activate KT12 hybridoma almost as
well as mouse cells. This could suggest that the rCD1d was expressed in rat thymus
at comparable level with mCD1d in mouse organ. Secondly, rat CD1d was
functional and could stimulate α-GalCer-dependent IL-2 production by mouse KT12
cells.
Because KT12 hybridoma possesses a high level of autoreactivity and may produce
significant amounts of IL-2 even in the absence of APCs, presented results can be
questioned. However, when KT12 hybridoma cells were stimulated with Ag-loaded
APCs, the cytokine secretion was more pronounced especially at lower doses of α-
GalCer. To confirm whether IL-2 production by KT12 hybridoma was due to Ag
presentation by F344 or LEW rat cells but not due to KT12’s autoreactivity,
additional assays with hybridoma expressing rat TCRinv would be needed.
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Figure 21: 
IL-2 production by KT12 hybridoma (5*104cells) after 24h stimulation 
with α-GalCer presented by mouse and rat thymoctes (1*106cells).
Comparing F344 and LEW rat CD1d-α-GalCer-TCRinv system it might be concluded 
that both strains had similar capability of α-GalCer presentation but they differed in 
terms of this Ag recognition.
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Chapter 4:
DISCUSSION
I. Properties of rat NKRP1A+TCR+ cells
1.1. Phenotype, frequency and α-GalCer-mCD1d tetramer
staining of rat splenocytes and IHLs
Mouse and human NKT cells are well characterised, while this population remains
poorly characterised in rat. It has been difficult to clone NKRP1+ T lymphocytes
from rat and only a few reports describing these cells are available.
Firstly, Knudsen has identified rat NKRP1+TCR+ cells, which phenotypically could
correspond to mouse NKT cells. The DN or CD4+ NKRP1+TCR+ clones, obtained
from PVG rat splenocytes cocultured with MIP-1α (macrophage inflammatory
protein-1α) in vitro, expressed Vβ8.2+ TCR and secreted various cytokines (Knudsen
et al., 1997). By contrast, freshly isolated rat splenic NKRP1+TCR+ cells are mostly
CD8+ with no skewing in the Vβ repertoire. Therefore, it is likely that Knudsen
cloned rare rat NKT cells.
The presence of rat NKRP1+TCR+ cells was additionally confirmed for allo- and
xenogeneic (rat-mouse) chimeras, in which approximately 80-90% of NKRP1+ cells
expressed α/βTCR (Kaufman et al., 1993).
In order to determine whether rat spleen-derived NKRP1+TCR+ clones, generated by
Knudsen, corresponded to mouse or human NKT cells, the phenotype, distribution,
frequency and functions of NKRP1+TCR+ cells were characterised in this thesis. All
experiments were done on F344 rat, since this strain was previously reported to
express an invariant Vα14+ TCR (Matsuura et al., 2000).
Firstly, the phenotype and distribution of F344 rat NKRP1+TCR+ lymphocytes in
diverse tissues were determined by FACS analysis.
It is well known that mouse Vα14+ and human Vα24+ NKT cells express several
NK-locus-encoded C type lectins (Bendelac et al., 1997; Exley et al., 1998).
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In mice, the NK locus encodes three NKRP1 molecules: NKRP1A, B and C.
NKRP1C has been reported to be an activating receptor, whereas NKRP1B is a
killer cell inhibitory receptor (Carlyle et al., 1999).
A human homologue of the mouse NK1.1 (NKRP1C) is NKRP1A, which may be
expressed on NK and T lymphocytes (Lanier et al., 1994) or on a subset of human
immature thymocytes (Poggi et al., 1996). Although human NKRP1A is not the
exact homologue of mouse NK1.1 (NKRP1C), this marker is commonly used to
identify NKT cells in the liver or perypherial blood (Ishihara et al., 1999; Exley et
al., 1998).
In rats, there are two genes encoding NKRP1 molecules. Similar to mouse, rat
NKRP1A functions as an activation receptor, while NKRP1B contains
immunoreceptor tyrosine-based inhibitory motif and therefore is an inhibitory
receptor (Brissette-Storkus et al., 1994; Ryan et al., 1995; Li et al., 2003).
Interestingly, similarly to anti-NK1.1 PK136 mAb that recognises both mouse
activating NKRP1C and inhibitory NKRP1B markers (Kung et al., 2001), anti-
NKRP1 mAb, used in the study, has a specificity for both A and B forms of rat
NKRP1 (Li et al., 2003).
By analogy to the human system, NKRP1A in rats corresponds to mouse NK1.1 and
is expressed by NK and NKT cells, to lesser extent by rat neutrophils (Kalia et al.,
2003; Chambers et al., 1992). Since the expression of NKRP1A is not exclusive
only for NKT cells, to identify F344 rat invariant T cells, anti-NKRP1A mAb
together with anti-TCR or anti-CD3 mAbs were used in the study. Only lymphocytes
coexpressing TCR/CD3 and NKRP1A marker were identified as rat NKT cells.
As tested by FACS staining, rat NKRP1A+TCR+ lymphocytes were the most
frequent in the liver. However, their frequency in this organ was 4-8 fold lower than
the frequency of mouse IHLs. Generally, NKRP1+TCR+ cells represented around
0.1-6% of total lymphocytes present in various rat tissues, while mouse counterparts
were present at higher frequencies (2-40%).
Interestingly, both species differed in the proportion of liver and splenic NKT cells.
Rat IHLs and splenocytes were expressed at the similar or comparable frequencies.
Liver contained 6.39% of NKRP1+CD3+ cells, while in rat spleen 4.04% of cells
with this phenotype could be found. By contrast, mouse NKT cells were around 10
fold more frequent in liver (32.18%) than in spleen (2.89%).
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In contrast to PVG NKT cell clones generated by Knudsen, hepatic and splenic F344
rat NKRP1A+TCR/CD3+ lyphocytes were more of CD8+ than of CD4+ phenotype.
However, the CD8 phenotype of F344 cells is consistent with data presented by
others. Matsuura and coworkers showed that the majority of F344 rat splenic and
hepatic NKT cells expressed CD8 (Matsuura et al., 2000). Similarly, CD8+ cells
have been found to be the main subset of NKT cells present in F344 rat lymph nodes
(LN) or submandibular salivary glans (SMG) (O’Sullivan et al., 2001).
The existence of CD8αβ+ rat NKT cells may contradict dogma on positive selection
of CD1d-α-GalCer specific TCRinv T cells (Eberl et al., 1999-c; Bendelac et al.,
1994; Benlagha et al., 2002; Gapin et al., 2001). It has been postulated that during
thymic development, NKT cells expressing CD8αβ, due to their high binding avidity
to CD1d are deleted (MacDonald 2000; Pellicci et al., 2002; Bendelac et al., 1994;
Eberl et al., 1999-b). The mechanisms of negative selection of NKT cells are
unknown and have been proven only indirectly. Data from experiments using
transgenic mice showed that CD1d-dependent CD8+ cells are absent, and
Vα14Jα18+ NKT cells can not develop in CD8α/β transgenic animals. Similarly, in
Vα14Jα18+ transgenic mice the CD8 compartment is depleted of Vβ7 and Vβ8 cells
(Bendelac et al., 1994; Lantz and Bendelac et al., 1994). Therefore, the canonical
NKT (Vα24+ TCRinv in human and Vα14+ TCRinv in mouse) cells can be either CD4-
CD8-(DN) or CD4+ but they never express heterodimeric CD8 (Davodeau et al.,
1997; Bendelac et al., 1994). However, the existence of CD8+ NKT cells in various
mouse organs has been previously reported. For instance, Hammond et al. as well as
Ohteki et al. suggested that the total population of hepatic NKT cells contains
around 4% of CD8α+β- T lymphocytes, which developed in a thymic- and
Vα14Jα281-independent manner (Hammond et al., 1999; Ohteki et al., 1994).
Mouse CD8α+β- as well as CD8α+β+ T cells have been also found in large intestine
(Bannai et al., 2001). However, in contrast to classical NKT cells, these CD8+ cells
possessed diverse and not invariant TCRα chain (Bannai et al., 2001).
Since rat CD8αβ+ cells represent the majority of splenic and hepatic NKRP1+TCR+
lymphocytes, it is tempting to suggest that CD8 marker may be more broadly
expressed as it has been previously appreciated. It would be interesting to determine
whether rat CD8+ NKT cells express Vα14+ TCRinv and whether they are generated
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according to the same or different developmental and selection mechanisms of
classical NKT cells.
The phenotype and low frequency of rat NKT cells may suggest more similarity to
human than to mouse NKT cell sub-populations.
It has been reported that the frequency of human NKT cells is much lower than the
frequency of mouse Vα14+ T cells and the phenotype and functions of these cells
may vary depending on the tissue distribution (Kim et al., 2002-a). Thus, the CD4+
or DN Vα24+NKRP1A+ NKT cells constitute only a small (between 0.01 and 0.1%)
proportion of human PBMCs, express low levels of NK cell markers and share the
functional features with mouse Vα14+ NKT cells (Dellabona et al., 1994; Porcelli et
al., 1993; Lee et al., 2002; Exley et al., 1997). By contrast, hepatic Vα24+ T cells
represent 0.5% of IHLs, express high levels of CD56, CD161 or CD69 and comprise
CD4+ as well as CD8+ cells (Kenna et al., 2003; Doherty et al., 1999; Ishihara et al.,
1999; Takahashi et al., 2002). Therefore, since human Vα24+ T cells may be CD8+
and are less frequent than Vα14+ T cells in mice F344 rat NKRP1A+TCR+ cells
would possibly correspond more to human than to mouse NKT cells.
The expression of NK1.1 on NKT cells may vary depending on the maturation level-
immature NKT cells usually lack the NK1.1 (Pellicci et al., 2002; Benlagha et al.,
2002), their activation state (Chen et al., 1998), as well as culture conditions- upon
in vitro activation NKT cells can lose NK1.1 expression (Chen et al., 1997-a).
Furthermore, a subpopulation of NKT cell may be present in strains negative for
NK1.1 (like BALB/c) (Hammond et al., 2001) or NK1.1 can be expressed by
lymphocytes, which are not CD1d-reactive like human and mouse activated CD8+
CTLs (McMahon et al., 2001; Assarsson et al., 2000) or mouse NK1.1+ cells that
neither express Vα14+ TCR nor are CD1d-dependent (Hammond et al., 1999; Eberl
et al., 1999-c).
Since NK1.1 is not exclusively expressed by NKT cells, the FACS staining with
anti-NK1.1 mAb seems to be not the most optimal method for the detection of
CD1d-restricted Vα14+ TCR positive cells. This problem has been overcome by
generating α-GalCer-CD1d tetramers. These tetramers are more sensitive than
monoclonal antibodies and are able to specifically recognise CD1d-restricted TCRinv
positive T cells within mixed lymphocyte populations (Matsuda et al., 2000;
Karadimitris et al., 2001; Benlagha et al., 2000-b). The usage of CD1d oligomers
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has an advantage- they can be used for both surface and intracellular phenotyping, as
well as for the in situ staining of Ag-specific T cells in tissues. Additionally, they
might be combined with functional assays (Klenerman et al., 2002).
CD1d-α-GalCer tetramers bind selectively to NKT cells, which express the invariant
TCR α-chain: Vα14-Jα18 in mice and Vα24-JαQ in humans, even if these cells are
present at very low frequencies (Gumperz et al., 2002; Matsuda et al., 2000;
Benlagha et al., 2000-b). The cells isolated from TCRJα18-/- or CD1d-/- mice are
tetramer negative (Matsuda et al., 2000; Benlagha et al., 2000-b).
Commonly used mouse and human CD1d tetramers are cross-reactive and recognise
mouse, human or rhesus macaque TCRinv positive NKT cells (Karadimitris et al.,
2001; Benlagha et al., 2000-b). However, the CD1d tetramer staining of
Vα14+/Vα24+ T lymphocytes can differ depending on the protocol used for CD1d
synthesis and Ag loading, or depending on the type of CD1d-α-GalCer multimer
used. The staining of Vα14+ cells with α-GalCer-loaded CD1d monomer usually
does not lead to labelling. CD1d dimers are more effective than monomers. The best
staining can be obtained when CD1d-α-GalCer tetramers are used (Benlagha et al.,
2000-b; Matsuda et al., 2000).
From the sequence analysis of mouse and rat CD1d we knew that these molecules
were highly homologous. Therefore, it appeared likely that due to structure and
amino acid homology, rat NKRP1A+TCR+ cells would be positively stained with
mCD1d-α-GalCer-tetramer, assuming that they express TCRinv.
When rat liver or spleen-derived lymphocytes were stained with mCD1d-α-GlaCer-
tetramer, only a few tetramer-binding cells could be detected. Because the staining
with mCD1d tetramer control gave also little reactivity, it was difficult to judge if
the binding of mCD1d-α-GlaCer-tetramer to rat cells was really specific. By
contrast, mouse IHLs or splenocytes, were positive in tetramer and clearly negative
in the control staining. It has been previously shown that around 80% of thymic or
liver and only 50% of spleen or BM NKT cells are α -GalCer-reactive and
Vα14Jα18 expressing T cells (Benlagha et al., 2000-b; Matsuda et al., 2000). When
the frequency of CD3+NK1.1+ mouse liver and splenic T cells was compared with
their affinity for CD1d-α-GalCer complex, 83% of IHLs and 73% of splenic
CD3+NK1.1+ T lymphocytes could bind to α-GalCer-loaded mouse CD1d tetramer.
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This relatively high number of tetramer positive mouse splenic cells may be
suprising, given that the spleen is an organ where mostly CD1d-independent NKT
cells are expressed. However, mouse spleen and BM may contain various cells with
different phenotype and functional features (Eberl et al., 1999-c; Hammond et al.,
2001). Therefore, apart from CD1d-independent cells, some CD1d-dependent NKT
cells were also present, and could bind to mouse CD1d-α-GalCer tetramer.
In both cases, when mouse or rat cells were labelled, a small population of CD3 or
CD4 negative cells that did bind to CD1d-αGalCer tetramer could be identified. The
presence of TCR-NK1.1-tetramer+ cells in mouse spleen has been also described by
Matsuda and colleagues (Matsuda et al., 2000). Because the majority of these TCR-
NK1.1- cells expressed also CD19 marker, they concluded that these cells were
splenic B lymphocytes, which bound to tetramer in α-GalCer independent manner.
Therefore, it is likely that “false tetramer positive” cells, detected in mCD1d
tetramer staining, represented TCR-NK1.1-tetramer+ splenic B lymphocytes or other
cell types, present in the cell preparation and unspecifically binding to mouse CD1d
tetramer. Relatively high background tetramer staining was also obtained for human
NKT cells. Lee and coworkers showed that among 0.01-0.1% of freshly isolated PB
Vα24/CD1d-α-GalCer NKT cells around 0.01-0.05% of unspecifically stained
noncanonical Vα24 cells could be found (Lee et al., 2002).
To exclude an unspecific binding and wrong interpretation of results, in future FACS
and tetramer stainings the anti-rat NKPR1A mAb will be used together with
additional markers such as CD3, CD19, rat homolog of mouse DX5 or human
CD56. The DX5 mAb was used for the staining of mouse NKT cells by Yang et al.
(2003), while the usage of anti-CD56 Ab for the detection of NK receptor positive
population of hepatic Vα24JαQ TCR cells was recommended by Doherty et al.
(1999).
It is generally accepted that α-GalCer tetramers stain only TCR invariant, Vα24+ in
human and Vα14+ in mice, NKT cells (Matsuda et al., 2000; Benlagha et al., 2000-
b). According to this, mouse thymus and liver CD4+ or DN NKT cells are α-GalCer-
reactive and are positively stained with CD1d tetramers. By contrast, CD1d-
independent CD8+ NK1.1+ T lymphocytes, present in mouse bone marrow and
spleen, do not express invariant TCR and do not bind to mCD1d-α-GalCer tetramer
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(Matsuda et al., 2000; Benlagha et al., 2000-b; Hammond et al., 2001). However,
some deviations from this rule have been observed. For example, Gadola et al.
suggested that the specific recognition of CD1d/α-GalCer in human can be mediated
by T cells expressing a TCR other than Vα24 and Vβ11 (Gadola et al., 2002).
According to Gadola, the population of PBMC-derived NKT cells is heterogenous
and may contain not only classical invariant Vα24+Vβ11+ NKT cells, but also
CD8α/β+ or CD4+ (but never CD4-CD8-) CD1d-α-GalCer specific Vα24- T cells
(Gadola et al., 2002). The subset of CD8α/β+ Vα24- T cells exhibited CD8-
dependent cytotoxicity, rarely expressed CD161 and expressed non-invariant TCR
(diverse TCRVα frequently paired with TCRVβ11) other than Vα24+, with low
affinity for α -GalCer-CD1d complex. Nevertheless, human CD8α/β+Vα24-
lymphocytes could be stained with CD1d-α-GalCer tetramer (Gadola et al., 2002).
The presence of these CD8αβ+ Vα24- tetramer-binding human NKT cells may be
surprising given that only T cell clones bearing Vα24+TCR were shown to be α-
GalCer-CD1d-reactive (Couedel et al., 1998).
In contrast to human CD8αβ+ NKT cells, introduced by Gadola and coworkers, rat
CD8+ NKT cells, tested in this thesis, coexpressed NKRP1A+ and did not have
specificity for α-GalCer-loaded mCD1d-tetramer. So, how do F344 rat CD8αβ+
NKRP1A+ cells correspond to human CD8αβ+ NKT cells?
Since human NKT cells may express TCR with other than Vα24+chain, which still
shows the specificity, although low, for α-GalCer-CD1d complex, it is likely that rat
CD8αβ+NKRP1A+ cells possessed analogous TCR. Therefore, at least two
hypothesis explaining the lack of mouse CD1d-α-GalCer tetramer binding to rat
liver or spleen dervived NKRP1A+ lymphocytes are possible. Firstly, rat CD8αβ+
NKRP1A+ lymphocytes, similarly to human CD8αβ+ NKT cells expressed α-
GalCer-reactive non-invariant TCR and therefore they could produce IL-4 and IFN-γ
when stimulated with α-GalCer in vitro. However, due to very low α-GalCer affinity
of this non-invariant TCR, rat CD8αβ+ NKRP1A+ cells could not be stained with
mouse CD1d-α-GalCer tetramer.
The second possibility, Vα14+ invariant TCR was expressed only by a small subset
of rat NKT cells (perhaps CD4+ cells), making detection of such cells with mCD1d-
α-GalCer tetramer infrequent.
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Alternatively, the lack of the mouse CD1d-α-GalCer tetramer binding to rat splenic
and hepatic TCR+NKRP1A+ lymphocytes could have been caused by the lack of
cross-reactivity of their TCR with mouse CD1d molecule. This hypothesis is
plausible only if the TCR of rat liver and spleen lympocytes had specificity only for
rat CD1d and was not able to recognise Ag presented by CD1d from other species.
In order to identify if rat TCR can recognise α-GalCer presented by mouse/rat
CD1d, the response of primary cells and TCRinv positive cell lines to α-GalCer
presented by mouse or rat CD1d+ APCs, in the presence or absence of blocking anti-
mouse and novel anti-rat CD1d mAbs, will be tested. Furthermore, the generation of
chimeric mouse/rat CD1d molecules will allow the identification of regions in the
rat/mouse CD1d sequence responsible for Ag presentation and the interaction with
TCRinv of mouse or rat origin. Both methods will help to better characterise the
model of the CD1d-α-GalCer-TCRinv interaction.
Additionally, since mCD1d-α-GalCer tetramer, which binds to human and mouse
NKT cells, seems to be of limited usage for the staining of rat cells, the generation of
rat CD1d-α-GalCer tetramers should be considered as a new tool for testing of the
differences in the recognition of α-GalCer–CD1d complexes by mouse and rat NKT
cells.
Because the population of rat NKRP1A+TCR+ cells was much smaller than the
population of mouse NKT cells, we took a few approaches to expand these cells in
vitro.
There are some reports presenting methods for the expansion of rare human or
rhesus macaque Vα24+ T cells by cultivating them with α-GalCer or α-GalCer
loaded APCs, and cytokines (Gansuvd et al., 2003; Takahashi et al., 2002; van der
Vliet et al., 2001; Maeda et al., 2001; Okai et al., 2002).
Additionally, rat NKRP1+α/βTCR+ cells could be successfully expanded using
syngeneic or xenogeneic bone marrow transplantation (BMT) models (Kaufman et
al., 1993) or by in vitro co-culture in the presence of MIP-1α (Knudsen et al., 1997).
Neither protocols for the expansion of rat NKRP1+TCR+ clones nor methods adapted
for the expansion of human NKT cells did work in our system. We were not able to
activate the proliferation of rat liver or spleen derived lymphocytes in vitro.
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It is well known that the in vivo or in vitro α-GalCer stimulation of mouse NKT cells
may trigger anergy (Fuji et al., 2002-1) or apoptotic death of these cells (Osman et
al., 2000; Leite-de-Moraes et al., 2000; Matsuda et al., 2000). Because α-GalCer
was used for stimulation and expansion of rat liver and splenic lymphocytes, an
apoptotic death triggered by coculture conditions could be the main reason why we
failed to expand these cells.
Since the expansion of rat NKRP1+TCR+ cells was not possible, we decided to
characterise their capability to produce cytokines upon Ag stimulation.
1.2. Stimulation of rat IHLs and splenocytes with α-GalCer in vitro
Human and mouse CD1d are not able to present pathogen-derived lipids but they
may efficiently present self lipid antigens to NKT cells (Porcelli et al., 1999;
Gumperz et al., 2000; Park et al., 1998-a; Joyce et al., 1998; Burdin et al., 1998).
Therefore, human, mouse, and macaque NKT cells, recognising self-lipid antigens in
vivo, can be stimulated with α-GalCer in various in vivo or in vitro systems. α-
GalCer as well as α-Glucosylceramide have been shown to selectively activate only
NKT cells, which express TCR invariant: Vα14/Vβ8.2 TCR in mice and
Vα24/Vβ11 TCR in humans (Kawano et al., 1997; Nieda et al., 1999; Spada et al.,
1998; Couedel et al., 1998; Porcelli et al., 1996).
The CD1d-restricted and TCRinv-dependent activation of NKT cells usually
stimulates their proliferation and cytokine secretion (Metelitsa et al., 2001; Nieda et
al., 1999; Spada et al., 1998; Brossay et al., 1998-c; Kawano et al., 1997). Activated
human and mouse NKT cells are able to produce various cytokines including IFN-γ,
TNF-α, GM-CSF, IL-2, IL-4, IL-5, IL-6, IL-10 and IL-13 (Kim et al., 2002-a;
Hayakawa et al., 1992; Burdin et al., 1999-a; Lee et al., 2002).
Since mouse NKT cells are activated upon α-GalCer stimulation, there was a need to
check whether rat NKRP1A+TCR+ cells possessed the same features.
Similar to mouse NKT cells or human CD1d-restricted clones cultured in vitro
(Gumperz et al., 2002), rat spleen or liver-derived lymphocytes were able to release
cytokines like IL-4 or IFN-γ in response to α-GalCer stimulation. However, it is not
clear if cytokines were produced by rat NKRP1+TCR+ cells or by other cells, present
105
in liver or spleen cell preparations. To determine the phenotype of cytokine
producing cells, the intracellular FACS staining of α-GalCer stimulated rat
lymphocytes will be performed.
F344 rat hepatic and splenic lymphocytes, when stimulated with α-GalCer in vitro,
produced both IL-4 and IFN-γ in Ag-dose dependent manner. Some background
levels of IFN-γ could be already detected for rat IHLs or splenocytes cultured in the
presence of medium or vehicle (DMSO). Since liver lymphocytes are known to be
very sensitive to stress, the long cell preparation and purification procedure could be
a source of stress triggering an unspecific IFN-γ production. Alternatively, this α-
GalCer-independent, unspecific IFN-γ production could be driven not by rat NKT
cells but rather by other cell types present in cell preparations. For instance, NK
cells, which are usually abundant in liver, may release large amounts of IFN-γ but
not IL-4 when triggered (Winnock et al., 1995). Furthermore, the detailed analysis
of cell types responsible for IFN-γ secretion in the response to in vivo stimulation
with α-GalCer showed that at least in mouse system, NK cells indeed served as the
major source of this cytokine (Carnaud et al., 1999). Therefore, it is very possible
that IFN-γ, detected in supernatants of rat liver or splenic lymphocytes incubated
with medium or vehicle was produced by NK cells present in the cell preparations
(Matsuda et al., 2000; Eberl et al., 2000).
When rat liver and splenic lymphocytes were stimulated with α-GalCer, the level of
IFN-γ in supernatants increased. The Ag-dependent IFN-γ production could be
driven by activated NKT cells alone or more possibly by NKT and NK cells
together. It is likely that especially in a long period culture, rat NKT cells were
activated as first and then they stimulated the IFN-γ production by NK cells. The last
hypothesis is in agreement with the fact that in natural in vivo situation both
populations are in constant “cross-talk” and they cooperatively affect immune
responses (Carnaud et al., 1999; Metelista et al., 2001; Eberl et al., 2000).
The phenotype of mouse NKT cells and their functions may vary in relation to the
presence of APCs, tissue distribution or culture and stimulation conditions.
Additionally, human Vα24+Vβ11+ T cells have been shown to be phenotypically and
functionaly even more heterogenous than mouse counterparts. However, the
stimulation of human and mouse NKT cells with α-GalCer (Brossay et al., 1998-c)
as well as usage of Vα14/Vα24+ TCR-specific CD1d-α-GalCer tetramers (Matsuda
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et al., 2000; Lee et al., 2002) allow the general classification of NKT cells according
to their cytokine secretion profile. Activated invariant CD4+tetramer+ T cells secrete
both Th1 (IFN-γ, TNF-α) and Th2 (IL-4, IL-5, IL-10, IL-13) cytokines and are
biased to Th0 phenotype, whereas DN NKT cells secrete mostly IFN-γ and TNF-α
and have Th1-like cytokine profile (Gumperz et al., 2002; Hammond et al., 1999;
Kim et al., 2002-a; Lee et al., 2002).
In contrast to human or mouse NKT cells, very little is known about the capacity of
rat invariant T cells to release cytokines. Among NKRP1+Vβ8.2+ TCR rat clones
generated upon in vitro culture with MIP-1α, the DN and CD4+ cells producing
diverse cytokines (IL-4, IL-2, IL-12, or IFN-γ)  could be distinguished (Knudsen et
al., 1997).
Tested in our system, F344 rat IHLs and splenocytes stimulated with α-GalCer in
vitro produced both IL-4 and IFN-γ, although IFN-γ seemed to be preferentially
secreted by rat hepatic lymphocytes. The preferential IFN-γ production was also
observed for rare human liver NKT cells (Takahashi et al., 2002; Kenna et al., 2003;
Exley et al., 2002). The hepatic CD161+, CD56+, and/or CD69+ CD8+ Vα24+Vβ11+
T cells, which exist as a minor NKT population, when stimulated with α-GalCer or
PMA/ionomycin, produce IFN-γ and TNF-α but not IL-2 or IL-4 (Kenna et al.,
2003; Takahashi et al., 2000). However, the dominant IFN-γ secretion by activated
F344 IHLs differs from results presented by Ohkawa, suggesting that rat CD8+NKT
cells in rat hepatic allografts preferentially produced IL-4 promoting the natural
tolerance (Ohkawa et al., 1999).
Several groups have reported that NKT cells produce cytokines in a developmental
and age-dependent manner (Benlagha et al., 2002). Immature mouse NK1.1- NKT
cells, as well as neonatal human cord blood NKT cells preferentially secrete IL-4,
while mature NKT cells are source of IL-4 and IFN-γ after polyclonal activation
(Pellicci et al., 2002; Kadowaki et al., 2001). The age-dependent increase in
cytokine production by mouse NKT cells upon α-GalCer stimulation has been also
reported (Inui et al., 2002). By contrast, the correlation between the age of animals
and the cytokine secretion pattern by NKT cells has never been tested in the rat
system. However, there are a few reports showing age-related changes in the
frequency of rat NKRP1A+ T lymphocytes. In an experimental model of chronic
marginal vitamine A status (the influence of vitamine A on ageing), the number and
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percentage of rat CD3interNKRP1dim cells in PBMC and spleen increased in older
animals (Dawson and Ross, 1999). This age-related increase in rat NKT cells
correlated with increased percentages of CD8+ T cells, confirming previous reports
by Brissette-Storkus et al. (1994), showing rat NKT cells to be CD8+ (Dawson and
Ross, 1999). The similar correlation between the number of mouse liver Vα14+NKT
cells and the age of animals has also been reported (Tsukahara et al., 1997). By
contrast, age-associated decreases in the percentage of human peripheral blood
Vα24+ cells have been described by others (DelaRosa et al., 2001).
To exclude the maturation-related differences in the frequency of NKT cells or
amounts of released cytokines, in all experiments animals of the same age were
used. Furthermore, cells prepared from male and female animals had the same
pattern of cytokines released. Therefore, we assume that the preferential IFN-γ
production by rat hepatic lymphocytes could not be a result of differences in the sex
or maturation stage of analysed animals.
To sum up, upon in vitro α-GalCer stimulation F344 rat liver and spleen derived
lymphocytes were able to release cytokines but it was difficult to define a correlation
between the phenotype of these cells and their cytokine secretion pattern.
Furthermore, since human hepatic lymphocytes have been reported to be
phenotypically and functionally more diverse than their mouse counterparts
(Doherty et al., 1999), it might be possible that the population of rat NKT cells is
heterogenous and consists of cells with different phenotype and cytokine production
capacities.
The level of cytokines produced by α-GalCer activated F344 rat liver and spleen-
derived T lymphocytes was usually lower than the levels of mouse cytokines. One
exception from this finding were rat IHLs, which seemed to be better IFN-γ
producers than their mouse counterparts. However, as it has been already discussed,
it is likely that this IFN-γ was secreted not by NKT but rather by other cells present
in liver preparations.
Since NKRP1A+TCR+ cells represented the only a minor subset of rat liver or spleen
lymphocytes, smaller amounts of secreted rat cytokines could be expected.
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Data from functional assays showed that the presence of CD1d in the culture was
required for efficient activation of rat intrahepatic and splenic lymphocytes. Total
splenocytes or preparations from rat liver contained some CD1d+ APCs. In the
absence of these APCs, the cytokine secretion was reduced. The same correlation
between the presence of CD1d and amounts of released cytokines has been
previously found in human and mouse CD1d-NKT cell systems (Fujii et al., 2003-b;
Exley et al., 1997; Kawano et al., 1997). Therefore, α -GalCer or α -
Glucosylceramide-pulsed DCs may be effectively used to induce the proliferation of
splenic Vα14Jα18 NKT cells (Kawano et al., 1997) or the activation and expansion
of human PBMC-derived Vα24+ NKT cells (Nieda et al., 1999; Fujii et al., 2003-b).
The cytokine secretion by human and mouse NKT cells depends on the tissue
location, stimulation conditions, cytokine balance in the microinveronment, as well
as cell-cell interactions (Ikarashi et al., 2001; Kawano et al., 1997; Yang et al.,
2003; Hayakawa et al., 2001).
Additionally, the cytokine profile and phenotype of NKT cells can be modulated by
APC from different tissues (Yang et al., 2003). Thus, mouse thymic NKT cells have
been shown to preferentially produce high amounts of IL-4, whereas splenic NKT
cells were better IFN-γ producers. These differences in the cytokine profiles
probably reflected the differences in the requirements of these cells for costimulatory
signals. According to this, CD8+ CD1d-independent splenic lymphocytes expressing
high level of NK cell markers produced high levels of IFN-γ and required both TCR
and CD28-mediated signals to be fully activated. By contrast, the engagement of
CD28 had no effect on the activation of CD1d-dependent thymic NKT cells, which
had an activated T cell phenotype and expressed low levels of NK cell markers
(Eberl et al., 1999-c; Yang et al., 2003).
Furthermore, the nature of Ag as well as the maturation status of APC may influence
the activation of NKT cells (Fujii et al., 2003-b). DCs have been shown to be
superior to monocytes as APCs for presenting α-GalCer and activating human NKT
cells. The maturation of DCs may further enhance NKT cell activation and cytokine
production (Fujii et al., 2003-b).
Since the NKT cell cytokine profile is strictly regulated by culture conditons, it
might be interesting to investigate whether different subpopulations of APCs present
in F344 rat liver and spleen may differently influence the cytokine secretion by rat
NKT cells. The usage of blocking anti-adhesion molecules or anti-cytokine
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antibodies will allow the definition of role CD40-CD40L (CD80/CD86-CD28)
costimulation and cytokines contribution in the activation of rat NKT cells.
Concluding, upon α-GalCer stimulation F344 rat liver and spleen-derived
lymphocytes were able to produce IL-4 and IFN-γ  in an Ag- and CD1d-dependent
manner. However, it remains to be determined whether rat NKRP1+TCR+ cells used
for stimulation are the same cells which produce cytokines and whether they express
invariant Vα14+ TCR. It is also not clear whether such activities found in vitro
represent the behaviour and features of rat Vα14+ T cells naturally present in vivo.
To this end, additional experiments with administration of α-GalCer in vivo would
be needed, but because of limited amounts of Ag they were not performed.
II. Characterisation of rat Vα14+TCR
Mouse and human NKT cells express α-GalCer-specific TCRinv. In order to
determine whether a homologous TCR might be expressed by F344 rat cells, the
frequency of lymphocytes expressing TCR with Vα14+Jα18+ rearrangement was
estimated by RT-PCR.
The Vα14+ signal was much weaker in rat than in mouse organs. It could be clearly
detected in rat liver and spleen but was hardly found in thymus and LN. This may
suggest that the population of Vα14+ TCR NKT cells does exist in F344 rat but is
much smaller than the population of mouse NKT cells. The low expression of
TRAV14 gene products in F344 rat liver, spleen and thymus was also reported by
Matsuura (Matsuura et al., 2000). The data from the RT-PCR analysis were
consistent with FACS staining results. Liver and spleen were organs, where rat
NKRP1A+TCR+ cells were the most frequent and the Vα14+ RT-PCR signal was the
strongest.
In addition to RT-PCR analysis more quantitative methods for the estimation of the
frequency of Vα14+ TCR NKT cells in different rat organs will be utilised in future.
When PCR products were cloned and analysed in terms of Vα14-JαC expression,
the Vα14Jα18 rearrangements could be detected but they were very rare.
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Furthermore, the rat Vα14-region could be joined not only with rat Jα18 region,
corresponding to mouse Jα18, but also with other diverse Jα-segments.
It has been postulated that Vα14Jα18 TCR is selected during T cell maturation and
therefore some differences in the expression of Vα14Jα18 rearrangements,
depending on maturation status, are possible in mice. The expression of Vα14Jα18
in CD4+CD8+ (about 50% of Vα14+ chain) immature thymocytes is low and become
high in mature single positive T cells (85% of Vα14+ chain) (Koseki et al., 1990). At
very early stages of the thymus maturation, the Vα14+ TCR may be joined with Jα
other than Jα18, and then the frequency of invariant Vα14Jα18 TCR expression
increases reaching maximum levels in adult animals at around 5-8 weeks after birth
(Koseki et al., 1991; Koseki et al., 1990).
However, because Vα14Jα18 α-chain was found in the spleen of athymic mice, it
has been suggested that Vα14Jα18 T cells may be positively selected in the
periphery (in BM, liver or intestine) without thymic influence (Makino et al., 1994).
Since F344 rat NKRP1+TCR+ cells were less frequent than mouse NKT cells, we
conclude that the subset of cells expressing Vα14+TCR should be also smaller and
the Vα14+PCR signal in rat organs might be weaker that this found in mouse tissues.
Therefore, the low number of rat clones expressing the right Vα14Jα18
rearrangement could be result of limited frequency of TCRinv-positive cells rather
than, as it was observed for mouse NKT cells, the differences correlated with the
thymic or extrathymic maturation.
2.1. Cloning of rat Vα14+ TCRinv
It has been reported that the expression of α/βTCRs in TCR-deficient recipient cells
may confer the specificity for Ag and CD1d isoforms (Grant et al., 1999). In this
thesis rat TCRinv was expresses in BWr/mCD28 cells and its α-GalCer reactivity was
tested in various in vitro functional assays. Unfortunately, none of two the cloned rat
TCRs corresponded to mouse TCRinv. The first rat Vα14+ TCR, obtained from F344
rat liver, was successfully expressed on the surface of BWr/mCD28 cells, however it
did not have specificity for α-GalCer.
The comparison of the rat liver Vα14+ TCR sequence with published rat and mouse
Vα14+ TCR sequences revealed the presence of three amino acid alterations. It is not
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clear whether these differences in the sequence were mutations or PCR errors and
whether they influenced α-GalCer-CD1d complex recognition. When compared to
published rat Vα14+ sequences, the cloned rat TCR contained lysine (K) instead of
arginine (R) at position 22 (1 according to IMGT). Since lysine 22 was also found in
the mouse Vα14+ TCR sequence, it is likely that this amino acid was not critical for
the Ag recognition.
The second “mutation”- the exchange of threonine for lysine at position 72 (51
according to IMGT) occurred in the CDR2 region of cloned rat Vα14+ TCR.
The amino acid composition of the CDR2 region is crucial for Αg recognition.
However, Sim et al. showed that some polymorphism in the mouse Tcra locus (a
three aa substitution in the CDR2 region between mouse TRAV11 alleles) does not
affect the interaction with the mCD1d/α-GalCer complex (Sim et al., 2003).
Matsuura et al. also reported that the CDR2 region (amino acids from 70 to 77) of
rat TCRinv contains some amino acid diversity. However, the threonine at position 72
is one of six amino acids which are conserved for TRAV14S1, TRAV14S2 and
TRAV14S4 sequences (Matsuura et al., 2000), implying that the appearance of K at
this position could negatively influence the α-GalCer-CD1d recognition by rat
TCRinv.
The third aa alteration in rat liver Vα14+ TCR sequence was found in the CDR3
region, in the position, where Vα and Jα segments are joined. The amino acid
sequence of Vα14TCR V-J-junction is conserved between species and is composed
of:
Human:         ICVVSDRGSTLGR
Rhesus macaque: ICVVSDRGSTLGK
Mouse:         ICVVSDRGSALGR
Rat:         ICVVSDRGSALGK (Kashiwase et al., 2003).
This homogeneity of CDR3 regions may suggest that the binding of lipid to CD1d
and their presentation to TCRinv are constant among various species (Matsuura et al.,
2000; Lantz and Bendelac 1994).
The nucleotide composition of V-J joining of mouse canonical TCRinv is well known.
The invariant TCR α gene, encoded by germline Vα14 and Jα18 segments, contains
one-nucleotide N region, in which any one of four nucleotides can be present,
resulting in the synthesis of glycine (Koseki et al., 1990; Shimamura et al., 2001;
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Lantz and Bendelac 1994; Shimamura et al., 1997). However, in some cases, alanine
or other residues can be expressed at this position. For instance, for NKT cells
generated by in vitro culture of fetal liver precursors, several sequences, in which the
3’-end codon of Vα14 (GGN) was converted to GCC, GCG, GTC or ATA, could be
found (Shimamura et al., 2001). The conversion from Gly to more hydrophobic
amino acid residues such as Ala, Val, or Ile did not alter the interaction between the
mouse TCR α-chain CDR3 region and CD1d (Shimamura et al., 1997; Shimamura
et al., 2001). Therefore, it has been postulated that the conversion from canonical
sequence may be a marker of the conversion from fetal to adult form. According to
this, the fetal-form sequence contains GCC, whereas in the adult-form GCG, GTC or
ATA at 3’ codon of Vα14-region can be found (Shimamura et al., 2001).
In contrast to mice, the rat germline sequence is unknown. The amino acid
composition of Vα14-Jα18 junction was predicted and could contain either alanine
(A) or valine (V) (Matsuura et al., 2000). Since, as discussed above, some amino
acid variability in Vα14Jα18 joining site of mouse Vα14TCR is possible, we
conclude that the third amino acid difference- the presence of valine at the Vα/Jα-
joining site of rat TCRinv probably could not be responsible for the lack of rat TCR
specificity for α-GalCer-CD1d complex.
The second rat Vα14 + TCR invariant was generated using molecular biology
methods. It possessed the amino acid sequence corresponding to germline sequences
but, for unknown reasons, it could not be successfully expressed on the surface of
BWr/mCD28 cell line. The new Vα14+ TCR could be paired with neither mouse nor
rat VβTCR chain. Because rat NKT clones generated by Knudsen preferentially
expressed Vβ8.2+ TCR, it is unlikely that rat Vα14+ TCR might be paired with other
than Vβ8.2 chain. Furthermore, rat Vβ8.2 and Vβ8.4 TCR, when expressed together
with mouse Vα14+ TCR, equally contributed to the recognition of α-GalCer-
rCD1d+APC complexes in vitro. Since both rat Vβ8 chains could be successfully
paired with mouse Vα14+ TCR, it was possible that the lack of surface expression of
rat TCRinv was due to the inability of Vα14+ TCR chain to combine with rat TCRβ-
chains.
The lack of the pairing of cloned rat Vα14+ TCR with rat Vβ8 TCR can be supported
by personal communication with H. U. Weltzien (Max-Planck-Institute for
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Immunobiology, Freiburg, Germany), who observed the same phenomenon in his
experimental system. The TCR of murine CD8+ CTL clone, specific for hapten TNP
was expressed in BW cell line. Only one (Vα17/Vβ16), from two possible TCR
rearrangements, could appear on the surface. The Vα3/Vβ16 combination
functionally expressed on CTLs could not be expressed at the surface of hybridoma
cells. However, the Vα3 TCR, which could not be transported to the surface in
combination with Vβ16 was successfully expressed with other unrelated TCR-β
chain. Therefore, it might be possible that similar to Weltzien’s observation, we
failed to express rat TCRinv because cloned Vα14+ TCR could not recognise a
particular CDR3 region of rat Vβ8.2 or Vβ8.4 TCR.
2.2. Stimulation of Vα14+ cell lines with α-GalCer
The high-affinity interaction of TCRinv with CD1d-α-GalCer (but not with unloaded
CD1d molecule) is stronger than that observed for α/βTCR–peptide-MHC class I
interaction (Cantu et al., 2003; Sidobre et al., 2002). The long half-life of CD1d-α-
GalCer-Vα14TCR complex creates optimal conditions for contacting of α- and β-
chain of TCRinv with CD1d and Ag, leading to efficient activation of NKT cells.
The mechanisms of α-GalCer recognition by TCRinv are not well known. It has been
reported that the α-chain of TCRinv is necessary but not sufficient without specific
Vβ chains for α-GalCer/CD1d recognition. The α-GalCer/CD1d reactivity can be
modulated by β-chain, which stabilises the interaction with an antigenic epitope (Gui
et al., 2001).
To show the specificity of TCRinv for α-GalCer, mouse Vα14+ cell lines were tested
in in vitro functional assays. When mock infected BWr/mCD28 cells were
stimulated with α-GalCer, some background level of IL-2 could be measured in
supernatants. Because these cells did not express TCR, as tested by FACS analysis,
they could not be triggered by Ag stimulation. By contrast, mouse thymocytes, used
in the assay as APCs, could be activated under stimulation conditions and by
themselves they could have been a source of cytokines. This observation is in
agreement with a finding, showing that mouse thymic NKT cells, which are
unresponsive to in vivo α-GalCer stimulation (which is incapable of reaching the
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thymus tissue) may be stimulated with this Ag in suspension culture, even in the
absence of exogenous APCs (Matsuda et al., 2000). Additionally, no IL-2 could be
detected in supernatants of CD1d-/- mouse thymic lymphocytes cultured with α-
GalCer, confirming above hypothesis.
When BWr/mCD28 cells transduced with mouse Vα14 TCR were stimulated with
α-GalCer-loaded CD1d+ mouse or rat thymocytes, some differences in amounts of
released IL-2, depending on TCR α/β-chain combination, could be observed.
It has been previously described that mouse Vα14+ TCR can be paired with random
(either Vβ8.2, Vβ7 or Vβ10) β-chains, and still maintain high specificity binding to
CD1d (Matsuda et al., 2001; Gui et al., 2001; Sidobre et al., 2002; Park et al., 1998-
b). We showed that TCR comprising mouse Vα14Jα18 chain and either mouse or rat
Vβ -chain (Vβ8.2 or Vβ8.4) could bind to α -GalCer-CD1d. However, the
recognition of Ag-CD1d complexes occurred with different avidity resulting in
different levels of IL-2 secretion.
In contrast to peptide-specific T cells, which show strong selection for CDR3β aa
(Wang et al., 1998), α-GalCer reactive T cells have polyclonal CDR3β sequences
(Matsuda et al., 2001). Furthermore, some aa diversity in CDR3β region of human
or mouse NKT cell TCR may be possible without influencing the CD1d-α-GalCer
interaction (Dellabona et al., 1994; Porcelli et al., 1996; Exley et al., 1997; Sidobre
et al., 2002). Thus, it is very likely that the Vα14+ TCR transgenic cells tested in this
thesis, even if they had various aa composition of the CDR3β regions, could be
activated and could secrete IL-2 in the response to α-GalCer/CD1d complex
stimulation.
It has been shown that the Vβ-chain may determine the affinity of TCRinv to the
physiologic self ligand or may regulate the specificity for α-GalCer by recognising a
sugar moiety of this antigen (Kawano et al., 1999; Burdin et al., 2000; Gui et al.,
2001; Sidobre et al., 2002). Furthermore, the TCRβ may be responsible not only for
T cell reactivity for mCD1 but also for certain selection mechanisms. For instance,
the transgenic expression of rearranged β-chain isolated from a thymus-derived
Vα14Jα18-expressing NK1.1+ T hybridoma promoted the positive selection of
thymocytes carrying canonical Vα14Jα18 α-chain and increased frequency of
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NK1.1+ T cells in the thymus of these TCR β-chain transgenic mice (Viret et al.,
2000). The influence of β-chain rearragements on the TCR sequence and specificity
of developing thymocytes has been also confirmed by Dudley et al. (1994).
Therefore, the results from in vitro functional assays as well as data presented by
others suggest that the β-chain of TCRinv may be much more critical for Ag
recognition as it has been previously appreciated. It might be possible that the Vβ-
chain influences the α-GalCer reactivity and IL-2 production by TCRinv positive
cells by discriminating between mouse and rat CD1ds. However, this hypothesis
needs to be confirmed and the mechanisms of the β-chain function and influence on
TCRinv specificity remain to be determined.
2.3. Tetramer staining of TCRinv transgenic cell lines
In order to confirm the specificity of cloned TCRinv for α-GalCer, BWr/mCD28 cells
expressing these receptors were stained with mCD1d-α-GalCer-tetramer. Because
tetramers themselves might form higher order oligomers (Klenerman et al., 2002), or
they might unspecifically bind to biotin or streptavidin labelled Abs, used for double
labelling, single colour staining was performed, to exclude unspecific binding. TCR
transgenic cells were stained with mCD1d-α-GalCer-tetramer PE and, in parallel,
with anti-mouse CD3 mAb, to control the level of the TCR expression.
As previously shown the tetramer staining is not restricted to particular Vα14Vβ
combinations. NKT cells with the Vα14+ TCR paired with diverse β-chains were
tetramer positive, while the staining hybridomas expressing Vα chains other than
Vα14+ with tetramer has been never observed (Matsuda et al., 2000).
In this thesis three mouse Vα14+ TCR transgenic cell lines expressing diverse Vβ-
chains were positive in mCD3 staining but they bound to mCD1d-α-GalCer-tetramer
with different avidity. The pattern of tetramer staining correlated with the capacity of
these cells to produce cytokines upon α-GalCer stimulation. TCR transgenic cell
lines secreting less IL-2 could bind to mouse tetramer with intermediate affinity,
even if they had a high level of CD3 expression, whereas good IL-2 producers were
very positive in both mCD3 and tetramer staining.
Presented data suggest that only mouse but not rat Vα14+ TCR transgenic cell lines
were fully functional and capable of cytokine secretion upon in vitro α-GalCer
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stimulation, as well as of binding to mCD1d-α-GalCer-tetramer. The cytokine
production correlated with the pattern of the tetramer staining and it was dependent
on the presence of CD1d+ APCs. BWr/mCD28 cells expressing rat liver Vα14+ TCR
were able to produce IL-2 upon Ab but not Ag stimulation and they did not have
reactivity to the mCD1d-α-GalCer-tetramer.
2.4. Comparison of IL-2 production by BWr/mCD28-Vα14+
transgenic cells and KT12 hybridoma in the response to α-GalCer
stimulation
KT12 hybridoma expressing canonical mouse Vα14Vβ8.2 TCR was used as positive
control in many of our experiments. This hybridoma was also a source of cDNA
used for cloning of mouse Vα14 and Vβ8.2 chains, done in parallel as a control for
the cloning of rat Vα14+ TCR invariant. Therefore, the Vα14Vβ8.2 TCR cloned
from KT12 hybridoma was expressed in BWr/mCD28 cells.
When KT12 hybridoma and BWr/mCD28 transgenic cells, both expressing the same
TCRinv, were stimulated with α-GalCer in vitro, some differences in amounts of
released IL-2 could be observed. KT12 hybridoma produced high amounts of IL-2 in
the response to α-GalCer presented by CD1d+ mouse/rat thymocytes and splenocytes
as well as by CD1d transgenic cell lines. In contrast, upon the same stimulation
conditions mouse Vα1 4 + TCR transgenic cells secreted much less IL-2 and
recognised α-GalCer, with different avidity, depending on APCs used for
stimulation.
NKT cells express inhibitory or/and stimulatory receptors, which keep the triggering
of activation in the check (Davodeau et al., 1997; Brossay et al., 1998-d). Thus, it is
likely that the differences in the level of secreted cytokines by KT12 and
BWr/mCD28 TCR transgenic cells might have reflected differences in the
expression level of their coreceptors.
BW cell line is known to be negative for NK inhibitory receptors. The expression of
other molecules may be down modulated. Therefore, in the absence of additional
receptors the costimulatory interactions were not strong enough to enhance the
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TCRinv-α-GalCer signal and therefore BWr/mCD28-mVα14+ transgenic cells
produced only limited amounts of IL-2 upon α-GalCer stimulation.
KT 12 hybridoma was generated by fusion of NK1.1+ T cell clone with BW5147αβ-
cells (Makowska et al., 2000). It has been shown that the expression of many
inhibitory receptors (like Ly49) on T hybridomas may be lost upon cell fusion
(Bendelac et al., 1995-c; Park et al., 1998-b). However, because NKT cells express
various NK markers and adhesion molecules, it is hard to believe that all these
receptors are lost during fusion. Therefore, we think that some of inhibitory and
activating receptors, absent on BWr/mCD28 cells, were still present on the surface
of KT12 cells and could positively influence triggering of the KT12 hybridoma
activation.
Concluding, the response of BWr/mCD28 cell line expressing mouse TCRinv and
KT12 hybridoma to α-GalCer-CD1d stimulation may have been different due to
differences in the expression level of their stimulatory/inhibitory receptors. KT12
hybridoma had low activation threshold and was able to recognise α-GalCer
presented by CD1d expressed at low level by thymocytes or splenocytes as well as
CD1d over-expressed in CD1d transgenic cell lines. The response of KT12
hybridoma to α-GalCer stimulation could be triggered easier than the response of
mVα14+ cell lines.
It has been shown that the lower activation threshold of T cell hybridomas may be
caused by the lack of inhibitory NK receptors, which are normally expressed by
freshly isolated NKT cells (Bendelac et al., 1997; Park et al., 1998-b). Therefore, the
comparison of the stimulatory/inhibitory receptors expression on freshly isolated
NKT cells, KT12 hybridoma and BWr/mCD28 transgenic cells, with their capability
to produce cytokine upon α-GalCer stimulation will allow the definition of optimal
conditions necessary for efficient activation of various Vα14+T cells.
2.5. Importance of CD80-CD28 costimulatory pathway in the
activation of Vα14+ cell lines
α-GalCer-mediated stimulation of mouse Vα14+ and human Vα24+ NKT cells is
CD1-d restricted and TCR/costimulatory molecule-dependent. CD1d and other
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molecules expressed by APCs as well as costimulatory receptors on NKT cells are
required for the activation of NKT cells and cytokine production (Kawano et al.,
1997; Hermans et al., 2003; Hayakawa et al., 2001; Kitamura et al., 1999). The
activation and proliferative responses of Vα14+NKT cells may be inhibited by
monoclonal antibodies against CD1d, B7, CTLA-4, CD28, CD40 or CD40L
(Kawano et al., 1997). Furthermore, experiments done on CD28 and CD40-deficient
mice showed that the response of NKT cells stimulated with α-GalCer in vitro or in
vivo could differ depending on which costimulatory pathway was involved
(Hayakawa et al., 2001). The blockade of CD28-CD80 interaction by anti-CD80 and
anti-CD86 mAbs inhibited IFN-γ and IL-4 production by splenic Vα14+ NKT cells,
while the inhibition of CD40-CD154 interaction influenced only the IFN-γ
production. Therefore, CD28-CD80 and CD40-CD154 stimulatory pathways seem
to be important for the regulation of Th1 and Th2 functions of NKT cells (Hayakawa
et al., 2001).
Interestingly, various subset of NKT cells may differ in their phenotype, cytokine
profiles and requirements for costimulatory signals, depending on the tissue
localisation, maturation state of APCs, or differences in the expression levels of
CD1d, CD86 or CD40 molecules (Yang et al., 2003; Fuji et al., 2002-2).
Since costimulation plays such a crucial role in the activation of human and mouse
NKT cells in vivo, we attempted to test if this situation could be mimicked in in vitro
system. Upon α-GalCer-CD1d stimulation BWr/mCD28 cells expressing mouse
TCRinv were able to produce IL-2 in Ag-dose dependent manner. To enhance the
response of these cells to α-GalCer, rat CD80 molecule was expressed together with
CD1d on the surface of P80 cell line. Over-expression of CD28 on BW and CD80
on APCs created optimal conditions for costimulation.
BWr/mCD28 cells expressing mouse TCRinv, stimulated with α-GalCer-loaded
P80rCD80CD1d transgenic cells, secreted IL-2 in a CD1d and CD80 dependent
manner. The incubation of these cells with anti-CD80 mAb inhibited the IL-2
production, suggesting that, similar to the situation in vivo, CD28-CD80 interaction
was necessary for efficient in vitro activation of Vα14+ cells. By contrast, the CD28-
CD80 costimulation was not so critical for activation KT12 hybridoma, since the IL-
2 production by hybridoma cells was decreased by anti-rat CD80 Ab only to some
extent. Therefore, the CD28-CD80 interaction seems to be not only one mechanism
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responsible for the activation of KT12 hybridoma. Other stimulatory or inhibitory
receptors present on hybridoma cells (as discussed earlier) could have probably
additionally contributed to the activation. One good candidate for such costimulatory
molecule might be NK1.1/NKRP1A. It has been shown that mouse NK1.1 and
human NKRP1A have costimulatory functions and their ligation may additionally
influence the cytokine secretion by human or mouse invariant NKT cells (Exley et
al., 1998; Arase et al., 1996). It would be interesting to check whether rat NKRP1A,
similarly to human NKRP1A or mouse NK1.1 may serve as a costimulatory
molecule or perhaps as alternative pathway for activation of rat NKT cells.
Furthermore, the determination of NKRP1A/NK1.1 as well as costimulatory
receptor expression levels on primary T cells and Vα14+ cell lines might be helpful
in the defining a molecular basis of their activation.
The in vitro model, used to test the role of CD28-CD80 interaction in the activation
of Vα14+ TCR cells, is rather artificial and does not represent the natural situation in
vivo, where several receptors are involved in Ag recognition and where there is
constant feed-back interaction between NKT cells and APCs (Gillessen et al., 2003;
Ikarashi et al., 2001), T (Hermans et al., 2003) and B cells (Kitamura et al., 1999;
Galli et al., 2003) or NK cells (Metelitsa et al., 2001; Carnaud et al., 1999).
Activated through TCRinv-α-GalCer-CD1d and CD28-CD80 stimulation, NKT
produce cytokines, which promote the IL-12 secretion by APCs (Kawamura et al.,
1998; Tomura et al., 1999) or induce upregulation of costimulatory molecules (like
CD86) on APCs (Fujii et al., 2003-a; Hermans et al., 2003). These interactions
between several molecules and cytokines, which usually accompany the activation
of NKT cells are missing in our in vitro system. Nevertheless using a cell line model
we were able to show that costimulation through CD28, which is required for the
activation of T cells (Chambers et al., 1997; Bennett et al., 1998) is also important
for the activation of NKT cells.
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III: Rat CD1d
3.1. Rat CD1d as Ag presenting molecule:
The CD1d molecule is expressed in various lymphoid and nonlymphoid rat organs
including spleen, thymus, liver, lung, kidney and skin (Kasai et al., 1997; Ichimiya
et al., 1994).
To confirm the co-localisation of both CD1d transcript and protein, the tissue
distribution of rat CD1d was analysed by Northern blot and RT-PCR analysis, in situ
hybridisation (IHS) or by immunohistochemistry (Ichimiya et al., 1994; Kasai et al.,
1997). In some of these techniques 1H1 and 3C11 rat anti-mouse CD1 mAbs were
used. However because of their reactivity with limited epitopes on rat CD1d, these
antibodies were successfully used in immonoblotting but failed to positively stain rat
thymocytes (Burke et al., 1994; Kasai et al., 1997). Similarly, 1H1 and 3C11 Abs
could not be used for flow cytometric or immunohistochemisric staining of human
thymic CD1d although they positively stained CD1d on transfected cells, B cells or
intestinal epithelial cells (Blumberg et al., 1991).
Since 1H1 and 3C11 anti-mouse CD1d antibodies appeared to be not cross-reactive
with rCD1d, another anti-mouse CD1d (clone 1B1) Ab was used for the
immunofluorescence staining of rat thymus or spleen derived T lymphocytes. 1B1
positively labelled mouse cells, used as control, but similarly to two other anti-
mouse CD1d antibodies, it did not show cross-reactivity with rat CD1d.
Additionally, the personal communication with Matsuura, who tested polyclonal and
monoclonal anti-mCD1d antibodies against rat CD1d transgenic cell lines, allows
the assumption that none of the commercially available anti-mouse CD1d antibodies
may be used for the FACS analysis of rat CD1d surface expression.
To confirm the presence of CD1d in rat organs and to elucidate the tissue
distribution, RT-PCR and cloning methods have been undertaken. In order to
characterise functions of rat CD1d, the capability of rat CD1d+ primary cells and
rCD1d transgenic cell lines to present Ag to Vα14+ cells were tested in detail. Since,
no anti-rat mAb is available we took attempts to generate such an antibody, as a tool
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for the determination of CD1d surface expression as well as for the identification of
mechanisms of α-GalCer recognition by rat NKT cells.
3.2. Cloning of rat CD1d
To closer characterise the CD1d-Ag-TCR interactions, rat CD1d was cloned. The
comparison of F344 rat bone marrow-derived rCD1d sequence with mouse
counterpart revealed that, similarly to data presented by Ichimiya et al. (1994), these
molecules were highly homologous, especially in their α-1 and α-2 domains.
Additionally, similar to mouse, the rat CD1d sequence contained in the cytoplasmic
tail a YXXZ- tyrosine targeting motif, required for endosomal localisation of CD1d
(Cernadas et al., 2003; Chiu et al., 2002; Brossay et al., 1998-d).
The high level of structural homology might have suggested that rat and mouse
CD1d molecules would also have the same functional features. Data from in vitro
assays showed that the activation of rat splenic and hepatic lymphocytes and their
cytokine secretion depended on the presence of CD1d+ APCs. Similarly,
BWr/mCD28 cells transduced with mouse TCRinv could produce IL-2 upon α-GalCer
stimulation but only when mouse or rat CD1d+ thymocytes were present in the
culture. This confirms that the CD1d naturally present on rat thymocytes and
splenocytes is expressed as a functional molecule able to present α-GalCer to
Vα14+TCR.
3.3. Presentation of α-GalCer by CD1d transgenic cells to KT12
hybridoma
NKT cells and cell lines with restricted Vα14Vβ8.2 TCR are able to recognise α-
GalCer presented by CD1d+ tissues or CD1d transfected cells (Brossay et al., 1998-
a; Burdin et al., 1998; Couedel 1998; Makowska et al., 2000). However, the CD1d
recognition is not limited only to NK1.1+ T cells. The CD1d-autoreactive
hybridomas expressing diverse TCR α-chain or hybridomas generated from CD4+ T
cells of MHC class II-deficient mice recognise CD1d and produce high amounts of
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cytokines but they do not show specificity for α-GalCer (Cardell et al., 1995;
Gumperz et al., 2000; Chiu et al., 1999; Makowska et al., 2000). Also in humans,
the pairing of the invariant Vα24 with Vβ11 is not absolutely required for CD1d
recognition. The expression of Vα24+ chain with other Vβs can generate CD1d-
reactive TCRs (Exley et al., 1997).
Because of high homology between human and mouse CD1d, mouse NKT cell
hybridomas produce IL-2 in the response to mCD1d or hCD1d loaded with Ag
(Brossay et al., 1998-a). By analogy, rat CD1d shows similarity with mouse CD1d
molecule and therefore we predicted that mouse KT12 hybridoma expressing
invariant Vα14Vβ8.2 TCR would have specificity for α-GalCer presented by rat
CD1d. To check this possibility, rat CD1d was expressed in different cell lines
which, after loading with α-GalCer, were used to stimulate Vα14+ KT12 hybridoma.
Autoreactive KT12 hybridoma, due to high self-presentation, could respond to α-
GalCer stimulation even in the absence of APCs. However, when rCD1d transgenic
cells were used as APCs, the amounts of IL-2 released by KT12 hybridoma
increased significantly in an Ag-dose dependent manner. Despite the fact that
transfectants had similar levels of CD1d expression, KT12 hybridoma produced
different amounts of IL-2 depending on the APCs used. These discrepancies in the
response of KT12 cells to α-GalCer stimulation might have reflected the differences
in organ or/and species origin of tested APCs (Kronenberg, 2002). However,
because KT12 hybridoma was able to recognise, although with different efficiency,
α-GalCer presented by CD1d transgenic cells of human, mouse and rat origin, the
diversity in the amounts of released IL-2 could be possibly caused by tissue rather
than species specificity. This finding is in agreement with data presented by Park,
who showed that mouse NKT cell hybridomas, when screened on mouse, rat and
human cell lines transfected with CD1d cDNA, could distinguish between CD1d
expressed by cells of distinct tissue types (Park et al., 1998-b). The high level of
tissue specificity of CD1d recognition might suggest that Vα14+ hybridomas
recognise diverse CD1d-bound ligands of cellular origin (Park et al., 1998-b;
Brossay et al., 1998-d). Alternativelly, the differences in the ability to recognise
CD1d, depending on tissue microenvironment, could reflect differences in CD1d
processing (Balk et al., 1994; Exley et al., 2000). In line with this, Makowska has
shown that the variability in the Vα14+ T hybridoma activation reflected the
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differences in the Ag-presenting mechanisms between the different APCs used
(Makowska et al., 2000).
Additionally, it could be possible that KT12 hybridoma by itself had some
preferences in CD1d recognition, conversely that CD1d transgenic cells had
different capabilities of α-GalCer presentation. Thus, the activation of KT12
hybridoma could be easier triggered by rCD1d expressed by professional “APCs”,
while CD1d transgenic cells unable to present Ag could not stimulate KT12
hybridoma. According to this, it is likely that the variability in the response of KT12
hybridoma to α-GalCer presented by different CD1d+ cell lines was caused by
differences in the Ag processing or/and the differences in the expression level of
costimulatory molecules.
Because the discrepancies in the responces of KT12 hybridoma to different APCs
were large, the interpretation of results was difficult. Therefore, in future
experiments the α-GalCer loaded CD1d transgenic cells will be used for stimulation
of various Vα14+ cells including mouse/rat NKT cells, Vα14+ transgenic cells lines
and KT12 hybridoma. Furthermore, to confirm the specificity of TCRinv for α -
GalCer, anti-mouse and novel anti-rat CD1d monoclonal antibodies will be used to
block the α-GalCer-dependent cytokine production.
3.4. Production of anti-rat CD1d mAb
Thymus and spleen are organs, where human, mouse or rat CD1d seem to be
constitutively expressed. However the level of CD1 expression might be
quantitatively different among species. It may also differ depending on the
sensitivity of the techniques used. (Brandbury et al., 1990; Balk et al., 1991).
Additionally, some heterogeneity in the level of the CD1d expression between
various tissues within one organism or even between various cells within the same
organ are possible. For instance, cortical thymocytes, which are predominantly
immature T cells, express high levels of CD1 protein during thymic development,
while medullary thymocytes are negative for CD1 staining (Brandbury et al., 1990;
Exley et al., 2000). Similarly, the CD1d in the spleen can be expressed at variable
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levels depending on the CD1d expression by different subsets of splenic
lymphocytes (Brossay et al., 1997).
To elucidate the tissue distribution of rat CD1d, we took an approach to produce
anti-rat CD1d monoclonal antibody.
Both mouse and rat splenic or thymic lymphocytes were positively stained with
culture supernatant from CD1d fusion hybridomas. The specificity of supernatants
for CD1d was confirmed in the staining of rCD1d transgenic cell lines (P80rCD1d,
RAJIrCD1d) and the staining of lymphocytes, isolated from CD1d-/- mouse. The
novel anti-rat CD1d mAb was cross-reactive, specifically recognising CD1d
expressed by rat and, to a lesser degree, by mouse thymocytes and splenocytes. This
might suggest that, similarly to a previous report (Kasai et al., 1997; Ichimiya et al.,
1994), the expression of CD1d on mouse lymphocytes may be lower than the
expression of CD1d on rat cells.
Furthermore, some tissue or inter-strain differences in the levels of CD1d expression
could be observed. Firstly, the expression of CD1d in LEW rat tissues seemed to be
higher than in F344 rat. Secondly, F344 and LEW thymocytes stained with fusion
supernatants were more positive than rat splenocytes (data not shown), suggesting
different levels of CD1d expression in these two rat tissues. This finding, however,
is in contrast to the staining of mouse cells, in which splenic APCs expressed
significantly higher levels of CD1d and CD86 than thymic APCs did (Yang et al.,
2003; Park et al., 1998-b).
To confirm the differences in CD1d distribution on the species, strain and tissue
levels, a purified, concentrated and titrated anti-rat CD1d monoclonal antibody will
be used. The rCD1d-specificity of this antibody will be further confirmed by
immunoprecipitation and Western-Blot techniques, as well as by
immunohistochemistry of CD1d+ tissues.
Data presented in the thesis imply that rat CD1d can be expressed as a functional
molecule able to present α-GalCer to Vα14+ cells. On the other hand, the activation
of TCRinv transgenic cell lines and to some extent KT12 hybridoma requires the
presence of CD1d and CD80 positive APCs. Therefore, the usage of anti-rat CD1d
mAb to block CD1-d-α-GalCer-TCRinv interaction will allow the determination of
CD1d expression, on primary rat or rCD1d transgenic cells, necessary for triggering
the acivation and IL-2 production by Vα14+ cells.
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Concluding, no anti-rat CD1d mAb has been available so far, although many
attempts in this direction have been undertaken. During this study 6 fusion
hybridomas, producing anti-rat CD1d specific monoclonal antibodies were generated
from CD1d-/- mice. Some of these antibodies are cross-reactive with mouse CD1d
and probably recognise different rat/mouse CD1d epitopes, which makes them a
precious tool for the comparison of CD1d expression in various mouse and rat
tissues/organs.
IV. The comparison of CD1d-α-GalCer-TCRinv system in
F344 and LEW rat
Mouse strains may differ in terms of NK1.1 expression (some of them express others
lack the NK1.1 molecule) and the frequency of NKT cells (Hammond et al., 2001).
It was possible that such variability would be also present among different rat
strains.
The F344/Crj and LEW/Crj- two rat strains of different genetic background were
compared in this thesis. When the distribution and the frequency of NKRP1A+TCR+
lymphocytes isolated from both strains were estimated by Vα14-specific RT-PCR,
the Vα14 TCR-positive PCR signal was much weaker in LEW than in F344 rat
organs. It remains to be determined whether the differences in the expression level of
Vα14 TCR-positive cells correlate with the differences in the frequency of F344 and
LEW NKT cells. Therefore, in addition to RT-PCR analysis the FACS staining of
F344 and LEW rat lymphocytes isolated from different organs will be performed.
Only α-GalCer has been postulated to be a specific Ag activating NKT cells. Other
lipid antigens, even if they bind to CD1d, are not antigenic and do not stimulate
Vα14+ cells (Sidobre et al., 2002; Naidenko et al., 1999). However, a chemical
analog of α-GalCer, called OCH has been recently described (Miyamoto et al.,
2001). This lipid has a shorter sphingosine base (C5 vs. C14) and acyl chain (C24
vs. C26) compared with α-GalCer, and has a different antigenic capacity to α-
GalCer. OCH used for stimulation of mouse NKT cells, was able to trigger
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preferential IL-4 and almost no IFN-γ production (Miyamoto et al., 2001). Since the
usage of two lipid antigens differentially influenced the cytokine secretion by mouse
NKT cells, we used α-GalCer and its chemical analog for stimulation of LEW and
F344 rat cells. When the capacities of F344 and LEW splenocytes to release
cytokines upon in vitro α-GalCer/OCH stimulation were tested, LEW lymphocytes
could respond only to a limited extent to α-GalCer but not OCH stimulation. By
contrast, F344 rat cells were more responsive to both  α-GalCer and OCH activation.
Interestingly, the stimulation of F344 rat splenocytes with OCH triggered the
secretion of both IL-4 and IFN-γ, not only IL-4 as was found by Miyamoto for
mouse NKT cells (Miyamoto et al., 2001). These discrepancies in the pattern of
released cytokines could reflect the differences in the stimulation protocols.
Additionally, it might be possible that mouse and rat NKT cells differ in their
response to OCH stimulation.
Rat has only one CD1 gene, however some polymorphism on the nucleotide level
among different rat strains can be present. A single nucleotide substitution, at codon
119, resulting in amino acid alteration (alanine into valine) has been described thus
generating two allelic CD1d forms. The alanine is expressed in seven rat strains
including F344Crj, while the valine can be found in other five strains, including
LEW/Crj (Katabami et al., 1998). Thus, according to this classification, F344 and
LEW express distinct allelic forms of CD1d.
The exchange of alanine to valine takes place within the α-2 domain of CD1d, which
together with the α-1 domain form antigen-binding groove. Therefore, it was
probable that LEW and F344 rat belonging to two different CD1d allelic groups
would have different capability of Ag presentation. However, when α-GalCer-
loaded F344 and LEW CD1d+ thymocytes or splenocytes were used for stimulation
of KT12 hybridoma, no differences in the response of KT12 hybridoma cells could
be observed. Furthermore, F344 and LEW thymocytes presented α-GalCer to
BWr/mCD28 cells expressing mouse Vα14+ TCR equally well. These results suggest
that F344 and LEW rat expressed two different allelic forms of CD1d but the aa
alteration did not influence α-GalCer presentation to Vα14+ cells.
Since CD1d+ APCs from both rat strains presented α-GalCer to Vα14+ cells as well
as mouse APCs did, we conclude that the differences in the CD1d-α-GalCer-TCRinv
system, observed between LEW and F344 rats, were probably caused by the
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differences in the frequency and functions of NKT cells. Mechanisms of α-GalCer
presentation by CD1d were the same in both rat strains. It remains to be determined
whether the differences in the proportions of NKT cells in LEW and F344 rat
correlate with the differences in their development and functions. Because the
population of Vα14+ NKT cells in LEW rat is possibly smaller than in F344 rat, it is
not clear if the smaller proportion of LEW NKT cells correlates with the higher
susceptibility of this rat strain to autoimunne diseases (like EAE) (Blankenhorn et
al., 1991). Nevertheless, the usage of α-GalCer stimulated rat NKT cells might
provide a new tool for treatment of EAE, experimental autoimmune uveitis (Shao et
al., 2003) and other immune disorders in animal models.
Additional experiments on rat strains other than LEW and F344 will allow the better
characterisation of rat NKT cell functions and their contribution in the regulation of
immunity.
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Summary:
Originally, NKT cells have been defined by their expression of T-cell receptor
(TCR) and NK cell markers NKRP1A in human and NK1.1 (NKRP1C) in mouse.
Most of these cells express CD1d-restricted TCR with a characteristic
rearrangement- Vα24JαQ/Vβ11 in human and Vα14Jα18/Vβ8.2 in mouse, and have
been implicated in playing an important role in first line defence and
immunoregulation. The subject of this thesis was the characterisation of the
hypothetical rat NKT cell population.
In the mouse system, CD1d-restricted NK1.1+ T cells represented around 30% of
intrahepatic and around 3% of splenic lymphocytes and could be visualised by
staining with α-GalCer-loaded mouse CD1d tetramer. Rat NKRP1A+TCR+ cells,
similar to mouse NKT cells, were predominantly expressed in the liver. However,
their frequency was around 5 fold lower than the frequency of mouse intrahepatic
lymphocytes. F344 rat NKT cells, in contrast to mouse CD4+ or DN NK1.1+ T
lymphocytes, were of CD8 rather than CD4 phenotype, and did not bind to mCD1d-
α-GalCer-tetramer.
Since human hepatic CD1d-restricted Vα24JQ+ T cells are not as frequent as their
mouse counterparts and may express CD8- a marker not expressed by mouse CD1d-
restricted cells, it is possible that the phenotype of F344 rat NKT cells corresponds
more to the phenotype of human than mouse NKT cells.
Similar to mouse NKT cells, F344 rat liver- and spleen-derived lymphocytes were
able to produce IL-4 and IFN-γ when stimulated with the synthetic ligand α-GalCer
in vitro. Therefore, the lack of binding of rat lymphocytes to mouse CD1d tetramer
could not be due to their inability to respond to α-GalCer.
To better characterise the reactivity of rat NKRP1A+TCR+ cells to α-GalCer, the rat
invariant TCR was analysed. RT-PCR of liver lymphocytes with Vα14-specific
primers and subsequent cloning revealed a much weaker PCR signal for rat
lymphocyte cDNA than for mouse cDNA. Furthermore the analysis of rat
AV14JA18 sequences showed that the rat Vα14+TCR invariant could be rearranged
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not only with AJ18 but also with other AJ segments. The low number of clones with
in frame Vα14Jα18 rearrangement could suggest that only a small proportion of
liver lymphocytes were CD1d restricted NKT cells.
Mouse and human NKT cells are able to recognise α-GalCer presented by the
CD1d-β2 microglobulin complex, leading to their activation, proliferation and
cytokine secretion. In order to compare the capacity of mouse and rat CD1d to
present α-GalCer, rat CD1d was cloned. Sequence analysis and functional tests in
vitro confirmed the structural and functional homology of rat CD1d with mouse
CD1d.
In parallel, to characterise the reactivity of rat NKRP1A+TCR+ cells to α-GalCer, rat
Vα14+TCR invariant was cloned and expressed in the TCR- T cell hybridoma
BWr/mCD28. Rat Vα14TCR +CD28 + transgenic cells secreted IL-2 upon
αTCR/CD3 antibody stimulation, but were not specific for α-GalCer. Such cells
were also negative in staining with mCD1d-α-GalCer tetramer. The lack of
reactivity to α-GalCer and the lack of binding to mouse tetramer were probably
caused by amino acid alterations, particularly at position 72 (51 according to IMTG
nomenclature) of cloned rat TCRinv. Reversal of these “alterations” using molecular
biology techniques was performed but the expression of this TCR on the surface of
BWr/mCD28 cells could not be achieved.
In contrast to rat TCRinv, mouse Vα14+TCR was fully functional and was specific for
mouse CD1d tetramer. KT12 hybridoma and BWr/mCD28 cells expressing mouse
TCRinv, when stimulated with α-GalCer presented by primary CD1d+ cells or rCD1d
transgenic cell lines, produced IL-2 in an Ag- and CD1d-dependent manner.
Transgenic lines expressing TCR comprising mouse Vα14 and rat Vβ8.4 responded
to α-GalCer presented by rat and mouse CD1d, and bound mCD1 tetramer. By
contrast, cell lines expressing TCR comprising mouse Vα14 and rat Vβ8.2
responded only to α-GalCer presented by rCD1d and bound weakly to mCD1d
tetramer. This suggests that germ line encoded regions of the β-chain (CDR2 or
CDR4) bind to species-specific determinants of CD1d. The cytokine secretion of the
cell lines was inhibited by anti-CD80 mAb, indicating the importance of CD80-
CD28 costimulation in their activation.
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To check whether rat NKT cells may exist in other rat strains, the frequency and
functions of NKRP1A+TCR+ in F344 and LEW rat were compared. F344 and LEW,
two rat strains expressing different allelic CD1d forms, varied slightly in the level of
CD1d expression, as assessed by staining with a newly generated CD1d specific
monoclonal antibody. By contrast, these rat strains differed in terms of α-GalCer
recognition. NKRP1A+TCR+ cells were less frequent in LEW than in F344 rats, and
did not respond to α-GalCer or the analogue OCH in vitro, a result which is of
special interest considering the susceptibility of LEW but not F344 rats to
experimentally induced organ specific autoimmune diseases.
In summary, the rat and mouse CD1d-invariant TCR systems show a high degree of
structural and functional homology, but it seems that invariant NKT cells in rat,
similar to such cells in human, occur at lower frequency than in mice. TCR
transgenic cell line species-specific patterns of CD1d α-GalCer reactivity will
provide a valuable tool for the mapping of CD1d/TCR contacts. Also monoclonal
antibodies specific for rat and mouse CD1d, generated in this study, provide
valuable tools to determine CD1d protein expression in various rat tissues and will
help to better characterise functions of CD1d-restricted rat T cells.
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Zusammenfassung
NKT Zellen wurden ursprünglich über die gleichzeitige Expresion eines T-
Zellantigenrezeptors (TZR) und den NK-Zellmarkern NKRP1A im Menschen bzw.
NK1.1. (NKRP1C) in der Maus definiert. In Mensch und Maus exprimieren die
meisten NKT Zellen CD1d restringierte TZR mit charakteristischen
Genumlagerungen- Vα24JαQ/Vβ11 im Menschen und Vα14Jα18/Vβb8.2 in der
Maus. Den NKT Zellen werden außerdem wichtige Funktionen in der „first line
defence“ und der Immunregulation zugesprochen. Gegenstand der Doktorarbeit war
die Charakterisierung eines hypothetischen Gegenstückes in der Ratte.
In der Maus wurden rund 30% der intrahepatischen Lymphozyten (IHL) und 3% der
Milzlymphozyten als CD1d restringierte NK T Zellen identifiziert und konnten
mittels α-GalCer beladenen Maus-CD1d Tetramer visualisiert werden. Wie in der
Maus wurden in der Ratte NKRP1A+TZR+ Zellen vorwiegend in der Leber
gefunden, waren aber fünfmal weniger häufig. F344 Ratten NKT Zellen waren
darüber hinaus im Gegensatz zu den CD4+ oder CD4-CD8- Maus NKT Zellen
meistens CD8 positiv und banden kein mCD1d Tetramer. Da in der menschlichen
Leber CD1d-restringierte Vα24JQ+ T Zellen ebenfalls viel seltener als in der Maus
sind, scheint es nun möglich, daß der Phänotyp der Ratten NKT Zellen eher dem des
Menschen als dem der Maus entspricht.
Ein Test der Fähigkeit von F344 Leber- und Milzlymphozyten nach Kultur mit α-
GalCer Cytokine zu produzieren, ergab ähnlich wie in der Maus eine Produktion von
IL-4 und IFN-γ. Aus diesem Grund kann eine fehlende Reaktivität von Ratten NKT
Zellen für α-GalCer nicht der Grund für eine fehlende mCD1d Tetramerbindung
sein.
Um die Reaktivität der NKRP1A+TZR+ Rattenzellen auf α-GalCer besser zu
verstehen, wurde der Ratten TZR analysiert. RT-PCR von Leberlymphozyten mit
Vα14-spezifischen Primern und die Analyse der klonierten PCR Produkte ergab ein
viel schwächeres Signal für Ratten als für Maus cDNA. Darüber hinaus zeigten
Sequenzanalysen, daß das Vα14 auch mit anderen J als dem für TCRinv typischem
Jα18 rearrangiert war. Die niedrige Anzahl von Vα14Jα18 „in frame“
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Umlagerungen legt Nahe, daß nur ein kleiner Anteil der Leber-lymphozyten CD1d
restringierte NKT Zellen sind.
Maus und humane NKT Zellen erkennen durch CD1d-β2m Komplexe präsentiertes
α-GalCer und reagieren mit Aktivierung, Proliferation und Cytokinproduktion. Um
die Fähigkeit von Maus und Ratten-CD1d α-GalCer zu präsentieren, zu testen,
wurde das CD1d Molekül der Ratte kloniert. Sequenzanlyse und funktionelle Tests
bestätigten die strukturelle und funktionelle Homologie des CD1d beider Spezies.
Gleichzeitig wurde zur Analyse der Reaktivität von NKRP1A+TZR+ Zellen auf α-
GalCer ein Ratten Vα14+ invarianter TZR kloniert und in einem TZR- T-
Zellhybridom (BWr/mCD28) exprimiert. Zellen die transgenen Ratten Vα14+TZR
und CD28 exprimierten, sezernierten IL-2 nach Stimulation mit αTZR/CD3
Antikörper aber zeigten keine Spezifität für α-GalCer. Die fehlende Reaktivität für
α-GalCer und die fehlende Bindung von mCD1-α-GalCer Tetramer waren
wahrscheinlich durch Aminosäuresubstitionen insbesondere an Position 71 (51 nach
IMGT Nomenklatur) der klonierten TZRα Kette begründet. Eine „Umkehrung“
dieser Änderung wurde mittels molekularbiologischer Techniken durchgeführt aber
Expression dieses TZR auf BWr/mCD28 wurde nicht erreicht.
Im Gegensatz zum invarianten Vα14+ Ratten TZR war der Maus Vα14+ TZR voll
funktional und spezifisch für mCD1d Tetramer. KT12 Hybridom und Maus TZRinv
exprimierende BWr/mCD28 Zellen wurden sowohl durch Ratten als durch Maus
CD1d präsentiertes α-GalCer aktiviert. Dasselbe galt für TZR, die eine Maus Vα14
TZR Kette und eine Ratten Vβ8.4 TZR Kette enthielten. Im Gegensatz hierzu
antworteten Linien mit mVα14 und Ratten Vβ8.2 nur auf durch Ratten und nicht auf
durch Maus CD1d präsentiertes α-GalCer und banden nahezu kein mCD1d
Tetramer. Dies legt Nahe, daß Keimbahn kodierte der β-Kettenbereiche (CDR2 oder
CDR4) speziesspezifische Bereiche des CD1d erkennen. Weiterhin wurde gefunden,
das die Zytokinsekretion der Zellinien durch CD80 spezifische monoklonale
Antikörper inhibiert wurde, was eine wichtige Rolle der CD80-CD28 Interaktion bei
der Aktivierung dieser Zellen nahelegt.
Um zu sehen ob NKT Zellen auch in anderen Rattenstämmen als F344 existieren,
wurde Häufigkeit und Funktion von NKRP1A+TZR+ Zellen in F344 und LEW
159
Ratten miteinander verglichen. F344 und LEW, zwei Rattenstämme die
unterschiedliche CD1d Allele tragen, zeigten in der Analyse mit einem neu
generierten rCD1d spezifischen monoklonalen Antikörper nur geringe Unterschiede
in der Expressionsstärke. Hingegen, unterschieden sich beide Stämme in der
Reaktivität für α-GalCer. NKRP1A+ Zellen waren in der LEW Ratte weniger häufig
als in der F344 Ratte und antworteten in vitro nicht auf α-GalCer oder sein
Analogon OCH. Ein Resultat, das insbesodere angesichts der besonderen
Empfänglichkeit von LEW Ratten für experimentell induzierte organspezifische
Autoimmunerkrankungen von besonderem Interesse ist.
Zusammgefasst kann gesagt werden, daß das Maus und Ratten CD1d/TZRinv NKT
Zellsystem hohe strukturelle und funktionale Homologie aufweist, aber daß es wie
im Menschen weniger invariante NKT Zellen in der Ratte als in der Maus gibt. TZR
transgene Zelllinien wiesen ein speziesspezifisches Muster in der α-GalCer
Erkennung auf, das für die Analyse von CDd/TZR-Kontaktbereichen von großem
Nutzen sein wird. Dasselbe gilt für den Ratten und Maus-CD1d-spezifischen
monoklonalen Antikörper, der im Rahmen der Studie generiert wurde. Dieser kann
bei der Charakterisierung der CD1d Proteinexpression in verschiedenen Geweben
und der besseren funktionellen Charakterisierung von CD1d restringierten T Zellen
der Ratte eingesetzt werden.
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